Section 54

EurekaMag Full Text Articles Chapter 53,613


Valea, F.A. 2007: Human papillomavirus testing for precancerous lesions of the cervix. North Carolina Medical Journal 68(2): 127-129
Grce, M.; Davies, P. 2008: Human papillomavirus testing for primary cervical cancer screening. Expert Review of Molecular Diagnostics 8(5): 599-605
Feldman, S. 2014: Human papillomavirus testing for primary cervical cancer screening: is it time to abandon Papanicolaou testing?. JAMA Internal Medicine 174(10): 1539-1540
Ghosh, S.K.; Choudhury, B.; Hansa, J.; Mondal, R.; Singh, M.; Singh, M.; Duttagupta, S.; Das, A.; Kumar, R.; Laskar, R.S.; Kannan, R.; Ghosh, P.R. 2011: Human papillomavirus testing for suspected cervical cancer patients from Southern Assam by fast-PCR. Asian Pacific Journal of Cancer Prevention: Apjcp 12(3): 749-751
Coupé, V.M.H.; Berkhof, J. 2008: Human papillomavirus testing improves follow-up after treatment for cervical intraepithelial neoplasia. Women's Health 4(2): 103-105
Castle, P.E.; Cremer, M. 2013: Human papillomavirus testing in cervical cancer screening. Obstetrics and Gynecology Clinics of North America 40(2): 377-390
Schache, A.; Croud, J.; Robinson, M.; Thavaraj, S. 2014: Human papillomavirus testing in head and neck squamous cell carcinoma: best practice for diagnosis. Methods in Molecular Biology 1180: 237-255
McGinley, K.F.; Hey, W.; Sussman, D.O.; Brown, G.A. 2011: Human papillomavirus testing in men. Journal of the American Osteopathic Association 111(3 Suppl 2: S26-S28
Rebolj, M.; Bonde, J.; Njor, S.H.; Lynge, E. 2011: Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. Bmj 342: D2757
Schiffman, M.; Wentzensen, N.; Wacholder, S.; Kinney, W.; Gage, J.C.; Castle, P.E. 2011: Human papillomavirus testing in the prevention of cervical cancer. Journal of the National Cancer Institute 103(5): 368-383
McKenna, M.; McMenamin, M.M. 2014: Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program. Cancer Cytopathology 122(9): 702-710
Kulasingam, S.L.; Rajan, R.; St Pierre, Y.; Atwood, C.Victoria.; Myers, E.R.; Franco, E.L. 2009: Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. Bmc Medicine 7: 69
Herbert, A.; Best, J.M.; Chana, P.; Ktori, E.; Nowicki, M.; Dunsmore, H.; Culora, G.; Arbyn, M.; Kubba, A.A. 2007: Human papillomavirus testing with conventional Pap smear screening in three inner London community clinics. Journal of Family Planning and Reproductive Health Care 33(3): 171-176
Covell, J.L.; Stoler, M.H. 2007: Human papillomavirus testing, vaccination, and gynecologic screening: fight or flight?. American Journal of Clinical Pathology 128(5): 726-728
Badaracco, G.; Venuti, A. 2007: Human papillomavirus therapeutic vaccines in head and neck tumors. Expert Review of Anticancer Therapy 7(5): 753-766
Morrow, M.P.; Yan, J.; Sardesai, N.Y. 2013: Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer. Expert Review of Vaccines 12(3): 271-283
Olsen, J.; Jepsen, M.R. 2010: Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark. International Journal of Technology Assessment in Health Care 26(2): 183-191
Rittà, M.; Landolfo, V.; Mazibrada, J.; De Andrea, M.; Dell'Oste, V.; Caneparo, V.; Peretti, A.; Giordano, C.; Pecorari, G.; Garzaro, M.; Landolfo, S. 2013: Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer. New Microbiologica 36(2): 133-144
Prescott, E.L.; Brimacombe, C.L.; Hartley, M.; Bell, I.; Graham, S.; Roberts, S. 2014: Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2. Journal of Virology 88(21): 12599-12611
Lace, M.J.; Anson, J.R.; Klussmann, J.P.; Wang, D.H.; Smith, E.M.; Haugen, T.H.; Turek, L.P. 2011: Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. Journal of Virology 85(4): 1645-1654
Bellone, S.; El-Sahwi, K.; Cocco, E.; Casagrande, F.; Cargnelutti, M.; Palmieri, M.; Bignotti, E.; Romani, C.; Silasi, D-Arin.; Azodi, M.; Schwartz, P.E.; Rutherford, T.J.; Pecorelli, S.; Santin, A.D. 2009: Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. Journal of Virology 83(13): 6779-6789
Mole, S.; Milligan, S.G.; Graham, S.V. 2009: Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. Journal of Virology 83(1): 357-367
Kim, M.-K.; Kim, H.S.; Kim, S.-H.; Oh, J.-M.; Han, J.Y.; Lim, J.M.; Juhnn, Y.-S.; Song, Y.-S. 2010: Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment. Biochemical Pharmacology 80(12): 1930-1935
Muto, V.; Stellacci, E.; Lamberti, A.G.; Perrotti, E.; Carrabba, A.; Matera, G.; Sgarbanti, M.; Battistini, A.; Liberto, M.C.; Focà, A. 2011: Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes. Journal of Virology 85(10): 5070-5080
Oh, J.-M.; Kim, S.-H.; Cho, E.-A.; Song, Y.-S.; Kim, W.-H.; Juhnn, Y.-S. 2010: Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells. Carcinogenesis 31(3): 402-410
Hao, M.; Wu, X.-z.; Wang, X.-l.; Bian, M.-l.; Liu, H.-t. 2009: Human papillomavirus type 16 E5 sequence evolution analysis. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(6): 452-454
Jabbar, S.; Strati, K.; Shin, M.K.; Pitot, H.C.; Lambert, P.F. 2010: Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice. Virology 407(1): 60-67
Cai, H.B.; Chen, C.C.; Ding, X.H. 2010: Human papillomavirus type 16 E6 gene variations in Chinese population. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 36(2): 160-163
Parroche, P.; Touka, M.; Mansour, M.; Bouvard, Véronique.; Thépot, Aélie.; Accardi, R.; Carreira, C.; Roblot, G.G.; Sylla, B.S.; Hasan, U.; Tommasino, M. 2011: Human papillomavirus type 16 E6 inhibits p21(WAF1) transcription independently of p53 by inactivating p150(Sal2). Virology 417(2): 443-448
Jong, J.E.; Jeong, K.W.; Shin, H.; Hwang, L.R.; Lee, D.; Seo, T. 2012: Human papillomavirus type 16 E6 protein inhibits DNA fragmentation via interaction with DNA fragmentation factor 40. Cancer Letters 324(1): 109-117
Williams, V.M.; Filippova, M.; Filippov, V.; Payne, K.J.; Duerksen-Hughes, P. 2014: Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. Journal of Virology 88(12): 6751-6761
Lee, T.-Y.; Kim, Y.-H.; Lee, K.-S.; Kim, J.-K.; Lee, I.-H.; Yang, J.-M.; Sung, M.-H.; Park, J.-S.; Poo, H. 2010: Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice. Cancer Immunology Immunotherapy: Cii 59(11): 1727-1737
McCloskey, R.; Menges, C.; Friedman, A.; Patel, D.; McCance, D.J. 2010: Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation. Journal of Virology 84(10): 5131-5139
Ramos, C.A.; Narala, N.; Vyas, G.M.; Leen, A.M.; Gerdemann, U.; Sturgis, E.M.; Anderson, M.L.; Savoldo, B.; Heslop, H.E.; Brenner, M.K.; Rooney, C.M. 2013: Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies. Journal of ImmunoTherapy 36(1): 66-76
McLaughlin-Drubin, M.E.; Huh, K.-W.; Münger, K. 2008: Human papillomavirus type 16 E7 oncoprotein associates with E2F6. Journal of Virology 82(17): 8695-8705
Park, J.W.; Nickel, K.P.; Torres, A.D.; Lee, D.; Lambert, P.F.; Kimple, R.J. 2014: Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 113(3): 337-344
Yu, Y.; Munger, K. 2013: Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis. Virology 446(1-2): 251-259
Srinivasan, M.; Taioli, E.; Ragin, C.C. 2009: Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis. Carcinogenesis 30(10): 1722-1728
Wang, Y.; Wang, A.; Jiang, R.; Pan, H.; Huang, B.; Lu, Y.; Wu, C. 2008: Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncology Reports 20(2): 333-339
Nam, K.; Kwak, J.; Kim, J.; Jeon, S. 2013: Human papillomavirus type 16 causes larger colposcopic lesions than other HPV types in patients with grade 3 cervical intraepithelial neoplasia. Journal of Lower Genital Tract Disease 17(1): 1-5
La Placa, M.; Venturoli, S.; Dika, E.; Saccani, E.; Rech, G.; Fanti, P.A. 2009: Human papillomavirus type 16 detected in four periungual squamous cell carcinomas from the same patient. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 144(2): 212-213
Hu, Y.; Zhu, Y.-Y.; Zhang, S.-H.; Zhu, H.; Shuai, C.-X. 2011: Human papillomavirus type 16 e6 gene variations in young Chinese women with cervical squamous cell carcinoma. Reproductive Sciences 18(4): 406-412
Schelhaas, M.; Ewers, H.; Rajamäki, M.-L.; Day, P.M.; Schiller, J.T.; Helenius, A. 2008: Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. Plos Pathogens 4(9): E1000148
Ma, Z.; Liu, L.; Zhang, F.; Yu, M.; Wang, K.; Luo, J.; Liu, K.; Chen, B.; Xu, L. 2009: Human papillomavirus type 16 exists in bacteria isolated from cervical cancer biopsies. Journal of International Medical Research 37(4): 1065-1074
Laniosz, V.; Dabydeen, S.A.; Havens, M.A.; Meneses, P.I. 2009: Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. Journal of Virology 83(16): 8221-8232
Hao, M.; Wang, X.-L.; Bian, M.-L.; Liu, H.-T. 2010: Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(1): 24-26
Marongiu, L.; Godi, A.; Parry, J.V.; Beddows, S. 2014: Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 26: 8-13
Yuan, H.; Ito, S.; Senga, T.; Hyodo, T.; Kiyono, T.; Kikkawa, F.; Hamaguchi, M. 2009: Human papillomavirus type 16 oncoprotein E7 suppresses cadherin-mediated cell adhesion via ERK and AP-1 signaling. International Journal of Oncology 35(2): 309-314
Fleury, M.J.J.; Touzé, A.; Coursaget, P. 2014: Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy. Molecular Biotechnology 56(5): 479-486
Shang, Q.; Wang, Y.; Fang, Y.; Wei, L.; Chen, S.; Sun, Y.; Li, B.; Zhang, F.; Gu, H. 2011: Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China. Journal of Clinical Microbiology 49(7): 2656-2663
Xiong, G.-W.; Yuan, Y.; Li, M.; Guo, H.-Y.; Zhang, X.-W. 2010: Human papillomavirus type 16 variant analysis of upstream regulatory region and E6, E7 oncogene from cervical cancer patients in Beijing. Yi Chuan 32(4): 339-347
Junes-Gill, K.; Sichero, L.; Maciag, P.C.; Mello, W.; Noronha, V.ân.; Villa, L.L. 2008: Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil. Journal of Medical Virology 80(9): 1639-1645
López-Revilla, R.én.; Pineda, M.A.; Ortiz-Valdez, J.; Sánchez-Garza, M.; Riego, L. 2009: Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosí City, Mexico. Infectious Agents and Cancer 4: 3
Xi, L.F.; Koutsky, L.A.; Castle, P.E.; Edelstein, Z.R.; Hulbert, A.; Schiffman, M.; Kiviat, N.B. 2010: Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections. Journal of Infectious Diseases 202(11): 1667-1670
Hanisch, R.A.; Cherne, S.L.; Sow, P.S.; Winer, R.L.; Hughes, J.P.; Feng, Q.; Gottlieb, G.S.; Toure, M.; Dem, A.; Kiviat, N.B.; Hawes, S.E. 2014: Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal. Cancer Epidemiology 38(4): 369-375
Custodio, A.; Ortega, L.; Sanz, G.; Sastre, J. 2011: Human papillomavirus type 16- associated primary squamous cell carcinoma of the rectum following cervical intraepithelial neoplasia. Medicina Clinica 136(5): 223-224
Croci-Torti, A.; Tamalet, C.; Segondy, M.; Dandurand, M.; Meunier, L.; Stoebner, P.-E. 2014: Human papillomavirus type 16-induced skin squamous cell carcinoma located on the groin of immunocompetent patients. British Journal of Dermatology 170(3): 753-754
Zhang, E.-Y.; Tang, X.-D. 2012: Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer. Asian Pacific Journal of Cancer Prevention: Apjcp 13(11): 5363-5369
Cheng, Y.-W.; Lee, H.; Shiau, M.-Y.; Wu, T.-C.; Huang, T.-T.; Chang, Y.-H. 2008: Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(15): 4705-4712
Xi, L.F.; Koutsky, L.A.; Castle, P.E.; Wheeler, C.M.; Galloway, D.A.; Mao, C.; Ho, J.; Kiviat, N.B. 2009: Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. Journal of the National Cancer Institute 101(3): 153-161
Ma, T.; Su, Z.; Chen, L.; Liu, S.; Zhu, N.; Wen, L.; Yuan, Y.; Lv, L.; Chen, X.; Huang, J.; Chen, H. 2012: Human papillomavirus type 18 E6 and E7 genes integrate into human hepatoma derived cell line Hep G2. Plos one 7(5): E37964
Arroyo Mühr, L.S.; Hultin, E.; Bzhalava, D.; Eklund, C.; Lagheden, C.; Ekström, J.; Johansson, H.; Forslund, O.; Dillner, J. 2015: Human papillomavirus type 197 is commonly present in skin tumors. International Journal of Cancer 136(11): 2546-2555
Handisurya, A.; Rieger, A.; Bankier, A.; Koller, A.; Salat, A.; Stingl, G.; Kirnbauer, R. 2007: Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy. British Journal of Dermatology 157(4): 788-794
Wanat, K.A.; Tyring, S.; Rady, P.; Kovarik, C.L. 2014: Human papillomavirus type 27 associated with multiple verruca within a tattoo: report of a case and review of the literature. International Journal of Dermatology 53(7): 882-884
Smith, J.L.; Campos, S.K.; Ozbun, M.A. 2007: Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. Journal of Virology 81(18): 9922-9931
Morandell, D.; Rostek, U.; Bouvard, V.; Campo-Fernández, B.; Fiedler, M.; Jansen-Dürr, P.; Zwerschke, W. 2008: Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression. Virology 379(1): 20-29
Rodrigues-Coutlée, C.; Archambault, J.; Money, D.; Ramanakumar, A.V.; Raboud, J.; Hankins, C.; Koushik, A.; Richardson, H.; Brassard, P.; Franco, E.L.; Coutlée, F.; Conners, J.; Grimshaw, R.; Haase, D.; Johnston, L.; Schlech, W.; Yuzicappi-Fayant, A.; Landis, S.; Smaill, F.; Wobeser, W.; Austin, T.; Hammerberg, O.; Ralph, T.; Coutlee, F.; Falutz, J.; Ferenczy, A.; Hankins, C.; Klein, M.; Labrecque, L.; Lapointe, N.; Lalonde, R.; Macleod, J.; Noel, G.; Perron, C.; Routy, J.-P.; Toma, E.; Touchie, C.; Victor, G.; Cote, L.; Senay, H.; Trottier, S.; Williams, K.; Piché, A.; Sandre, R.; Binder, L.; Keystone, D.; Phillips, A.; Rachlis, A.; Salit, I.; Wagner, C.; Raboud, J.; Blitz, S.; Walmsley, S.; Braitstein, P.; Burdge, D.; Harris, M.; Money 2013: Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 58(4): 660-665
Shimizu, A.; Tamura, A.; Abe, M.; Amano, H.; Motegi, S.; Nakatani, Y.; Hoshino, H.; Ishikawa, O. 2012: Human papillomavirus type 56-associated Bowen disease. British Journal of Dermatology 167(5): 1161-1164
Mendes Araújo, F.; dos Santos Gon, A.; Sichero, L.; Simão Sobrinho, J.ão. 2013: Human papillomavirus type 57 in generalized verrucosis without immunodeficiency. Journal of the American Academy of Dermatology 69(4): E189-E190
Danielewski, J.A.; Garland, S.M.; McCloskey, J.; Hillman, R.J.; Tabrizi, S.N. 2013: Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia. Plos one 8(5): E63892
Matsukura, T.; Mitsuishi, T.; Sugase, M.; Kawashima, M. 2010: Human papillomavirus type 7-associated condyloma. Dermatology 221(1): 5-8
Introcaso, C.E.; Rady, P.L.; He, Q.; Tyring, S.K.; Kovarik, C.L. 2012: Human papillomavirus type 73 associated with multiple cutaneous squamous cell carcinomas in an immunosuppressed patient. International Journal of Dermatology 51(6): 713-715
Guldbakke, K.K.; Brodsky, J.; Liang, M.; Schanbacher, C.F. 2008: Human papillomavirus type 73 in primary and recurrent periungual squamous cell carcinoma. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 34(3): 407-413
Oldak, M.; Maksym, R.B.; Sperling, T.; Yaniv, M.; Smola, H.; Pfister, H.J.; Malejczyk, J.; Smola, S. 2010: Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes. Journal of Virology 84(3): 1376-1386
Sperling, T.; Ołdak, M.; Walch-Rückheim, B.; Wickenhauser, C.; Doorbar, J.; Pfister, H.; Malejczyk, M.; Majewski, S.ła.; Keates, A.C.; Smola, S. 2012: Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. Plos Pathogens 8(7): E1002833
Wang, K.-L.; Wang, T.-Y.; Huang, Y.-C.; Lai, J.C.-Y.; Chang, T.-C.; Yen, M.-S. 2009: Human papillomavirus type and clinical manifestation in seven cases of large-cell neuroendocrine cervical carcinoma. Journal of the Formosan Medical Association 108(5): 428-432
Abalos, A.T.; Harris, R.B.; Nyitray, A.G.; Mitchell, A.; Thompson, P.A.; Giuliano, A.R.; Garcia, F. 2012: Human papillomavirus type distribution among heterosexual couples. Journal of Lower Genital Tract Disease 16(1): 10-15
Bekele, A.; Baay, M.; Mekonnen, Z.; Suleman, S.; Chatterjee, S. 2010: Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia. Tropical Medicine and International Health: Tm and Ih 15(8): 890-893
Menegazzi, P.; Barzon, L.; Palù, G.; Reho, E.; Tagliaferro, L. 2009: Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italy. Infectious Diseases in Obstetrics and Gynecology 2009: 198425
Li, N.; Franceschi, S.; Howell-Jones, R.; Snijders, P.J.F.; Clifford, G.M. 2011: Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. International Journal of Cancer 128(4): 927-935
Hoots, B.E.; Palefsky, J.M.; Pimenta, J.M.; Smith, J.S. 2009: Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. International Journal of Cancer 124(10): 2375-2383
Pista, A.; de Oliveira, C.F.; Lopes, C.; Cunha, M.J.ão.; Tavares, A.; Dias, M.; Rocha, E.én.; Telhado, M.d.C.ção.; Afonso, A.; Loureiro, M.; Horgan, C.; Marques, I.; Cortes, E.; Alegra, S.; Serra, M.d.C.; Lima, J.; Afonso, E.; Ladeíra, A.P.; Gonçalves, L.; Sobral, N.; Reforço, A.S.; Pacheco, M.A.ál.; Enriquez, J.é L.; Lagoa, A.ón.; Ribeiro, V.; Ferreira, L.; Cadilla, A.ón.J.ús.; Furtado, J.é M.; Rodrigues, J.; de Castro, P.V.; e Silva, A.ón.A.; Mota, F.; Moura, P.; da Silva, T.S.õe.; Jardim, O.; Nascimento, M.; Dacosta, A.; Borrego, J.; Fernandes, R.; Vitorino, A.; Paula, T.; Palma, F.át.; Paula, M.; Fatela, A.; Sobral, D.; Pereira, P.; Grilo, I.; Ambrosio, P.; Torrezão, I.; Biscaia, I.; Nunes, S.; Araújo, M.; Sâncio, S.; 2013: Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE Ii Study. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 23(3): 500-506
Quek, S.C.; Lim, B.K.; Domingo, E.; Soon, R.; Park, J.-S.; Vu, T.N.; Tay, E.H.; Le, Q.T.; Kim, Y.-T.; Vu, B.Q.; Cao, N.T.; Limson, G.; Pham, V.T.; Molijn, A.; Ramakrishnan, G.; Chen, J. 2013: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 23(1): 148-156
Munjal, K.; Adamson, C.S-C.; Rajendran, V.; Nandedkar, S.; Cooper, K.; Evans, M.F. 2014: Human papillomavirus type distribution in invasive cervical cancers from Madhya Pradesh: implications for vaccination programs in central India. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 33(5): 531-536
Bryant, D.; Rai, N.; Rowlands, G.; Hibbitts, S.; Jones, J.; Tristram, A.; Fiander, A.; Powell, N. 2011: Human papillomavirus type distribution in vulval intraepithelial neoplasia determined using PapilloCheck DNA Microarray. Journal of Medical Virology 83(8): 1358-1361
Bao, Y.-P.; Li, N.; Smith, J.S.; Qiao, Y.-L. 2008: Human papillomavirus type distribution in women from Asia: a meta-analysis. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 18(1): 71-79
Chen, A.C.-H.; McMillan, N.A.J.; Antonsson, A. 2008: Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure. Journal of General Virology 89(Part 11): 2891-2897
Yam, Y.; Chew, E.; Yang, L.; Chengchew, S.; Ding, M. 1995: Human papillomavirus type-16 DNA integration in nuclear matrix and chromosome scaffold associated DNA in a cervical-carcinoma cell-line. Oncology Reports 2(6): 1093-1096
Chen, W.; Zhang, X.; Molijn, A.; Jenkins, D.; Shi, J.-F.; Quint, W.; Schmidt, J.E.; Wang, P.; Liu, Y.-L.; Li, L.-K.; Shi, H.; Liu, J.-H.; Xie, X.; Niyazi, M.; Yang, P.; Wei, L.-H.; Li, L.-Y.; Li, J.; Liu, J.-F.; Zhou, Q.; Hong, Y.; Li, L.; Li, Q.; Zhou, H.-L.; Bian, M.-L.; Chen, J.; Qiao, Y.-L.; Smith, J.S. 2009: Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes and Control: Ccc 20(9): 1705-1713
Wang, H.; Qiao, Y.L. 2008: Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis. International Journal of Std and Aids 19(10): 680-684
Smith, J.S.; Backes, D.M.; Hoots, B.E.; Kurman, R.J.; Pimenta, J.M. 2009: Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstetrics and Gynecology 113(4): 917-924
Söderlund-Strand, A.; Kjellberg, L.; Dillner, J. 2014: Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia. Journal of Medical Virology 86(4): 634-641
Tachezy, R.; Smahelova, J.; Kaspirkova, J.; Salakova, M. 2013: Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. Plos one 8(11): E79156
Ding, X.; Liu, Z.; Su, J.; Yan, D.; Sun, W.; Zeng, Z. 2014: Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing. Journal of Medical Virology 86(11): 1937-1943
Park, J.-J.; Kim, S.-H.; Lee, J.H.; Lee, J.-B.; Yun, S.J. 2011: Human papillomavirus types 1, 16 and 18 detected in a lesion of verrucous carcinoma of the cheek. British Journal of Dermatology 165(3): 694-696
Xi, L.F.; Edelstein, Z.R.; Meyers, C.; Ho, J.; Cherne, S.L.; Schiffman, M. 2009: Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 18(9): 2507-2512
Zampronha, R.d.A.új.C.ão.; Freitas-Junior, R.; Murta, E.F.C.; Michelin, M.ár.A.; Barbaresco, A.A.; Adad, S.J.; Oliveira, A.M.d.; Rassi, A.B.; Oton, G.ór.J.B. 2013: Human papillomavirus types 16 and 18 and the prognosis of patients with stage i cervical cancer. Clinics 68(6): 809-814
Jayaprakash, V.; Reid, M.; Hatton, E.; Merzianu, M.; Rigual, N.; Marshall, J.; Gill, S.; Frustino, J.; Wilding, G.; Loree, T.; Popat, S.; Sullivan, M. 2011: Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral oncology 47(11): 1048-1054
Gnanamony, M.; Peedicayil, A.; Subhashini, J.; Ram, T.Samuel.; Christopher, S.; Gravitt, P.; Abraham, P. 2009: Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 19(8): 1415-1420
Keam, S.J.; Harper, D.M. 2008: Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix. Drugs 68(3): 359-372
Keam, S.J.; Harper, D.M. 2008: Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]: profile report. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 22(3): 205-208
Sutcliffe, S.; Viscidi, R.P.; Till, C.; Goodman, P.J.; Hoque, A.M.; Hsing, A.W.; Thompson, I.M.; Zenilman, J.M.; De Marzo, A.M.; Platz, E.A. 2010: Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 19(2): 614-618
King, C.M.; Johnston, J.S.; Ofili, K.; Tam, M.; Palefsky, J.; Da Costa, M.; Mathur, Y.; Barbosa, P. 2014: Human papillomavirus types 2, 27, and 57 Identified in plantar verrucae from HIV-positive and HIV-negative individuals. Journal of the American Podiatric Medical Association 104(2): 141-146
Takehara, K.; Toda, T.; Nishimura, T.; Sakane, J.; Kawakami, Y.; Mizunoe, T.; Nishiwaki, M.; Taniyama, K. 2011: Human papillomavirus types 52 and 58 are prevalent in uterine cervical squamous lesions from Japanese women. Pathology Research International 2011: 246936
Poynten, I.Mary.; Waterboer, T.; Jin, F.; Templeton, D.J.; Prestage, G.; Donovan, B.; Pawlita, M.; Fairley, C.K.; Garland, S.M.; Grulich, A.E. 2013: Human papillomavirus types 6 and 11 seropositivity: risk factors and association with ano-genital warts among homosexual men. Journal of Infection 66(6): 503-511
Wang, H.; Qiao, Y.-l. 2007: Human papillomavirus types and their related diseases. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 29(5): 678-684
Porras, C.; Rodríguez, A.C.; Hildesheim, A.; Herrero, R.; González, P.; Wacholder, S.; Burk, R.D.; Schiffman, M. 2009: Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 18(3): 863-865
Heard, I.; Tondeur, L.; Arowas, L.; Falguières, M.; Demazoin, M.-C.; Favre, M. 2013: Human papillomavirus types distribution in organised cervical cancer screening in France. Plos one 8(11): E79372
Firnhaber, C.; Sello, M.; Maskew, M.; Williams, S.; Schulze, D.; Williamson, A.-L.; Allan, B.; Lewis, D. 2011: Human papillomavirus types in HIV seropositive men with penile warts in Johannesburg, South Africa. International Journal of Std and Aids 22(2): 107-109
Guan, P.; Clifford, G.M.; Franceschi, S. 2013: Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies. International Journal of Cancer 132(1): 248-250
Usubütün, A.; Alemany, L.; Küçükali, T.ür.; Ayhan, A.; Yüce, K.; de Sanjosé, S.; Font, R.; Lloveras, B.; Klaustermeier, J.; Quint, W.; Muñoz, N.; Bosch, F.X. 2009: Human papillomavirus types in invasive cervical cancer specimens from Turkey. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 28(6): 541-548
Siegler, E.; Lahat, N.; Shiner, M.; Mackuli, L.; Aroudi, Y.; Shapiro, S.; Auslander, R.; Lavie, O. 2011: Human papillomavirus types in women with cervical cancer in Haifa District. Harefuah 150(11): 837
Arioz, D.T.; Altindis, M.; Tokyol, C.; Kalayci, R.; Saylan, A.; Yilmazer, M. 2009: Human papillomavirus typing and soluble interleukin-2 receptor levels in female sex workers with a negative cervical smear result. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 106(3): 210-212
Antonishyn, N.A.; Horsman, G.B.; Kelln, R.A.; Severini, A. 2009: Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy. Archives of Pathology and Laboratory Medicine 133(10): 1577-1586
Sturegård, E.; Johansson, H.; Ekström, J.; Hansson, B-Göran.; Johnsson, A.; Gustafsson, E.; Dillner, J.; Forslund, O. 2013: Human papillomavirus typing in reporting of condyloma. Sexually Transmitted Diseases 40(2): 123-129
Palm, M.D.; Tyring, S.K.; Rady, P.L.; Tharp, M.D. 2010: Human papillomavirus typing of verrucae in a patient with WHIM syndrome. Archives of Dermatology 146(8): 931-932
Tomson, N.; Sterling, J.; Ahmed, I.; Hague, J.; Berth-Jones, J. 2011: Human papillomavirus typing of warts and response to cryotherapy. Journal of the European Academy of Dermatology and Venereology: Jeadv 25(9): 1108-1111
Lin, C.-Y.; Chao, A.; Yang, Y.-C.; Chou, H.-H.; Ho, C.-M.; Lin, R.-W.; Chang, T.-C.; Chiou, J.-Y.; Chao, F.-Y.; Wang, K.-L.; Chien, T.-Y.; Hsueh, S.; Huang, C.-C.; Chen, C.-J.; Lai, C.-H. 2008: Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 42(4): 361-367
Shiau, M.-Y.; Fan, L.-C.; Yang, S.-C.; Tsao, C.-H.; Lee, H.; Cheng, Y.-W.; Lai, L.-C.; Chang, Y.-H. 2013: Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas. Plos one 8(1): E54423
Brotherton, J.Ml. 2014: Human papillomavirus vaccination. British Journal of Hospital Medicine 75 Suppl. 11: C165-C168
Kliewer, E.V.; Mahmud, S.M.; Demers, A.A.; Lambert, P. 2013: Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada. Vaccine 32(1): 33-38
Barbaro, B.; Brotherton, J.M.L.; Gertig, D.M. 2012: Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, Victoria. Medical Journal of Australia 196(7): 445
Brogly, S.B.; Perkins, R.B.; Zepf, D.; Longtine, J.; Yang, S. 2014: Human papillomavirus vaccination and cervical cytology in young minority women. Sexually Transmitted Diseases 41(8): 511-514
Mammas, I.; Stewart, J.; Hughes, A. 2010: Human papillomavirus vaccination and school nurses: a British survey. International Journal of Std and Aids 21(1): 73
Rysavy, M.B.; Kresowik, J.D.K.; Liu, D.; Mains, L.; Lessard, M.; Ryan, G.L. 2014: Human papillomavirus vaccination and sexual behavior in young women. Journal of Pediatric and Adolescent Gynecology 27(2): 67-71
Forster, A.S.; Marlow, L.A.V.; Stephenson, J.; Wardle, J.; Waller, J. 2012: Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine 30(33): 4939-4944
Roberts, S.A.; Brabin, L.; Stretch, R.; Baxter, D.; Elton, P.; Kitchener, H.; McCann, R. 2011: Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiology and Infection 139(3): 400-405
Klosky, J.L.; Foster, R.H.; Hodges, J.; Peasant, C.; Gamble, H.; McDermott, M.J.; Rao, P. 2012: Human papillomavirus vaccination and the primary prevention of cancer: implications for survivors of childhood cancer. Studies in Health Technology and Informatics 172: 33-42
Anonymous 2013: Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States. Mmwr. Morbidity and Mortality Weekly Report 62(29): 591-595
Stokley, S.; Jeyarajah, J.; Yankey, D.; Cano, M.; Gee, J.; Roark, J.; Curtis, R.C.; Markowitz, L. 2014: Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States. MMWR. Morbidity and mortality weekly report 63(29): 620-624
Ache, K.A.; Wallace, L.S. 2008: Human papillomavirus vaccination coverage on YouTube. American Journal of Preventive Medicine 35(4): 389-392
Hayashi, Y.; Mitsushita, J.; Netsu, S.; Konno, R. 2011: Human papillomavirus vaccination for prevention of cervical cancer. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(9): 1594-1598
Skinner, S.Rachel.; Garland, S.M.; Stanley, M.A.; Pitts, M.; Quinn, M.A. 2008: Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26?. Medical Journal of Australia 188(4): 238-242
Mehta, N.R.; Julian, P.J.; Meek, J.I.; Sosa, L.E.; Bilinski, A.; Hariri, S.; Markowitz, L.E.; Hadler, J.L.; Niccolai, L.M. 2012: Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers. Obstetrics and Gynecology 119(3): 575-581
Ouedraogo, N.; Müller, O.; Jahn, A.; Gerhardus, A. 2011: Human papillomavirus vaccination in Africa. Lancet 378(9788): 315-316
Svane, D. 2009: Human papillomavirus vaccination in Denmark. Ugeskrift for Laeger 171(13): 1088
Russell, M.; Raheja, V.; Jaiyesimi, R. 2013: Human papillomavirus vaccination in adolescence. Perspectives in Public Health 133(6): 320-324
Barroso, L.F.; Wilkin, T. 2011: Human papillomavirus vaccination in males: the state of the science. Current Infectious Disease Reports 13(2): 175-181
Klosky, J.L.; Gamble, H.L.; Spunt, S.L.; Randolph, M.E.; Green, D.M.; Hudson, M.M. 2009: Human papillomavirus vaccination in survivors of childhood cancer. Cancer 115(24): 5627-5636
Kim, J.J. 2008: Human papillomavirus vaccination in the UK. Bmj 337: A842
Astbury, K.; Turner, M.J. 2009: Human papillomavirus vaccination in the prevention of cervical neoplasia. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 19(9): 1610-1613
Juntasopeepun, P.; Davidson, P.M.; Suwan, N.; Phianmongkhol, Y.; Srisomboon, J. 2011: Human papillomavirus vaccination intention among young women in Thailand. Asian Pacific Journal of Cancer Prevention: Apjcp 12(12): 3213-3219
Krawczyk, A.L.; Perez, S.; Lau, E.; Holcroft, C.A.; Amsel, R.; Knäuper, Bärbel.; Rosberger, Z. 2012: Human papillomavirus vaccination intentions and uptake in college women. Health Psychology: Official Journal of the Division of Health Psychology American Psychological Association 31(5): 685-693
Capone, A.; Favato, G. 2012: Human papillomavirus vaccination is not exclusively a matter of price. PharmacoEconomics 30(5): 443-4; author reply 444-5
Weiss, T.W.; Zimet, G.D.; Rosenthal, S.L.; Brenneman, S.K.; Klein, J.D. 2010: Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 47(1): 3-11
Jim, C.C.; Lee, J.W.-Y.; Groom, A.V.; Espey, D.K.; Saraiya, M.; Holve, S.; Bullock, A.; Howe, J.; Thierry, J. 2012: Human papillomavirus vaccination practices among providers in Indian health service, tribal and urban Indian healthcare facilities. Journal of Women's Health 21(4): 372-378
Daley, M.F.; Crane, L.A.; Markowitz, L.E.; Black, S.R.; Beaty, B.L.; Barrow, J.; Babbel, C.; Gottlieb, S.L.; Liddon, N.; Stokley, S.; Dickinson, L.M.; Kempe, A. 2010: Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 126(3): 425-433
Sauvageau, C.; Kiely, M. 2010: Human papillomavirus vaccination program. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 7(4): 50-52
Lo, B. 2007: Human papillomavirus vaccination programmes. Bmj 335(7616): 357-358
Yasmin, S.; Gerberry, D.J.; Blower, S. 2011: Human papillomavirus vaccination programs and human immunodeficiency virus epidemics. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 53(8): 845-846
Dempsey, A.F.; Schaffer, S.E. 2011: Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines. Preventive Medicine 52(3-4): 268-269
Dorell, C.G.; Yankey, D.; Santibanez, T.A.; Markowitz, L.E. 2011: Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics 128(5): 830-839
Pérez Cachafeiro, S. 2007: Human papillomavirus vaccination strategies. Emerging Infectious Diseases 13(12): 1958-1959
Haug, C.J. 2008: Human papillomavirus vaccination--reasons for caution. New England Journal of Medicine 359(8): 861-862
Klein, K.; Luedtke, S. 2008: Human papillomavirus vaccination: a case for mandatory immunization?. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 13(1): 47-50
Palmer, A.K.; Harris, A.L.; Jacobson, R.M. 2014: Human papillomavirus vaccination: a case study in translational science. Clinical and Translational Science 7(5): 420-424
Alameda González, César.; de Lorenzo-Cáceres Ascanio, A. 2008: Human papillomavirus vaccination: attitude to a consultation on a therapeutic novelty. Atencion Primaria 40(4): 205-208
Schim van der Loeff, M.F.; Giuliano, A.R. 2012: Human papillomavirus vaccination: component of an integrated HIV prevention program?. Aids 26(17): 2251-2252
Gattoc, L.; Nair, N.; Ault, K. 2013: Human papillomavirus vaccination: current indications and future directions. Obstetrics and Gynecology Clinics of North America 40(2): 177-197
Peigue-Lafeuille, H. 2007: Human papillomavirus vaccination: differing views and issues at stake. La Revue de Medecine Interne 28(12): 805-809
Markowitz, L.E.; Dunne, E.F.; Saraiya, M.; Chesson, H.W.; Curtis, C.Robinette.; Gee, J.; Bocchini, J.A.; Unger, E.R. 2014: Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mmwr. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports 63(Rr-05): 1-30
Leyland, E. 2008: Human papillomavirus vaccination: stabbing in the dark?. Lancet 372(9639): 614
Howell-Jones, R. 2007: Human papillomavirus vaccination: the United Kingdom s recommendation and update on European licensure and efficacy data. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 12(11): E071115.4
Pernas, S.; Tolaney, S.M.; Winer, E.P.; Goel, S. 2018: CDK4/6 inhibition in breast cancer: current practice and future directions. Therapeutic Advances in Medical Oncology 10: 1758835918786451
Brotherton, J.M.L. 2014: Human papillomavirus vaccination: where are we now?. Journal of Paediatrics and Child Health 50(12): 959-965
Garland, S.M. 2011: Human papillomavirus vaccination: where to now?. Sexually Transmitted Infections 87(Suppl 2): Ii23-Ii24
Stupiansky, N.W.; Rosenthal, S.L.; Wiehe, S.E.; Zimet, G.D. 2010: Human papillomavirus vaccine acceptability among a national sample of adult women in the USA. Sexual Health 7(3): 304-309
Madhivanan, P.; Li, T.; Srinivas, V.; Marlow, L.; Mukherjee, S.; Krupp, K. 2014: Human papillomavirus vaccine acceptability among parents of adolescent girls: obstacles and challenges in Mysore, India. Preventive Medicine 64: 69-74
Gerend, M.A.; Barley, J. 2009: Human papillomavirus vaccine acceptability among young adult men. Sexually Transmitted Diseases 36(1): 58-62
Bodurka, D.C.; Schlumbrecht, M.P. 2010: Human papillomavirus vaccine acceptability: is multimedia education ready for prime time?. Gynecologic Oncology 118(2): 101-102
Belani, H.K.; Sekar, P.; Guhaniyogi, R.; Abraham, A.; Bohjanen, P.R.; Bohjanen, K. 2014: Human papillomavirus vaccine acceptance among young men in Bangalore, India. International Journal of Dermatology 53(11): E486-E491
Malo, T.L.; Staras, S.A.S.; Bynum, S.A.; Giuliano, A.R.; Shenkman, E.A.; Vadaparampil, S.T. 2014: Human papillomavirus vaccine administration among Medicaid providers who consistently recommended vaccination. Sexually Transmitted Diseases 41(1): 24-28
Cui, Y.; Baldwin, S.B.; Wiley, D.J.; Fielding, J.E. 2010: Human papillomavirus vaccine among adult women: disparities in awareness and acceptance. American Journal of Preventive Medicine 39(6): 559-563
Dempsey, A.F.; Zimet, G.D. 2008: Human papillomavirus vaccine and adolescents. Current Opinion in Obstetrics and Gynecology 20(5): 447-454
Oaknin, A.; Barretina, M.Pilar. 2008: Human papillomavirus vaccine and cervical cancer prevention. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 10(12): 804-811
McIntosh, J.; Sturpe, D.A.; Khanna, N. 2008: Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists. Journal of the American Pharmacists Association: Japha 48(1): E1
Stupiansky, N.W.; Alexander, A.B.; Zimet, G.D. 2012: Human papillomavirus vaccine and men: what are the obstacles and challenges?. Current Opinion in Infectious Diseases 25(1): 86-91
Narducci, A.; Einarson, A.; Bozzo, P. 2012: Human papillomavirus vaccine and pregnancy. Canadian Family Physician Medecin de Famille Canadien 58(3): 268-269
Liddon, N.C.; Leichliter, J.S.; Markowitz, L.E. 2012: Human papillomavirus vaccine and sexual behavior among adolescent and young women. American Journal of Preventive Medicine 42(1): 44-52
Wang, S-Ming.; Zhang, S-Kai.; Pan, X-Fei.; Ren, Z-Fang.; Yang, C-Xia.; Wang, Z-Zhen.; Gao, X-Hong.; Li, M.; Zheng, Q-Qing.; Ma, W.; Zhao, F-Hui.; Qiao, Y-Lin.; Sivasubramaniam, P. 2014: Human papillomavirus vaccine awareness, acceptability, and decision-making factors among Chinese college students. Asian Pacific journal of cancer prevention: APJCP 15(7): 3239-3245
Bhatta, M.P.; Phillips, L. 2015: Human papillomavirus vaccine awareness, uptake, and parental and health care provider communication among 11- to 18-year-old adolescents in a rural Appalachian Ohio county in the United States. Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association 31(1): 67-75
Mullins, T.L.Kowalczyk.; Griffioen, A.M.; Glynn, S.; Zimet, G.D.; Rosenthal, S.L.; Fortenberry, J.Dennis.; Kahn, J.A. 2013: Human papillomavirus vaccine communication: perspectives of 11-12 year-old girls, mothers, and clinicians. Vaccine 31(42): 4894-4901
Yuji, K.; Matsumura, T.; Miyano, S.; Tsuchiya, R.; Kami, M. 2010: Human papillomavirus vaccine coverage. Lancet 376(9738): 329
Brotherton, J.M.L.; Murray, S.L.; Hall, M.A.; Andrewartha, L.K.; Banks, C.A.; Meijer, D.; Pitcher, H.C.; Scully, M.M.; Molchanoff, L. 2013: Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Medical Journal of Australia 199(9): 614-617
Eberth, J.M.; Hossain, M.Monir.; Tiro, J.A.; Zhang, X.; Holt, J.B.; Vernon, S.W. 2013: Human papillomavirus vaccine coverage among females aged 11 to 17 in Texas counties: an application of multilevel, small area estimation. Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 23(2): E131-E141
Taylor, L'shan.D.; Hariri, S.; Sternberg, M.; Dunne, E.F.; Markowitz, L.E. 2011: Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Preventive medicine 52(5): 398-400
Breitkopf, C.R.; Pearson, H.C.; Dinh, T.A.; Tran, B.-C.T.; Vu, T.; Phan, G.A.B.; Ngo, Q.V.; Tran, V.D.; Rosenthal, S.L. 2009: Human papillomavirus vaccine decision-making in da Nang, Vietnam: perceived spousal and adolescent-parent concordance. Vaccine 27(17): 2367-2371
LaMontagne, D.Scott.; Barge, S.; Le, N.Thi.; Mugisha, E.; Penny, M.E.; Gandhi, S.; Janmohamed, A.; Kumakech, E.; Mosqueira, N.Rocio.; Nguyen, N.Quy.; Paul, P.; Tang, Y.; Minh, T.Hung.; Uttekar, B.Patel.; Jumaan, A.O. 2011: Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bulletin of the World Health Organization 89(11): 821-830b
McRee, A-Laurie.; Gottlieb, S.L.; Reiter, P.L.; Dittus, P.J.; Tucker Halpern, C.; Brewer, N.T. 2012: Human papillomavirus vaccine discussions: an opportunity for mothers to talk with their daughters about sexual health. Sexually Transmitted Diseases 39(5): 394-401
Smith-McCune, K.K. 2008: Human papillomavirus vaccine efficacy: aligning expectations with reality. Gynecologic Oncology 111(1): 1-2
Finn, O.J.; Edwards, R.P. 2009: Human papillomavirus vaccine for cancer prevention. New England Journal of Medicine 361(19): 1899-1901
Anonymous 2007: Human papillomavirus vaccine for children and adolescents. Paediatrics and Child Health 12(7): 599-610
Kriescher, M. 2007: State workplace wellness initiatives. Ncsl Legisbrief 15(26): 1-2
Mayer, A.P.; Vegunta, S.; Files, J.A. 2012: Human papillomavirus vaccine for women over forty: it's not just for kids. Journal of Women's Health 21(9): 982-983
Etter, D.J.; Zimet, G.D.; Rickert, V.I. 2012: Human papillomavirus vaccine in adolescent women: a 2012 update. Current Opinion in Obstetrics and Gynecology 24(5): 305-310
Clothier, H.J.; Lee, K.J.; Sundararajan, V.; Buttery, J.P.; Crawford, N.W. 2013: Human papillomavirus vaccine in boys: background rates of potential adverse events. Medical Journal of Australia 198(10): 554-558
Goldstein, M.A. 2008: Human papillomavirus vaccine in males. New England Journal of Medicine 359(8): 863-864
Pellegrino, P.; Carnovale, C.; Perrone, V.; Salvati, D.; Gentili, M.; Antoniazzi, S.; Clementi, E.; Radice, S. 2014: Human papillomavirus vaccine in patients with systemic lupus erythematosus. Epidemiology 25(1): 155-156
Tsu, V.Davis.; LaMontagne, D.Scott. 2012: Human papillomavirus vaccine inaccuracies. American journal of public health 102(3): 389-90; author reply 390
Ratanasiripong, N.T. 2014: Human papillomavirus vaccine increases high-risk sexual behaviors: a myth or valid concern. Journal of School Nursing: the Official Publication of the National Association of School Nurses 30(6): 456-463
Guerry, S.L.; De Rosa, C.J.; Markowitz, L.E.; Walker, S.; Liddon, N.; Kerndt, P.R.; Gottlieb, S.L. 2011: Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 29(12): 2235-2241
Lu, P-Jun.; Williams, W.W.; Li, J.; Dorell, C.; Yankey, D.; Kepka, D.; Dunne, E.F. 2013: Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey. American Journal of Preventive Medicine 44(4): 330-338
Gottlieb, S.L.; Brewer, N.T.; Sternberg, M.R.; Smith, J.S.; Ziarnowski, K.; Liddon, N.; Markowitz, L.E. 2009: Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 45(5): 430-437
Patel, D.A.; Zochowski, M.; Peterman, S.; Dempsey, A.F.; Ernst, S.; Dalton, V.K. 2012: Human papillomavirus vaccine intent and uptake among female college students. Journal of American college health: J of ACH 60(2): 151-161
Crosby, R.A.; DiClemente, R.J.; Salazar, L.F.; Nash, R.; Younge, S.; Head, S. 2012: Human papillomavirus vaccine intention among college men: what's oral sex got to do with it?. Journal of American college health: J of ACH 60(1): 8-12
Wheldon, C.W.; Buhi, E.R.; Daley, E.M.; Hernandez, N.D.; Anstey, E.H.; Kolar, S.; Giuliano, A.R. 2015: Human papillomavirus vaccine intentions among males: a test of the Parallel Processing Model. Journal of Health Psychology 20(4): 427-437
Daley, E.M.; Marhefka, S.L.; Buhi, E.R.; Vamos, C.A.; Hernandez, N.D.; Giuliano, A.R. 2010: Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sexually Transmitted Diseases 37(10): 644-652
Nghi, N.Q.; Lamontagne, D.S.; Bingham, A.; Rafiq, M.; Mai, L.T.P.; Lien, N.T.P.; Khanh, N.C.; Hong, D.T.; Huyen, D.T.T.; Tho, N.T.T.; Hien, N.T. 2010: Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sexual Health 7(3): 262-270
Jit, M.; Demarteau, N.; Elbasha, E.; Ginsberg, G.; Kim, J.; Praditsitthikorn, N.; Sinanovic, E.; Hutubessy, R. 2011: Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models. Bmc Medicine 9: 54
Markowitz, L.E.; Tsu, V.; Deeks, S.L.; Cubie, H.; Wang, S.A.; Vicari, A.S.; Brotherton, J.M.L. 2012: Human papillomavirus vaccine introduction--the first five years. Vaccine 30(Suppl 5): F139-F148
Dekker, R.L. 2008: Human papillomavirus vaccine legislation in Kentucky: a policy analysis. Policy Politics and Nursing Practice 9(1): 40-49
Anonymous 2011: Human papillomavirus vaccine misconception could mean women do not attend screening, putting them at risk of cervical cancer. ImmunoTherapy 3(9): 1026
Laemmle-Ruff, I.; Barbaro, B.; Brotherton, J. 2013: Human papillomavirus vaccine national catch-up program - insights into under-notification. Australian Family Physician 42(12): 880-884
Kepka, D.; Berkowitz, Z.; Yabroff, K.R.; Roland, K.; Saraiya, M. 2012: Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?. Sexually Transmitted Infections 88(6): 433-435
Mudur, G. 2010: Human papillomavirus vaccine project stirs controversy in India. Bmj 340: C1775
Kahn, J.A.; Cooper, H.P.; Vadaparampil, S.T.; Pence, B.C.; Weinberg, A.D.; LoCoco, S.J.; Rosenthal, S.L. 2009: Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 18(8): 2325-2332
Spila-Alegiani, S.; Da Cas, R.; Giambi, C.; Raschetti, R.; Salmaso, S. 2013: Human papillomavirus vaccine register. Recenti Progressi in Medicina 104(6): 262-266
MacDonald, N.; Stanbrook, M.B.; Hébert, P.C. 2008: Human papillomavirus vaccine risk and reality. Cmaj: Canadian Medical Association Journal 179(6): 503; 505
Gold, M.S.; McIntyre, P. 2010: Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance. Sexual Health 7(3): 320-324
Borja-Hart, N.L.; Benavides, S.; Christensen, C. 2009: Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Event Reporting System. Annals of PharmacoTherapy 43(2): 356-359
Patel, D.A.; Grunzweig, K.A.; Zochowski, M.K.; Dempsey, A.F.; Carlos, R.C.; Dalton, V.K. 2013: Human papillomavirus vaccine stages of change among male and female university students: ready or not?. Journal of American College Health: J of Ach 61(6): 336-346
Sengupta, A.; Shenoi, A.; Sarojini, N.B.; Madhavi, Y. 2011: Human papillomavirus vaccine trials in India. Lancet 377(9767): 719
Laz, T.H.; Rahman, M.; Berenson, A.B. 2013: Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer 119(7): 1386-1392
Wong, C.A.; Berkowitz, Z.; Dorell, C.G.; Anhang Price, R.; Lee, J.; Saraiya, M. 2011: Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008. Cancer 117(24): 5612-5620
Laz, T.H.; Rahman, M.; Berenson, A.B. 2013: Human papillomavirus vaccine uptake among 9-17 year old males in the United States: the National Health Interview Survey, 2010. Human Vaccines and Immunotherapeutics 9(4): 874-878
Bednarczyk, R.A.; Birkhead, G.S.; Morse, D.L.; Doleyres, H.; McNutt, L-Anne. 2011: Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine 29(17): 3138-3143
Stöcker, P.; Dehnert, M.; Schuster, M.; Wichmann, O.; Deleré, Y. 2013: Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010. Human Vaccines and Immunotherapeutics 9(1): 74-82
Conroy, K.; Rosenthal, S.L.; Zimet, G.D.; Jin, Y.; Bernstein, D.I.; Glynn, S.; Kahn, J.A. 2009: Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Women's Health 18(10): 1679-1686
Lavelanet, A.F.; Stampler, K.M.; Dunton, C.J. 2015: Human papillomavirus vaccine uptake: what works and what can we do better?. Journal of Lower Genital Tract Disease 19(1): E17-E22
Tiro, J.A.; Tsui, J.; Bauer, H.M.; Yamada, E.; Kobrin, S.; Breen, N. 2012: Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey. Journal of Women's Health 21(6): 656-665
Baden, L.R.; Curfman, G.D.; Morrissey, S.; Drazen, J.M. 2007: Human papillomavirus vaccine--opportunity and challenge. New England Journal of Medicine 356(19): 1990-1991
Abarca, K.; Valenzuela, M.Teresa.; Vergara, R.; Luchsinger, V.; Muñoz, A.; Jiménez de la J, J.; Ripoll, E.; O'Ryan, M. 2008: Human papillomavirus vaccine. Statement of the Advisory Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008. Revista medica de Chile 136(11): 1485-1492
Abarca V, K.; Valenzuela B, M.Teresa.; Vergara F, R.; Luchsinger F, V.; Muñoz M, A.; Jiménez de la Jara, J.; Ripoll M, E.; O'Ryan G, M. 2008: Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008. Revista chilena de infectologia: organo oficial de la Sociedad Chilena de Infectologia 25(6): 428-434
Savas, L.S.; Fernández, M.E.; Jobe, D.; Carmack, C.C. 2012: Human papillomavirus vaccine: 2-1-1 helplines and minority parent decision-making. American Journal of Preventive Medicine 43(6 Suppl 5: S490-S496
Shin, G.Y. 2008: Human papillomavirus vaccine: Effect of ethnic group should be clarified. Bmj 336(7654): 1146
Brown, E.C.F. 2008: Human papillomavirus vaccine: Some issues around consent remain unresolved. Bmj 336(7654): 1146
Jenson, H.B. 2009: Human papillomavirus vaccine: a paradigm shift for pediatricians. Current Opinion in Pediatrics 21(1): 112-121
Goel, S.; DeCristo, M.J.; McAllister, S.S.; Zhao, J.J. 2018: CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest. Trends in Cell Biology 28(11): 911-925
Luedtke, S. 2008: Human papillomavirus vaccine: are the concerns unfounded?. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(22): 2150-2151
Jenson, H.B.; Baltimore, R.S. 2011: Human papillomavirus vaccine: now for boys too?. Current Opinion in Pediatrics 23(1): 78-84
Martínez-González, M.A.; Carlos, S.; de Irala, J. 2008: Human papillomavirus vaccine: optimism versus prudence. Medicina Clinica 131(7): 256-263
Dinh, T.A.; Benoit, M.F. 2007: Human papillomavirus vaccine: progress and the future. Expert Opinion on Biological Therapy 7(4): 479-485
Fisher, R.; Darrow, D.H.; Tranter, M.; Williams, J.V. 2008: Human papillomavirus vaccine: recommendations, issues and controversies. Current Opinion in Pediatrics 20(4): 441-445
Bornstein, J. 2007: Human papillomavirus vaccine: the beginning of the end for cervical cancer. Israel Medical Association Journal: Imaj 9(3): 156-158
MacDonald, N.; Hébert, P.C. 2007: Human papillomavirus vaccine: waiting for a miracle. Cmaj: Canadian Medical Association Journal 177(5): 433; 435
No, J.Hong.; Kim, M-Kyung.; Jeon, Y-Tark.; Kim, Y-Beom.; Song, Y-Sang. 2011: Human papillomavirus vaccine: widening the scope for cancer prevention. Molecular Carcinogenesis 50(4): 244-253
Berer, M. 2007: Human papillomavirus vaccines. Contraception 75(4): 323; Author Reply 323
Brun, J.-L. 2008: Human papillomavirus vaccines. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 37(Suppl 1): S155-S166
Satyaprakash, A.; Creed, R.; Ravanfar, P.; Mendoza, N. 2009: Human papillomavirus vaccines. Dermatologic Therapy 22(2): 150-157
Franceschi, S.; De Vuyst, H. 2009: Human papillomavirus vaccines and anal carcinoma. Current Opinion in HIV and Aids 4(1): 57-63
Rathfisch, Gülay.; Güngör, İlkay.; Uzun, E.; Keskin, Özlem.; Tencere, Z. 2015: Human papillomavirus vaccines and cervical cancer: awareness, knowledge, and risk perception among Turkish undergraduate students. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 30(1): 116-123
Ault, K.A. 2007: Human papillomavirus vaccines and the potential for cross-protection between related HPV types. Gynecologic Oncology 107(2 Suppl 1: S31-S33
De Sanjosé, S.; Alemany, L.; Castellsagué, X.; Bosch, F.X. 2008: Human papillomavirus vaccines and vaccine implementation. Women's Health 4(6): 595-604
Sahasrabuddhe, V.V.; Sherman, M.E. 2012: Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. Journal of the National Cancer Institute 104(22): 1698-1701
De Vuyst, H.; Franceschi, S. 2007: Human papillomavirus vaccines in HIV-positive men and women. Current Opinion in Oncology 19(5): 470-475
Ganry, O.; Bernin-Mereau, A-S.; Gignon, M.; Merlin-Brochard, J.; Schmit, J-L. 2013: Human papillomavirus vaccines in Picardy, France: coverage and correlation with socioeconomic factors. Revue d'Epidemiologie et de Sante Publique 61(5): 447-454
Giorgi, C.; Franconi, R.; Rybicki, E.P. 2010: Human papillomavirus vaccines in plants. Expert Review of Vaccines 9(8): 913-924
Dawar, M.; Deeks, S.; Dobson, S. 2007: Human papillomavirus vaccines launch a new era in cervical cancer prevention. Cmaj: Canadian Medical Association Journal 177(5): 456-461
Shaw, A.R. 2013: Human papillomavirus vaccines six years after approval. Annual Review of Medicine 64: 91-100
Markman, M. 2007: Human papillomavirus vaccines to prevent cervical cancer. Lancet 369(9576): 1837-1839
Stanley, M. 2008: Human papillomavirus vaccines versus cervical cancer screening. Clinical Oncology 20(6): 388-394
Stanley, M.; Pinto, L.A.; Trimble, C. 2012: Human papillomavirus vaccines--immune responses. Vaccine 30(Suppl 5): F83-F87
Who 2009: Human papillomavirus vaccines: WHO position paper. Biologicals: journal of the International Association of Biological Standardization 37(5): 338-344
Anonymous 2014: Human papillomavirus vaccines: WHO position paper, October 2014. Releve Epidemiologique Hebdomadaire 89(43): 465-491
Singh, A.; Wong, T.; Howlett, R.I. 2008: Human papillomavirus vaccines: Why the time is right to implement immunization and surveillance programs in Canada. Canadian Journal of Infectious Diseases and Medical Microbiology 19(4): 294-296
Jenkins, D. 2008: Human papillomavirus vaccines: a complex decision focused on cancer prevention and cost-effectiveness. Lancet. Infectious Diseases 8(10): 589
Trollfors, B. 2008: Human papillomavirus vaccines: an outsider's point of view. Expert Review of Vaccines 7(8): 1131-1133
Ault, K.A. 2008: Human papillomavirus vaccines: an update for gynecologists. Clinical Obstetrics and Gynecology 51(3): 527-532
Kawana, K.; Yasugi, T.; Taketani, Y. 2009: Human papillomavirus vaccines: current issues and future. Indian Journal of Medical Research 130(3): 341-347
Garland, S.M.; Smith, J.S. 2010: Human papillomavirus vaccines: current status and future prospects. Drugs 70(9): 1079-1098
Isidean, S.D.; Tota, J.E.; Gagnon, J.A.; Franco, E.L. 2015: Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs. Expert Review of Vaccines 14(1): 119-133
Luciani, S.; Jauregui, B.; Kieny, C.; Andrus, J.Kim. 2009: Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries. ImmunoTherapy 1(5): 795-807
Neels, P.; van Damme, P.; van Ranst, M.; Dogné, J.-M. 2013: Human papillomavirus vaccines: understanding the benefit-risk. Annals of Medicine 45(3): 203-205
Firnhaber, C.; Wilkin, T. 2012: Human papillomavirus vaccines: where do they fit in HIV-infected individuals?. Current Hiv/Aids Reports 9(3): 278-286
Freitas, A.C.; Mariz, F.C.; Silva, M.A.R.; Jesus, A.L.S. 2013: Human papillomavirus vertical transmission: review of current data. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 56(10): 1451-1456
Bencomo-Álvarez, A.E.; Limones-Perches, I.; Suárez-Rincón, A.E.; Ramírez-Jirano, L.J.; Borrayo-Carbajal, E.; Sánchez-Corona, J.; Montoya-Fuentes, H. 2012: Human papillomavirus viral load in cervical intraepithelial neoplasia as a prognostic factor in a Mexican population. Genetics and Molecular Research: Gmr 11(4): 4720-4727
Labani, S.; Asthana, S. 2014: Human papillomavirus viral load on careHPV testing of self-collected vaginal samples vs. clinician-collected cervical samples. European Journal of Obstetrics Gynecology and Reproductive Biology 181: 233-239
Ingles, D.J.; Pierce Campbell, C.M.; Messina, J.A.; Stoler, M.H.; Lin, H.-Y.; Fulp, W.J.; Abrahamsen, M.; Sirak, B.A.; O'Keefe, M.T.; Papenfuss, M.; Gage, C.; Carvalho da Silva, R.; Gonzalez Sosa, R.; Rojas Juarez, O.; Villa, L.L.; Lazcano Ponce, E.; Giuliano, A.R. 2015: Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) Study. Journal of Infectious Diseases 211(7): 1060-1067
Feng, S.; Zheng, J.; Du, X.; Tan, Y.; Yang, H.; Zhang, H.; Zhang, Z. 2013: Human papillomavirus was not detected by PCR using multiple consensus primer sets in esophageal adenocarcinomas in Chinese patients. Journal of Medical Virology 85(6): 1053-1057
Yanatatsaneejit, P.; Mutirangura, A.; Kitkumthorn, N. 2011: Human papillomavirus's physical state and cyclin A1 promoter methylation in cervical cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 21(5): 902-906
Gilman, M.; Gilman, S.L.; Johns, M.M. 2009: Human papillomavirus, abstinence, and the other risks. Lancet 373(9673): 1420-1421
Cachay, E.R.; Mathews, W.C. 2013: Human papillomavirus, anal cancer, and screening considerations among HIV-infected individuals. Aids Reviews 15(2): 122-133
Heard, I. 2011: Human papillomavirus, cancer and vaccination. Current Opinion in HIV and Aids 6(4): 297-302
Lowy, D. 2008: Human papillomavirus, cervical cancer prevention, and more. Vaccine 26 Suppl. 10: Iii-Iiv
Tovar, J.M.; Bazaldua, O.V.; Vargas, L.; Reile, E. 2008: Human papillomavirus, cervical cancer, and the vaccines. Postgraduate Medicine 120(2): 79-84
Teitelman, A.M.; Stringer, M.; Averbuch, T.; Witkoski, A. 2009: Human papillomavirus, current vaccines, and cervical cancer prevention. Journal of Obstetric Gynecologic and Neonatal Nursing: Jognn 38(1): 69-80
Hsueh, P.-R. 2009: Human papillomavirus, genital warts, and vaccines. Journal of Microbiology Immunology and Infection 42(2): 101-106
Brestovac, B.; Wong, M.E.; Tjendera, R.; Costantino, P.J.; Mamotte, C.; Witt, C.S. 2013: Human papillomavirus, high-grade intraepithelial neoplasia and killer immunoglogulin-like receptors: a Western Australian cohort study. Infectious Agents and Cancer 8(1): 33
Denny, L.A.; Franceschi, S.; de Sanjosé, S.; Heard, I.; Moscicki, A.B.; Palefsky, J. 2012: Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 30(Suppl 5): F168-F174
Smith, E.M.; Rubenstein, L.M.; Hoffman, H.; Haugen, T.H.; Turek, L.P. 2010: Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infectious Agents and Cancer 5: 4
Hoefling, N.L.; McHugh, J.B.; Light, E.; Kumar, B.; Walline, H.; Prince, M.; Bradford, C.; Carey, T.E.; Mukherji, S.K. 2013: Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma. AJNR. American Journal of Neuroradiology 34(5): 1062-1066 S1-2
Sinha, P.; Logan, H.L.; Mendenhall, W.M. 2012: Human papillomavirus, smoking, and head and neck cancer. American Journal of Otolaryngology 33(1): 130-136
Lippman, A.; Melnychuk, R.; Shimmin, C.; Boscoe, M. 2007: Human papillomavirus, vaccines and women's health: questions and cautions. Cmaj: Canadian Medical Association Journal 177(5): 484-487
Altinbas, S.K.; Tapisiz, O.L. 2012: Human papillomavirus, vaccines, and protection from cervical cancer. Saudi Medical Journal 33(12): 1270-1277
Shepherd, L.J.; Bryson, S.C.P. 2008: Human papillomavirus--lessons from history and challenges for the future. Journal of Obstetrics and Gynaecology Canada: Jogc 30(11): 1025-1033
Mileo, A.M.; Abbruzzese, C.; Mattarocci, S.; Bellacchio, E.; Pisano, P.; Federico, A.; Maresca, V.; Picardo, M.; Giorgi, A.; Maras, B.; Schininà, M.E.; Paggi, M.G. 2009: Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival. Plos one 4(10): E7254
Kalantari, M.; Villa, L.L.; Calleja-Macias, I.E.; Bernard, H.-U. 2008: Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. International Journal of Cancer 123(8): 1832-1840
Lee, L.-A.; Huang, C.-G.; Liao, C.-T.; Lee, L.-Y.; Hsueh, C.; Chen, T.-C.; Lin, C.-Y.; Fan, K.-H.; Wang, H.-M.; Huang, S.-F.; Chen, I.-H.; Kang, C.-J.; Ng, S.-H.; Yang, S.-L.; Tsao, K.-C.; Chang, Y.-L.; Yen, T.-C. 2012: Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. Plos one 7(7): E40767
Heideman, D.ël.A.M.; Waterboer, T.; Pawlita, M.; Delis-van Diemen, P.; Nindl, I.; Leijte, J.A.; Bonfrer, J.M.G.; Horenblas, S.; Meijer, C.J.L.M.; Snijders, P.J.F. 2007: Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(29): 4550-4556
Meyer, M.S.; Applebaum, K.M.; Furniss, C.Sloane.; Peters, E.S.; Luckett, B.G.; Smith, J.F.; Bryan, J.; McClean, M.D.; Marsit, C.; Kelsey, K.T. 2008: Human papillomavirus-16 modifies the association between fruit consumption and head and neck squamous cell carcinoma. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 17(12): 3419-3426
Aguayo, F.; Anwar, M.; Koriyama, C.; Castillo, A.; Sun, Q.; Morewaya, J.; Eizuru, Y.; Akiba, S. 2010: Human papillomavirus-16 presence and physical status in lung carcinomas from Asia. Infectious Agents and Cancer 5: 20
Horewicz, Vônica.V.; Feres, M.; Rapp, G.E.; Yasuda, V.; Cury, P.R. 2010: Human papillomavirus-16 prevalence in gingival tissue and its association with periodontal destruction: a case-control study. Journal of Periodontology 81(4): 562-568
Ngan, H.Y.S.; Cheung, A.N.Y.; Tam, K.F.; Chan, K.K.L.; Tang, H.W.; Bi, D.; Descamps, D.; Bock, H.L. 2010: Human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in healthy Chinese women from Hong Kong. Hong Kong Medical Journal 16(3): 171-179
Lyseng-Williamson, K.A. 2014: Human papillomavirus-16/18 AS04-adjuvanted vaccine (cervarix®): a guide to its two-dose schedule in girls aged 9-14 years in the EU. Paediatric Drugs 16(3): 247-253
Liu, N.; Wang, J.; Lei, L.; Li, Y.; Zhou, M.; Dan, H.; Zeng, X.; Chen, Q. 2013: Human papillomavirus-32-associated focal epithelial hyperplasia accompanying HPV-16-positive papilloma-like lesions in oral mucosa. Journal of Craniofacial Surgery 24(3): 905-908
DePond, W.; Kure, K.; Lankachandra, K.; Gidwani, R.; Nelson, B.V.; Zimmerman, H.; Talboy, G.E.; Miranda, R.N. 2009: Human papillomavirus-58 and -73-associated digital squamous cell carcinoma in a patient with aggressive digital papillary adenocarcinoma. American Journal of Dermatopathology 31(4): 375-378
Weinberger, P.M.; Merkley, M.A.; Khichi, S.S.; Lee, J.R.; Psyrri, A.; Jackson, L.L.; Dynan, W.S. 2010: Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope 120(8): 1531-1537
Chang, A.M.V.; Nikiforova, M.N.; Johnson, J.T.; Bauman, J.E.; Perez-Ordonez, B.; Seethala, R.R.; Krane, J.F.; Chiosea, S.I. 2014: Human papillomavirus-associated adenocarcinoma of the base of tongue: potentially actionable genetic changes. Head and Neck Pathology 8(2): 151-156
Damato, S.; Thavaraj, S.; Winter, S.; Shah, K.A. 2014: Human papillomavirus-associated adenocarcinoma of the palatine tonsil. Human Pathology 45(4): 893-894
Wikström, A.; Hedblad, M.-A.; Syrjänen, S. 2013: Human papillomavirus-associated balanoposthitis--a marker for penile intraepithelial neoplasia?. International Journal of Std and Aids 24(12): 938-943
Anonymous 2012: Human papillomavirus-associated cancers - United States, 2004-2008. Mmwr. Morbidity and Mortality Weekly Report 61: 258-261
Grce, M.; Mravak-Stipetić, M. 2014: Human papillomavirus-associated diseases. Clinics in Dermatology 32(2): 253-258
Kreuter, A.; Wieland, U. 2009: Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Current Opinion in Infectious Diseases 22(2): 109-114
Gonçalves, A. 2018: CDK4/6 inhibitors: biomarkers, mechanisms of resistance and interest of the study of the circulating tumor DNA. Bulletin du Cancer 105(6): 545-546
Salazar, C.R.; Smith, R.V.; Garg, M.K.; Haigentz, M.; Schiff, B.A.; Kawachi, N.; Anayannis, N.; Belbin, T.J.; Prystowsky, M.B.; Burk, R.D.; Schlecht, N.F. 2014: Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment. Head and Neck Pathology 8(1): 77-87
Kreuter, A.; Skrygan, M.; Gambichler, T.; Brockmeyer, N.H.; Stücker, M.; Herzler, C.; Potthoff, A.; Altmeyer, P.; Pfister, H.; Wieland, U. 2009: Human papillomavirus-associated induction of human beta-defensins in anal intraepithelial neoplasia. British Journal of Dermatology 160(6): 1197-1205
Nguyen, N.P.; Chi, A.; Nguyen, L.M.; Ly, B.H.; Karlsson, U.; Vinh-Hung, V. 2010: Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. Qjm: Monthly Journal of the Association of Physicians 103(4): 229-236
Ukpo, O.C.; Pritchett, C.V.; Lewis, J.E.; Weaver, A.L.; Smith, D.I.; Moore, E.J. 2009: Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients. Annals of Otology Rhinology and Laryngology 118(5): 368-373
Chau, N.G.; Rabinowits, G.; Haddad, R.I. 2014: Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options. Current Treatment Options in Oncology 15(4): 595-610
Sato, Y.; Nozaki, T.; Matsusako, M.; Eto, H.; Matsui, M.; Ohtake, N.; Suzuki, K.; Starkey, J.; Saida, Y. 2014: Human papillomavirus-associated plantar epidermoid cysts: MR and US imaging appearance. Skeletal Radiology 43(2): 257-261
Jung, K.-D.; Kim, P.-S.; Lee, J.-H.; Yang, J.-M.; Lee, E.-S.; Lee, D.-Y.; Jang, K.-T.; Kim, D.-S. 2009: Human papillomavirus-associated recurrent plantar epidermal cysts in a patient after organ transplantation. Journal of the European Academy of Dermatology and Venereology: Jeadv 23(7): 837-839
Turowski, C.Bansal.; Ross, A.S.; Cusack, C.Ann. 2009: Human papillomavirus-associated squamous cell carcinoma of the nail bed in African-American patients. International journal of dermatology 48(2): 117-120
Stelow, E.B.; Jo, V.Y.; Stoler, M.H.; Mills, S.E. 2010: Human papillomavirus-associated squamous cell carcinoma of the upper aerodigestive tract. American Journal of Surgical Pathology 34(7): E15-E24
Ojha, R.P.; Tota, J.E.; Offutt-Powell, T.N.; Klosky, J.L.; Minniear, T.D.; Jackson, B.E.; Gurney, J.G. 2013: Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. Plos one 8(8): E70349
Krüger-Corcoran, D.; Stockfleth, E.; Jürgensen, J.S.; Maltusch, A.; Nindl, I.; Sterry, W.; Lange-Asschenfeldt, B.; Ulrich, C. 2010: Human papillomavirus-associated warts in organ transplant recipients. Incidence, risk factors, management. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 61(3): 220-229
Denny, L.; Kuhn, L.; Hu, C-Chi.; Tsai, W-Yann.; Wright, T.C. 2010: Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. Journal of the National Cancer Institute 102(20): 1557-1567
Arbyn, M.; Martin-Hirsch, P.; Wentzensen, N. 2010: Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis. Bjog: An International Journal of Obstetrics and Gynaecology 117(6): 641-644
Valerón-Almazán, P.; Bastida, Jús.; Rivero, P.; Vilar, J.; Dehesa, L.; Díaz-Cascajo, C.; Carretero, G. 2011: Human papillomavirus-induced lesions on tattoos may show features of seborrheic keratosis. Archives of Dermatology 147(3): 370
Ramirez-Fort, M.K. 2012: Human papillomavirus-induced periungual pigmented Bowen's disease. Dermatology Practical and Conceptual 2(1): 57-59
Millán, A.Fernández-San.; Gómez-Sebastián, S.; Nuñez, Mía.C.; Veramendi, J.; Escribano, Jé.M. 2010: Human papillomavirus-like particles vaccine efficiently produced in a non-fermentative system based on insect larva. Protein Expression and Purification 74(1): 1-8
Feller, L.; Wood, N.H.; Khammissa, R.A.G.; Lemmer, J. 2010: Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: human papillomavirus-mediated carcinogenesis. Head and Face Medicine 6: 14
Feller, L.; Wood, N.H.; Khammissa, R.A.G.; Lemmer, J. 2010: Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma. Head and Face Medicine 6: 15
Thariat, J.; Cecille, B.; Claire, F.; Pierre-yves, M.; Adrien, R.Christian. 2010: Human papillomavirus-positive basaloid squamous cell carcinomas of the head and neck. Human pathology 41(10): 1505-6; author reply 1506
Chernock, R.D.; Lewis, J.S.; Zhang, Q.; El-Mofty, S.K. 2010: Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Human Pathology 41(7): 1016-1023
Sharma, A.; Méndez, E.; Yueh, B.; Lohavanichbutr, P.; Houck, J.; Doody, D.R.; Futran, N.D.; Upton, M.P.; Schwartz, S.M.; Chen, C. 2012: Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 146(5): 739-745
Ginori, A.; Barone, A.; Santopietro, R.; Barbanti, G.; Cecconi, F.; Tripodi, S.A. 2015: Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection. International Journal of Urology: Official Journal of the Japanese Urological Association 22(2): 222-225
Ortiz, A.P.; Pérez-Irizarry, J.; Soto-Salgado, M.; Suárez, E.; Pérez, N.; Cruz, M.; Palefsky, J.; Tortolero-Luna, G.; Miranda, S.; Colón-López, V. 2014: Human papillomavirus-related cancers among people living with AIDS in Puerto Rico. Preventing Chronic Disease 11: E80
Hwang, S.Jin.; Ok, S.; Lee, H-Man.; Lee, E.; Park, I-Ho. 2015: Human papillomavirus-related carcinoma with adenoid cystic-like features of the inferior turbinate: a case report. Auris Nasus Larynx 42(1): 53-55
Bishop, J.A.; Ogawa, T.; Stelow, E.B.; Moskaluk, C.A.; Koch, W.M.; Pai, S.I.; Westra, W.H. 2013: Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. American Journal of Surgical Pathology 37(6): 836-844
Bishop, J.A.; Guo, T.W.; Smith, D.F.; Wang, H.; Ogawa, T.; Pai, S.I.; Westra, W.H. 2013: Human papillomavirus-related carcinomas of the sinonasal tract. American Journal of Surgical Pathology 37(2): 185-192
Ryu, C.H.; Ryu, J.; Cho, K.H.; Moon, S.H.; Yun, T.; Lee, S.-H.; Choi, M.K.; Park, W.S.; Jung, Y.-S. 2014: Human papillomavirus-related cell cycle markers can predict survival outcomes following a transoral lateral oropharyngectomy for tonsillar squamous cell carcinoma. Journal of Surgical Oncology 110(4): 393-399
Steele, C.B.; Thomas, C.N.; Richardson, L.C. 2008: Human papillomavirus-related content in state and tribal comprehensive cancer control plans. Journal of Women's Health 17(1): 5-10
Palefsky, J.M. 2010: Human papillomavirus-related disease in men: not just a women's issue. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 46(4 Suppl): S12-S19
Palefsky, J. 2009: Human papillomavirus-related disease in people with HIV. Current Opinion in HIV and Aids 4(1): 52-56
Stier, E.A.; Baranoski, A.S. 2008: Human papillomavirus-related diseases in HIV-infected individuals. Current Opinion in Oncology 20(5): 541-546
Zekan, J.; Skerlev, M.; Milić, L.; Karelović, D. 2014: Human papillomavirus-related diseases of the female lower genital tract: oncogenic aspects and molecular interaction. Collegium Antropologicum 38(2): 779-786
Gillison, M.L. 2008: Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 43(4 Suppl): S52-S60
Gormley, R.H.; Kovarik, C.L. 2012: Human papillomavirus-related genital disease in the immunocompromised host: Part i. Journal of the American Academy of Dermatology 66(6): 867.E1
Gormley, R.H.; Kovarik, C.L. 2012: Human papillomavirus-related genital disease in the immunocompromised host: Part Ii. Journal of the American Academy of Dermatology 66(6): 883.E1
Growdon, W.B.; Del Carmen, M. 2008: Human papillomavirus-related gynecologic neoplasms: screening and prevention. Reviews in Obstetrics and Gynecology 1(4): 154-161
Stelow, E.B. 2013: Human papillomavirus-related head and neck squamous cell carcinoma. Cancer Cytopathology 121(11): 599-600
Psyrri, A.; Gouveris, P.; Vermorken, J.Baptist. 2009: Human papillomavirus-related head and neck tumors: clinical and research implication. Current Opinion in Oncology 21(3): 201-205
Vainshtein, J.; McHugh, J.B.; Spector, M.E.; Walline, H.M.; Komarck, C.M.; Stenmark, M.H.; Prince, M.E.; Worden, F.P.; Wolf, G.T.; Bradford, C.R.; Chepeha, D.B.; Carey, T.; Eisbruch, A. 2015: Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor. Head and Neck 37(1): 8-11
Qi, S-Zhen.; Wang, S-Ming.; Shi, J-Fang.; Wang, Q-Qiu.; Chen, X-Sheng.; Sun, L-Jun.; Liu, A.; Zhang, N.; Jiang, N.; Siva, P.; Xu, X-Lian.; Qiao, Y-Lin. 2014: Human papillomavirus-related psychosocial impact of patients with genital warts in China: a hospital-based cross-sectional study. Bmc Public Health 14: 739
Dzeletovic, I.; Pasha, S.; Leighton, J.A. 2010: Human papillomavirus-related rectal squamous cell carcinoma in a patient with ulcerative colitis diagnosed on narrow-band imaging. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 8(5): E47-E48
Bishop, J.A.; Westra, W.H. 2011: Human papillomavirus-related small cell carcinoma of the oropharynx. American Journal of Surgical Pathology 35(11): 1679-1684
Chernock, R.D.; Zhang, Q.; El-Mofty, S.K.; Thorstad, W.L.; Lewis, J.S. 2011: Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Archives of Otolaryngology--Head and Neck Surgery 137(2): 163-169
Imko-Walczuk, B.; Cegielska, A.; Placek, W.; Kaszewski, S.; Fiedor, P. 2014: Human papillomavirus-related verrucous carcinoma in a renal transplant patient after long-term immunosuppression: a case report. Transplantation Proceedings 46(8): 2916-2919
Rabelo-Santos, S.H.; Derchain, S.F.ço.M.; Villa, L.ís.L.; Costa, M.C.íl.; Sarian, L.O.áv.Z.; do Amaral Westin, M.C.; Kornegay, J.; Zeferino, L.C. 2009: Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 28(3): 272-278
Nieto, K.; Gissmann, L.; Schädlich, L. 2010: Human papillomavirus-specific immune therapy: failure and hope. Antiviral Therapy 15(7): 951-957
Ko, Y.H.; Won, H.S.; Sun, D.S.; An, H.J.; Jeon, E.K.; Kim, M.S.; Lee, H.H.; Kang, J.H.; Jung, C.K. 2014: Human papillomavirus-stratified analysis of the prognostic role of miR-21 in oral cavity and oropharyngeal squamous cell carcinoma. Pathology International 64(10): 499-507
Dede, M.; Kubar, A.; Yenen, M.Cemal.; Alanbay, I.; Guven, S.; Mesten, Z.; Baser, I. 2007: Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata. Acta Obstetricia et Gynecologica Scandinavica 86(8): 968-972
Chou, Y-Yu.; Lin, M-Chieh.; Huang, L-Wen. 2013: Human papillomavirus-unrelated gastric type of cervical adenocarcinoma presenting with a metastatic ovarian tumor: report of a case. Journal of Lower Genital Tract Disease 17(2): 218-222
McCullers, J. 2008: Frailty: the looming epidemic. Alabama Nurse 35(4): 25-26
Nielsen, A.R.; Hayney, M.S. 2014: Human papillomavirus: a brief overview and recommendations for pharmacists. Journal of the American Pharmacists Association: Japha 54(5): 558-561
Maher, H.K. 2007: Human papillomavirus: a new vaccine. Aaohn Journal: Official Journal of the American Association of Occupational Health Nurses 55(4): 176
Gallegos-Hernández, Jé.Francisco.; Paredes-Hernández, E.; Flores-Díaz, R.; Minauro-Muñoz, G.; Apresa-García, T.; Hernández-Hernández, D.María. 2007: Human papillomavirus: association with head and neck cancer. Cirugia y Cirujanos 75(3): 151-155
Adelstein, D.J.; Rodriguez, C.P. 2010: Human papillomavirus: changing paradigms in oropharyngeal cancer. Current Oncology Reports 12(2): 115-120
Juckett, G.; Hartman-Adams, H. 2010: Human papillomavirus: clinical manifestations and prevention. American Family Physician 82(10): 1209-1213
Malik, H.; Khan, F.H.; Ahsan, H. 2014: Human papillomavirus: current status and issues of vaccination. Archives of Virology 159(2): 199-205
Weaver, B.A.; Cymet, T.C. 2011: Human papillomavirus: every answer raises more questions. Journal of the American Osteopathic Association 111(3 Suppl. 2): Sii
Graham, S.V. 2010: Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiology 5(10): 1493-1506
Anonymous 2007: Human papillomavirus: often harmless but in some cases carcinogenic. Prescrire International 16(89): 115-119
Liu, H.-t. 2009: Human papillomavirus: opportunities and challenges for us. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(2): 81
De Aguiar, S.R.V.; Villanova, F.E.; Martins, L.C.íc.; dos Santos, M.S.; Maciel, J.d.P.; Falcão, L.F.áb.M.; Fuzii, H.T.; Quaresma, J.A.ôn.S.õe. 2014: Human papillomavirus: prevalence and factors associated in women prisoners population from the Eastern Brazilian Amazon. Journal of Medical Virology 86(9): 1528-1533
Entiauspe, L.Gonçalves.; Teixeira, L.Ortiz.; Mendoza-Sassi, R.Andrés.; Gonçalves, C.Vitola.; Gonçalves, P.; Martinez, A.Maria.Barral.de. 2010: Human papillomavirus: prevalence and genotypes found among HIV-positive and negative women at a reference center in the far south of Brazil. Revista da Sociedade Brasileira de Medicina Tropical 43(3): 260-263
Bosch, F.X. 2011: Human papillomavirus: science and technologies for the elimination of cervical cancer. Expert Opinion on PharmacoTherapy 12(14): 2189-2204
Ciarrocca, K.; Jackson, L.L.; De Rossi, S.S. 2013: Human papillomavirus: the fundamentals of HPV for oral health care providers. Journal of the California Dental Association 41(5): 349-355
Rajaram, S.; Mehta, S.; Goel, N. 2010: Human papillomavirus: the silent intruder. Indian Journal of Dermatology Venereology and Leprology 76(6): 701-703
Dempsey, A.F. 2008: Human papillomavirus: the usefulness of risk factors in determining who should get vaccinated. Reviews in Obstetrics and Gynecology 1(3): 122-128
Cho, N.H. 2014: Human papillomavirus: wearisome or awesome issue?. Journal of Gynecologic Oncology 25(4): 265-266
Barras, V.; Jacot-Guillarmod, M. 2014: Human papillomavirus: what do young people really know about it?. Revue Medicale Suisse 10(434): 1297-1301
Falter Ii, K.J.; Frimer, M.; Lavy, D.; Samuelson, R.; Shahabi, S. 2013: Human papillomavirusassociated cancers as acquired immunodeficiency syndrome defining illnesses. Rare Tumors 5(2): 93-94
Kane, M.A. 2008: Human papillomaviruses (HPV) vaccines: implementation and communication issues. Journal of Family Planning and Reproductive Health Care 34(1): 3-4
Sourvinos, G.; Mammas, I.N.; Derdas, S.; Spandidos, D.A. 2013: Human papillomaviruses (HPVs) in lung cancer: a causative trigger or just a co-incidence?. Lung Cancer 79(1): 95-96
Moody, C.A.; Laimins, L.A. 2009: Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. Plos Pathogens 5(10): E1000605
Fu, Y.L.; Hu, Y.X.; Ling, H.L.; Ye, Z.Z.; Liang, T.; Zhang, M.G.; Liu, Y.K.; Kang, B.; Luo, Y.J.; He, S.Y.; Lian, Y.J. 1994: Human papillomaviruses and papillomatosis lesions of the female lower genital tract. Infectious Diseases in Obstetrics and Gynecology 1(5): 235-241
Beglin, M.; Melar-New, M.; Laimins, L. 2009: Human papillomaviruses and the interferon response. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 29(9): 629-635
Alos, L.; Moyano, S.; Nadal, A.; Alobid, I.; Blanch, J.L.; Ayala, E.; Lloveras, B.én.; Quint, W.; Cardesa, A.; Ordi, J. 2009: Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer 115(12): 2701-2709
Skálová, A.; Kašpírková, J.; Andrle, P.; Hostička, L.; Vaneček, T.áš 2013: Human papillomaviruses are not involved in the etiopathogenesis of salivary gland tumors. Ceskoslovenska Patologie 49(2): 72-75
Mumba, E.; Ali, H.; Turton, D.; Cooper, K.; Grayson, W. 2008: Human papillomaviruses do not play an aetiological role in Müllerian adenosarcomas of the uterine cervix. Journal of Clinical Pathology 61(9): 1041-1044
Kato, M.; Shimizu, A.; Takeuchi, Y.; Hattori, T.; Abe, M.; Amano, H.; Motegi, S.-i.; Tamura, A.; Ishikawa, O. 2014: Human papillomaviruses in anogenital epithelial lesions. Acta Dermato-Venereologica 94(5): 597-599
Al-Ahdal, M.N.; Al-Arnous, W.K.; Bohol, M.F.; Abuzaid, S.M.; Shoukri, M.M.; Elrady, K.S.; Firdous, N.; Aliyan, R.; Taseer, R.; Al-Hazzani, A.A.; Al-Qahtani, A.A. 2014: Human papillomaviruses in cervical specimens of women residing in Riyadh, Saudi Arabia: a hospital-based study. Journal of Infection in Developing Countries 8(3): 320-325
Syrjänen, S. 2007: Human papillomaviruses in head and neck carcinomas. New England Journal of Medicine 356(19): 1993-1995
Hoffmann, M.; Folz, B.J.; Niemann, A.M.; Gottschlich, S.; Lippert, B.M.; Mahnke, C.G.; Werner, J.A. 1998: Human papillomaviruses in hypopharyngeal squamous cell carcinoma. Indian Journal of Otolaryngology and Head and Neck Surgery: Official Publication of the Association of Otolaryngologists of India 50(3): 233-240
Carrilho, C.; Gouveia, P.íc.; Yokohama, H.; Lopes, J.é M.; Lunet, N.; Ferro, J.; Ismail, M.; Walboomers, J.; Sobrinho-Simões, M.; David, L. 2013: Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 22(6): 566-568
Syrjänen, S.; Lodi, G.; von Bültzingslöwen, I.; Aliko, A.; Arduino, P.; Campisi, G.; Challacombe, S.; Ficarra, G.; Flaitz, C.; Zhou, H.M.; Maeda, H.; Miller, C.; Jontell, M. 2011: Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Diseases 17(Suppl 1): 58-72
Von Knebel Doeberitz, M.; Reuschenbach, M. 2010: Human papillomaviruses in the pathogenesis of intraepithelial neoplasia (AIN) and carcinoma of the anus. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 61(1): 13-20
Tolstov, Y.; Hadaschik, B.; Pahernik, S.; Hohenfellner, M.; Duensing, S. 2014: Human papillomaviruses in urological malignancies: a critical assessment. Urologic Oncology 32(1): 46.E19-46.E27
Melar-New, M.; Laimins, L.A. 2010: Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. Journal of Virology 84(10): 5212-5221
Sagna, T.; Djigma, F.; Zeba, M.; Bisseye, C.; Karou, S.D.; Ouermi, D.; Pietra, V.; Gnoula, C.; Sanogo, K.; Nikiema, J.B.; Simpore, J. 2010: Human papillomaviruses prevalence and genital co-infections in HIV-seropositive women in Ouagadougou (Burkina Faso). Pakistan Journal of Biological Sciences: Pjbs 13(19): 951-955
Al Moustafa, A-Eddin.; Al-Awadhi, R.; Missaoui, N.; Adam, I.; Durusoy, R.; Ghabreau, L.; Akil, N.; Ahmed, H.Gadelkarim.; Yasmeen, A.; Alsbeih, G. 2014: Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions. Human Vaccines and Immunotherapeutics 10(7): 1812-1821
Galloway, D.A. 2009: Human papillomaviruses: a growing field. Genes and Development 23(2): 138-142
Burk, R.D.; Chen, Z.; Van Doorslaer, K. 2009: Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics 12(5-6): 281-290
Anonymous 2004: Human papillomaviruses: some genital-mucosal types. Report on carcinogens: carcinogen profiles 11: III142-5
Jones, S.H.; Younghusband, O.Z.; Evans, J.A. 1948: Human parabiotic pygopagus twins with hypertension; report of a case with clinical, psychologic and endocrinologic observations. Journal of the American Medical Association 138(9): 642-645
Anonymous 2010: Human paragonimiasis after eating raw or undercooked crayfish --- Missouri, July 2006-September 2010. Mmwr. Morbidity and Mortality Weekly Report 59(48): 1573-1576
Aka, N.'D.A.; Adoubryn, K.; Rondelaud, D.; Dreyfuss, G. 2008: Human paragonimiasis in Africa. Annals of African Medicine 7(4): 153-162
Lane, M.A.; Barsanti, M.C.; Santos, C.A.; Yeung, M.; Lubner, S.J.; Weil, G.J. 2009: Human paragonimiasis in North America following ingestion of raw crayfish. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 49(6): E55-E61
Ford, W.R.; Blair, A.E.; Evans, R.L.; John, E.; Bugert, J.J.; Broadley, K.J.; Kidd, E.J. 2013: Human parainfluenza type 3 virus impairs the efficacy of glucocorticoids to limit allergy-induced pulmonary inflammation in guinea-pigs. Clinical Science 125(10): 471-482
Villaran, M.V.; García, J.; Gomez, J.; Arango, A.E.; Gonzales, M.; Chicaiza, W.; Alemán, W.; Lorenzana de Rivera, I.; Sanchez, F.; Aguayo, N.; Kochel, T.J.; Halsey, E.S. 2014: Human parainfluenza virus in patients with influenza-like illness from Central and South America during 2006-2010. Influenza and other respiratory viruses 8(2): 217-227
Ustun, C.; Slabý, J.ří; Shanley, R.M.; Vydra, J.; Smith, A.R.; Wagner, J.E.; Weisdorf, D.J.; Young, J.-A.H. 2012: Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(10): 1580-1588
Ruampunpong, H.; Payungporn, S.; Samransamruajkit, R.; Pratheepamornkul, T.; Theamboonlers, A.; Poovorawan, Y. 2014: Human parainfluenza virus infection in Thai children with lower respiratory tract infection from 2010 to 2013. Southeast Asian Journal of Tropical Medicine and Public Health 45(3): 610-621
Palermo, L.M.; Porotto, M.; Yokoyama, C.C.; Palmer, S.G.; Mungall, B.A.; Greengard, O.; Niewiesk, S.; Moscona, A. 2009: Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. Journal of Virology 83(13): 6900-6908
Chen, Y.; Zhong, J.-Y.; Lin, T. 2009: Human parainfluenza virus infections in children with acute respiratory infections in Guangzhou area in 2007. Zhonghua Liu Xing Bing Xue Za Zhi 30(6): 646-647
Zhao, L-qing.; Qian, Y.; Wang, F.; Zhu, R-nan.; Deng, J. 2007: Human parainfluenza virus infections in infants and young children with acute respiratory infections in Beijing. Zhonghua Er Ke Za Zhi 45(2): 91-95
Bartlett, E.J.; Cruz, A.-M.; Esker, J.; Castaño, A.; Schomacker, H.; Surman, S.R.; Hennessey, M.; Boonyaratanakornkit, J.; Pickles, R.J.; Collins, P.L.; Murphy, B.R.; Schmidt, A.C. 2008: Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates. Journal of Virology 82(18): 8965-8977
Ma, G.-F.; Miettinen, S.; Porola, P.; Hedman, K.; Salo, J.; Konttinen, Y.ö T. 2009: Human parainfluenza virus type 2 (HPIV2) induced host ADAM8 expression in human salivary adenocarcinoma cell line (HSY) during cell fusion. Bmc Microbiology 9: 55
Nishio, M.; Tsurudome, M.; Garcin, D.; Komada, H.; Ito, M.; Le Mercier, P.; Nosaka, T.; Kolakofsky, D. 2011: Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping. Journal of Virology 85(2): 725-732
Hara, K.; Fukumura, M.; Ohtsuka, J.; Kawano, M.; Nosaka, T. 2013: Human parainfluenza virus type 2 vector induces dendritic cell maturation without viral RNA replication/transcription. Human Gene Therapy 24(7): 683-691
Cunha, B.A.; Mickail, N.; Schoch, P. 2011: Human parainfluenza virus type 3 (HPIV 3) community-acquired pneumonia (CAP) mimicking pertussis in an adult: the diagnostic importance of hoarseness and monocytosis. Heart and Lung: the Journal of Critical Care 40(6): 569-573
Cunha, B.A.; Corbett, M.; Mickail, N. 2011: Human parainfluenza virus type 3 (HPIV 3) viral community-acquired pneumonia (CAP) mimicking swine influenza (H1N1) during the swine flu pandemic. Heart and Lung: the Journal of Critical Care 40(1): 76-80
Roth, J.P.; Li, J.K.-K.; Barnard, D.L. 2010: Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP). Current Protocols in Microbiology Chapter 15: Unit 15f.1
Sasaki, M.; Ishii, A.; Orba, Y.; Thomas, Y.; Hang'ombe, B.M.; Moonga, L.; Mweene, A.S.; Ogawa, H.; Nakamura, I.; Kimura, T.; Sawa, H. 2013: Human parainfluenza virus type 3 in wild nonhuman primates, Zambia. Emerging Infectious Diseases 19(9)
Mao, N.; Ji, Y.; Xie, Z.; Wang, H.; Wang, H.; An, J.; Zhang, X.; Zhang, Y.; Zhu, Z.; Cui, A.; Xu, S.; Shen, K.; Liu, C.; Yang, W.; Xu, W. 2012: Human parainfluenza virus-associated respiratory tract infection among children and genetic analysis of HPIV-3 strains in Beijing, China. Plos one 7(8): E43893
Amonsen, M.; Smith, D.F.; Cummings, R.D.; Air, G.M. 2007: Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with alpha2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin. Journal of Virology 81(15): 8341-8345
Fledelius, H.C.; Goldschmidt, E.; Haargaard, B.; Jensen, H. 2014: Human parallels to experimental myopia? A literature review on visual deprivation. Acta Ophthalmologica 92(8): 724-729
Gallup, A.C.; Hack, G.D. 2011: Human paranasal sinuses and selective brain cooling: a ventilation system activated by yawning?. Medical Hypotheses 77(6): 970-973
Bajaj, P.; Tripathy, R.K.; Aggarwal, G.; Pande, A.H. 2014: Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives. Thescientificworldjournal 2014: 854391
Coombes, R.H.; Meek, E.C.; Dail, M.B.; Chambers, H.W.; Chambers, J.E. 2014: Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype. Toxicology Letters 230(1): 57-61
She, Z.-G.; Zheng, W.; Wei, Y.-S.; Chen, H.-Z.; Wang, A.-B.; Li, H.-L.; Liu, G.; Zhang, R.; Liu, J.-J.; Stallcup, W.B.; Zhou, Z.; Liu, D.-P.; Liang, C.-C. 2009: Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. Circulation Research 104(10): 1160-1168
Mendonça, M.I.; Dos Reis, R.P.; Freitas, A.I.; Sousa, A.C.; Pereira, A.; Faria, P.; Gomes, S.; Silva, B.; Santos, N.; Serrão, M.; Ornelas, I.íd.; Freitas, S.ón.; Araújo, J.é J.; Brehm, A.ón.; Cardoso, A.A. 2008: Human paraoxonase gene polymorphisms and coronary artery disease risk. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 27(12): 1539-1555
Koncsos, Péter.; Seres, Ió.; Harangi, M.; Illyés, Ián.; Józsa, L.; Gönczi, F.; Bajnok, László.; Paragh, Görgy. 2010: Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels. Pediatric Research 67(3): 309-313
Maselli, L.M.F.; da Cunha, J.; Gutierrez, E.B.; Maranhão, R.C.; Spada, C.; Bydlowski, S.ér.P. 2014: Human paraoxonase-1 activity is related to the number of CD4+ T-cells and is restored by antiretroviral therapy in HIV-1-infected individuals. Disease Markers 2014: 480201
Tsai, H-Chin.; Chen, Y-Shen.; Yen, C-Min. 2013: Human parasitic meningitis caused by Angiostrongylus cantonensis infection in Taiwan. Hawai'i Journal of Medicine and Public Health: a Journal of Asia Pacific Medicine and Public Health 72(6 Suppl. 2): 26-27
Yang, C.Y.; Meng, C.L.; Wong, P.Y. 1993: Human parathyroid hormone fragment stimulates the de novo synthesis of prostaglandin endoperoxide synthase in chick calvaria. Mediators of Inflammation 2(2): 143-147
Lee, J.-H.; Hwang, K.-J.; Kim, M.-Y.; Lim, Y.-J.; Seol, I.-J.; Jin, H.-J.; Jang, Y.-K.; Choi, S.-J.; Oh, W.; Cho, Y.-H.; Lee, Y.-H. 2012: Human parathyroid hormone increases the mRNA expression of the IGF system and hematopoietic growth factors in osteoblasts, but does not influence expression in mesenchymal stem cells. Journal of Pediatric Hematology/Oncology 34(7): 491-496
Adriaansen, J.; Perez, P.; Zheng, C.; Collins, M.T.; Baum, B.J. 2011: Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer. Human Gene Therapy 22(1): 84-92
Selvarangan, R.; Nzabi, M.; Selvaraju, S.B.; Ketter, P.; Carpenter, C.; Harrison, C.J. 2011: Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatric Infectious Disease Journal 30(3): 238-242
Luo, L.; Zhu, R.; Zhao, L.; Deng, J.; Wang, F.; Sun, Y.; Song, Q.; Ding, Y.; Qian, Y. 2014: Human parechovirus associated sepsis and central nervous system infections in hospitalized children. Zhonghua Er Ke Za Zhi 52(6): 444-448
Verboon-Maciolek, M.A.; Groenendaal, F.; Hahn, C.D.; Hellmann, J.; van Loon, A.M.; Boivin, G.; de Vries, L.S. 2008: Human parechovirus causes encephalitis with white matter injury in neonates. Annals of Neurology 64(3): 266-273
Felsenstein, S.; Yang, S.; Eubanks, N.; Sobrera, E.; Grimm, J.P.; Aldrovandi, G. 2014: Human parechovirus central nervous system infections in southern California children. Pediatric Infectious Disease Journal 33(4): E87-E91
Alam, M.M.; Khurshid, A.; Shaukat, S.; Rana, M.S.; Sharif, S.; Angez, M.; Nisar, N.; Naeem, M.; Zahoor Zaidi, S.S. 2013: Human parechovirus genotypes -10, -13 and -15 in Pakistani children with acute dehydrating gastroenteritis. Plos one 8(11): E78377
Sharp, J.; Bell, J.; Harrison, C.J.; Nix, W.A.; Oberste, M.S.; Selvarangan, R. 2012: Human parechovirus in respiratory specimens from children in Kansas City, Missouri. Journal of Clinical Microbiology 50(12): 4111-4113
Pham, N.T.K.; Takanashi, S.; Tran, D.N.; Trinh, Q.D.; Abeysekera, C.; Abeygunawardene, A.; Khamrin, P.; Okitsu, S.; Shimizu, H.; Mizuguchi, M.; Ushijima, H. 2011: Human parechovirus infection in children hospitalized with acute gastroenteritis in Sri Lanka. Journal of Clinical Microbiology 49(1): 364-366
Davis, J.; Fairley, D.; Christie, S.; Coyle, P.; Tubman, R.; Shields, M.D. 2015: Human parechovirus infection in neonatal intensive care. Pediatric Infectious Disease Journal 34(2): 121-124
Fischer, T.K.; Midgley, S.; Dalgaard, C.; Nielsen, A.Y. 2014: Human parechovirus infection, Denmark. Emerging Infectious Diseases 20(1): 83-87
Shan, T.L.; Wang, C.M.; Cui, L.; Delwart, E.; Yuan, C.L.; Zhao, W.; Guo, W.; Dai, X.Q.; Yu, Y.; Hua, X.G. 2010: Human parechovirus infections in monkeys with diarrhea, China. Emerging Infectious Diseases 16(7): 1168-1169
Piralla, A.; Furione, M.; Rovida, F.; Marchi, A.; Stronati, M.; Gerna, G.; Baldanti, F. 2012: Human parechovirus infections in patients admitted to hospital in Northern Italy, 2008-2010. Journal of medical virology 84(4): 686-690
Schuffenecker, I.; Javouhey, E.; Gillet, Y.; Kugener, B.éa.; Billaud, G.èv.; Floret, D.; Lina, B.; Morfin, F. 2012: Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 54(4): 337-341
De Vries, M.; Pyrc, K.; Berkhout, R.; Vermeulen-Oost, W.; Dijkman, R.; Jebbink, M.F.; Bruisten, S.; Berkhout, B.; van der Hoek, L. 2008: Human parechovirus type 1, 3, 4, 5, and 6 detection in picornavirus cultures. Journal of Clinical Microbiology 46(2): 759-762
Kolehmainen, P.; Jääskeläinen, A.; Blomqvist, S.; Kallio-Kokko, H.; Nuolivirta, K.; Helminen, M.; Roivainen, M.; Lappalainen, M.; Tauriainen, S. 2014: Human parechovirus type 3 and 4 associated with severe infections in young children. Pediatric Infectious Disease Journal 33(11): 1109-1113
Calvo, C.; García-García, M.L.; Arroyas, M.; Trallero, G.; Cabrerizo, M. 2014: Human parechovirus-3 infection in a neonate with fever and suspected sepsis. Anales de Pediatria 81(1): 49-51
Levorson, R.E.; Jantausch, B.A.; Wiedermann, B.L.; Spiegel, H.M.L.; Campos, J.M. 2009: Human parechovirus-3 infection: emerging pathogen in neonatal sepsis. Pediatric Infectious Disease Journal 28(6): 545-547
Piñeiro, L.; Vicente, D.; Montes, M.; Hernández-Dorronsoro, U.; Cilla, G. 2010: Human parechoviruses in infants with systemic infection. Journal of Medical Virology 82(10): 1790-1796
Kokko, H. 2008: Human parental age difference and offspring count: and we still do not know what men or women want. Biology letters 4(3): 259-60; author reply 261
Kanai, R.; Bahrami, B.; Rees, G. 2010: Human parietal cortex structure predicts individual differences in perceptual rivalry. Current Biology: Cb 20(18): 1626-1630
Kouritas, V.K.; Hatzoglou, C.; Foroulis, C.N.; Gourgoulianis, K.I. 2008: Human parietal pleura present electrophysiology variations according to location in pleural cavity. Interactive Cardiovascular and Thoracic Surgery 7(4): 544-547
Molinari, E.; Baraldi, P.; Campanella, M.; Duzzi, D.; Nocetti, L.; Pagnoni, G.; Porro, C.A. 2013: Human parietofrontal networks related to action observation detected at rest. Cerebral Cortex 23(1): 178-186
Bräuer, L.; Möschter, S.; Beileke, S.; Jäger, K.; Garreis, F.; Paulsen, F.P. 2009: Human parotid and submandibular glands express and secrete surfactant proteins A, B, C and D. Histochemistry and Cell Biology 132(3): 331-338
Abdolhosseini, M.; Sotsky, J.B.; Shelar, A.P.; Joyce, P.B.M.; Gorr, S.-U. 2012: Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain. Molecular and Cellular Biochemistry 359(1-2): 1-8
Hao, J.; Zhu, W.; Sheng, C.; Yu, Y.; Zhou, Q. 2009: Human parthenogenetic embryonic stem cells: one potential resource for cell therapy. Science in China. Series C Life Sciences 52(7): 599-602
Turovets, N.; D'Amour, K.A.; Agapov, V.; Turovets, I.; Kochetkova, O.; Janus, J.; Semechkin, A.; Moorman, M.A.; Agapova, L. 2011: Human parthenogenetic stem cells produce enriched populations of definitive endoderm cells after trichostatin a pretreatment. Differentiation; Research in Biological Diversity 81(5): 292-298
Benjamin, L.A.; Lewthwaite, P.; Vasanthapuram, R.; Zhao, G.; Sharp, C.; Simmonds, P.; Wang, D.; Solomon, T. 2011: Human parvovirus 4 as potential cause of encephalitis in children, India. Emerging Infectious Diseases 17(8): 1484-1487
Slavov, S.N.; Kashima, S.; Rocha-Junior, M.C.; Silva-Pinto, A.C.; Oliveira, L.C.; Eis-Hübinger, A.M.; Covas, D.T. 2015: Human parvovirus 4 in Brazilian patients with haemophilia, beta-thalassaemia major and volunteer blood donors. Haemophilia: the Official Journal of the World Federation of Hemophilia 21(1): E86-E88
Biagini, P.; Dussol, B.; Touinssi, M.; Brunet, P.; Picard, C.; Moal, V.ér.; Belhouchet, M.; Gallian, P.; Cantaloube, J.-F.ço.; Attoui, H.; Berland, Y.; de Micco, P. 2008: Human parvovirus 4 in kidney transplant patients, France. Emerging Infectious Diseases 14(11): 1811-1812
Drexler, J.F.; Reber, U.; Muth, D.; Herzog, P.; Annan, A.; Ebach, F.; Sarpong, N.; Acquah, S.; Adlkofer, J.; Adu-Sarkodie, Y.; Panning, M.; Tannich, E.; May, J.ür.; Drosten, C.; Eis-Hübinger, A.M. 2012: Human parvovirus 4 in nasal and fecal specimens from children, Ghana. Emerging Infectious Diseases 18(10): 1650-1653
Servant-Delmas, A.; Laperche, S.; Mercier, M.él.; Elghouzzi, M.-H.él.èn.; Lionnet, F.ço.; Stankovic, K.; Girot, R.; Lefrère, J.-J. 2009: Human parvovirus 4 in recipients of cellular products and in blood donors: epidemiologic similarity with B19 parvovirus. Transfusion 49(8): 1771-1773
Delwart, E. 2012: Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?. Transfusion 52(7): 1398-1403
Servant-Delmas, A.; Laperche, S.; Lionnet, F.ço.; Sharp, C.; Simmonds, P.; Lefrère, J.-J. 2014: Human parvovirus 4 infection in low- and high-risk French individuals. Transfusion 54(3): 744-745
Lavoie, M.; Sharp, C.P.; Pépin, J.; Pennington, C.; Foupouapouognigni, Y.; Pybus, O.G.; Njouom, R.; Simmonds, P. 2012: Human parvovirus 4 infection, Cameroon. Emerging Infectious Diseases 18(4): 680-683
May, J.ür.; Drexler, J.F.; Reber, U.; Sarpong, N.; Adjei, O.; Panning, M.; Drosten, C.; Eis-Hübinger, A.M. 2012: Human parvovirus 4 viremia in young children, Ghana. Emerging Infectious Diseases 18(10): 1690-1692
Cefalo, M.G.; Arlotta, A.; Maurizi, P.; Russo, I.; Sani, I.; Battista, A.; Mastrangelo, S.; Ruggiero, A.; Riccardi, R. 2012: Human parvovirus B 19 and Epstein-Barr virus co-infection in a child with hereditary spherocytosis. European Review for Medical and Pharmacological Sciences 16(2): 265-269
Zakrzewska, K.; Corcioli, F.; Carlsen, K.M.; Giuggioli, D.; Fanci, R.; Rinieri, A.; Ferri, C.; Azzi, A. 2009: Human parvovirus B19 (B19V) infection in systemic sclerosis patients. Intervirology 52(5): 279-282
Lou, S.; Luo, Y.; Cheng, F.; Huang, Q.; Shen, W.; Kleiboeker, S.; Tisdale, J.F.; Liu, Z.; Qiu, J. 2012: Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M. Journal of Virology 86(19): 10748-10758
Tsai, C.-C.; Chiu, C.-C.; Hsu, J.-D.; Hsu, H.-S.; Tzang, B.-S.; Hsu, T.-C. 2013: Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice. Plos one 8(3): E59724
Jain, P.; Jain, A.; Khan, D.N.; Kumar, M. 2013: Human parvovirus B19 associated dilated cardiomyopathy. BMJ Case Reports
Wan, Z.; Zhi, N.; Wong, S.; Keyvanfar, K.; Liu, D.; Raghavachari, N.; Munson, P.J.; Su, S.; Malide, D.; Kajigaya, S.; Young, N.S. 2010: Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. Journal of Clinical Investigation 120(10): 3530-3544
Knoester, M.; von dem Borne, P.A.; Vossen, A.C.T.M.; Kroes, A.C.M.; Claas, E.C.J. 2012: Human parvovirus B19 genotype 3 associated with chronic anemia after stem cell transplantation, missed by routine PCR testing. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 54(4): 368-370
Khameneh, Z.R.; Hanifian, H.; Barzegari, R.; Sepehrvand, N. 2014: Human parvovirus B19 in Iranian pregnant women: a serologic survey. Indian Journal of Pathology and Microbiology 57(3): 442-444
Ibrahem, W.N.; Hasony, H.J.; Hassan, J.G. 2014: Human parvovirus B19 in childhood acute lymphoblastic leukaemia in Basrah. JPMA. Journal of the Pakistan Medical Association 64(1): 9-12
Eid, A.J.; Chen, S.F. 2013: Human parvovirus B19 in solid organ transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 13(Suppl 4): 201-205
Thammasri, K.; Rauhamäki, S.; Wang, L.; Filippou, A.; Kivovich, V.; Marjomäki, V.; Naides, S.J.; Gilbert, L. 2013: Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. Plos one 8(6): E67179
Von Landenberg, P.; Lehmann, H.W.; Modrow, S. 2007: Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmunity Reviews 6(5): 278-285
Luo, Y.; Kleiboeker, S.; Deng, X.; Qiu, J. 2013: Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication. Journal of Virology 87(23): 12766-12775
Nagai, Y.; Hara, N.; Maeda, T.; Iwata, M.; Domon, K.; Ishii, T.; Yoshizawa, S.; Akimoto, T.; Kato, H.; Urita, S.; Nakanishi, K.; Sugimoto, M. 2009: Human parvovirus B19 infection in 15 adults--two-year Toho University Hospital study. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 83(1): 45-51
Alves, M.Teodoro.; Vilaça, S.Simone.; Carvalho, M.das.Graças.; Fernandes, A.Paula.; Dusse, L.Maria.Sant'.Ana.; Gomes, K.Braga. 2013: Human parvovirus B19 infection in a renal transplant recipient: a case report. Bmc Research Notes 6: 28
Diallo, D.-A.; Guindo, A.; Dorie, A.; Djibo, N.; Algiman, E.; Ouane, O.-D.; Diakité, A.-A.; Traoré, F.-F.; Ag Baraika, M.; Dembélé, A.-K.; Tchernia, G. 2011: Human parvovirus B19 infection in sickle cell anemia patient in Mali: a case-control study. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 18(9): 962-965
Ignatovich, I.V.; Hobbs, J.A. 2013: Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression. Virology 446(1-2): 173-179
Saeki, T.; Shibuya, M.; Sawada, H.; Miyamura, S.; Nakano, M.; Gejyo, F.; Arakawa, M. 2001: Human parvovirus B19 infection mimicking systemic lupus erythematosus. Modern Rheumatology 11(4): 308-313
Tzang, B.-S.; Chen, D.-Y.; Tsai, C.-C.; Chiang, S.-Y.; Lin, T.-M.; Hsu, T.-C. 2010: Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen. Journal of Biomedical Science 17: 40
Sánchez-Rodríguez, S.P.; Münch-Anguiano, Lía.; Echeverría, O.; Vázquez-Nin, G.; Mora-Pale, M.; Dordick, J.S.; Bustos-Jaimes, I. 2012: Human parvovirus B19 virus-like particles: In vitro assembly and stability. Biochimie 94(3): 870-878
Bock, C-Thomas.; Klingel, K.; Kandolf, R. 2010: Human parvovirus B19-associated myocarditis. New England Journal of Medicine 362(13): 1248-1249
Shimohata, H.; Higuchi, T.; Ogawa, Y.; Fujita, S.; Nagai, M.; Imaizumi, M.; Maruyama, H.; Hirayama, K.; Kobayashi, M. 2013: Human parvovirus B19-induced acute glomerulonephritis: a case report. Renal Failure 35(1): 159-162
Kobayashi, Y.; Hatta, Y.; Ishiwatari, Y.; Kanno, H.; Takei, M. 2014: Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature. Bmc Research Notes 7: 137
Zhang, X. 2010: Human parvovirus B19/PARV4 infection is probably associated with chronic hepatitis B/C. Bing du Xue Bao 26(2): 153-157
Rogo, L.D.; Mokhtari-Azad, T.; Kabir, M.H.; Rezaei, F. 2014: Human parvovirus B19: a review. Acta Virologica 58(3): 199-213
Slavov, S.N.; Kashima, S.; Pinto, A.C.S.; Covas, D.T. 2011: Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. Fems Immunology and Medical Microbiology 62(3): 247-262
Corcioli, F.; Zakrzewska, K.; Fanci, R.; De Giorgi, V.; Innocenti, M.; Rotellini, M.; Di Lollo, S.; Azzi, A. 2010: Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virology Journal 7: 272
Liu, S.-C.; Tsai, C.-T.; Wu, C.-K.; Yu, M.-F.; Wu, M.-Z.; Lin, L.-I.; Wang, S.-S.; Hwang, J.-J.; Tseng, Y.-Z.; Chiang, F.-T.; Tseng, C.-D. 2009: Human parvovirus b19 infection in patients with coronary atherosclerosis. Archives of Medical Research 40(7): 612-617
Bork, K. 2011: Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency. Expert Review of Clinical Immunology 7(6): 723-733
Zhu, S.-C.; Shi, D.-P.; Xuan, A. 2012: Human patellar cartilage: echo planar diffusion-weighted MR imaging findings at 3.0 T. Clinical Imaging 36(3): 199-202
Reeves, N.D.; Maganaris, C.N.; Maffulli, N.; Rittweger, J. 2009: Human patellar tendon stiffness is restored following graft harvest for anterior cruciate ligament surgery. Journal of Biomechanics 42(7): 797-803
Lippold, S.; Xu, H.; Ko, A.; Li, M.; Renaud, G.; Butthof, A.; Schröder, R.; Stoneking, M. 2014: Human paternal and maternal demographic histories: insights from high-resolution y chromosome and mtDNA sequences. Investigative Genetics 5: 13
Tarkhnishvili, D.; Gavashelishvili, A.; Murtskhvaladze, M.; Gabelaia, M.; Tevzadze, G. 2014: Human paternal lineages, languages, and environment in the Caucasus. Human Biology 86(2): 113-130
Barnett-Cowan, M.; Bülthoff, H.H. 2013: Human path navigation in a three-dimensional world. Behavioral and Brain Sciences 36(5): 544-545; Discussion: 571-587
Sutherland, K.P.; Shaban, S.; Joyner, J.L.; Porter, J.W.; Lipp, E.K. 2011: Human pathogen shown to cause disease in the threatened eklhorn coral Acropora palmata. Plos one 6(8): E23468
Panayidou, S.; Ioannidou, E.; Apidianakis, Y. 2014: Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings. Virulence 5(2): 253-269
Venclíková, K.ýn.; Betášová, L.; Sikutová, S.; Jedličková, P.; Hubálek, Z.ěk.; Rudolf, I. 2014: Human pathogenic borreliae in Ixodes ricinus ticks in natural and urban ecosystem (Czech Republic). Acta Parasitologica 59(4): 717-720
Wu, S.X.; Guo, N.R.; Li, X.F.; Liao, W.Q.; Chen, M.; Zhang, Q.Q.; Li, C.Y.; Li, R.Y.; Bulmer, G.S.; Li, D.M.; Xi, L.Y.; Lu, S.; Liu, B.; Zheng, Y.C.; Ran, Y.P.; Kuan, Y.Z. 2011: Human pathogenic fungi in China--emerging trends from ongoing national survey for 1986, 1996, and 2006. Mycopathologia 171(6): 387-393
Krüger, D.H.; Schönrich, Günther.; Klempa, B. 2011: Human pathogenic hantaviruses and prevention of infection. Human Vaccines 7(6): 685-693
Mazaheritehrani, E.; Sala, A.; Orsi, C.Francesca.; Neglia, R.Giovanna.; Morace, G.; Blasi, E.; Cermelli, C. 2014: Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro. Virus Research 179: 153-160
Sapkota, A.R.; Berger, S.; Vogel, T.M. 2010: Human pathogens abundant in the bacterial metagenome of cigarettes. Environmental Health Perspectives 118(3): 351-356
Létourneau, V.ér.; Nehmé, B.; Mériaux, A.; Massé, D.; Cormier, Y.; Duchaine, C. 2010: Human pathogens and tetracycline-resistant bacteria in bioaerosols of swine confinement buildings and in nasal flora of hog producers. International Journal of Hygiene and Environmental Health 213(6): 444-449
Sidhu, J.P.S.; Toze, S.G. 2009: Human pathogens and their indicators in biosolids: a literature review. Environment International 35(1): 187-201
Tryland, M.; Nesbakken, T.; Robertson, L.; Grahek-Ogden, D.; Lunestad, B.T. 2014: Human pathogens in marine mammal meat – a northern perspective. Zoonoses and Public Health 61(6): 377-394
Cinquemani, C. 2011: Human pathogens, nosocomial infections, heat-sensitive textile implants, and an innovative approach to deal with them. Journal of Industrial Microbiology and Biotechnology 38(1): 29-37
DeCOURSEY, E. 1948: Human pathologic anatomy of ionizing radiation effects of the atomic bomb explosions. Military Surgeon 102(6): 427-432
Nishihara, H. 2014: Human pathological basis of blood vessels and stromal tissue for nanotechnology. Advanced Drug Delivery Reviews 74: 19-27
Ivanova, M.M.; Borodachev, E.N.; Sazonova, M.A. 2012: Human pathologies associated with mutations of mitochondrial genome. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 115-122
DeMaria, S.; Levine, A.I.; Cohen, L.B. 2008: Human patient simulation and its role in endoscopic sedation training. Gastrointestinal Endoscopy Clinics of North America 18(4): 801
McQueen, S.; Dickinson, M.; Pimblett, M. 2010: Human patient simulation can aid staff training in non-invasive ventilation. Nursing Times 106(26): 20
Jansson, M.M.; Ala-Kokko, T.I.; Ohtonen, P.P.; Meriläinen, M.H.; Syrjälä, H.P.; Kyngäs, H.A. 2014: Human patient simulation education in the nursing management of patients requiring mechanical ventilation: a randomized, controlled trial. American Journal of Infection Control 42(3): 271-276
Davis, A.H.; Kimble, L.P. 2011: Human patient simulation evaluation rubrics for nursing education: measuring the Essentials of Baccalaureate Education for Professional Nursing Practice. Journal of Nursing Education 50(11): 605-611
Seybert, A.L.; Kobulinsky, L.R.; McKaveney, T.P. 2008: Human patient simulation in a pharmacotherapy course. American Journal of Pharmaceutical Education 72(2): 37
Roche, J. 2010: Human patient simulation in critical care. AACN Advanced Critical Care 21(1): 17-20
Murray, W.Bosseau.; Wood, J.; Schwab, M.; Fritz, M.; Karpa, K.Dowhower. 2010: Human patient simulation in pharmacology graduate education: bridging the bench-to-bedside gap. Molecular Interventions 10(3): 127-132
Shinnick, M.A.; Woo, M.A.; Mentes, J.C. 2011: Human patient simulation: state of the science in prelicensure nursing education. Journal of Nursing Education 50(2): 65-72
Henneman, E.A.; Cunningham, H.; Roche, J.P.; Curnin, M.E. 2007: Human patient simulation: teaching students to provide safe care. Nurse Educator 32(5): 212-217
Hassan, Z-Udin.; D'Addario, M.; Sloan, P.A. 2007: Human patient simulator for training oral and maxillofacial surgery residents in general anesthesia and airway management. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons 65(9): 1892-1897
Browne, H.; Cheetham, O.; Mason, J. 2012: Human patient simulator-based training … for the olympics!. Journal of Surgical Education 69(2): 137
Howard, V.M.; Ross, C.; Mitchell, A.M.; Nelson, G.M. 2010: Human patient simulators and interactive case studies: a comparative analysis of learning outcomes and student perceptions. Computers Informatics Nursing: Cin 28(1): 42-48
El-Bahnasawy, M.M.; Abdel, F.E.E.; Morsy, T.A. 2012: Human pediculosis: a critical health problem and what about nursing policy?. Journal of the Egyptian Society of Parasitology 42(3): 541-562
Chowdhury, A.Y.; Tavis, J.E.; George, S.L. 2014: Human pegivirus (GB virus C) NS3 protease activity inhibits induction of the type i interferon response and is not inhibited by HCV NS3 protease inhibitors. Virology 456-457: 300-309
Chivero, E.T.; Bhattarai, N.; Rydze, R.T.; Winters, M.A.; Holodniy, M.; Stapleton, J.T. 2014: Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro. Journal of General Virology 95(Pt 6): 1307-1319
Trinks, J.; Maestri, M.; Oliveto, Fán.; Del Pino, Ní.; Weissenbacher, M.; Torres, O.Walter.; Oubiña, Jé.Raúl. 2014: Human pegivirus molecular epidemiology in Argentina: potential contribution of Latin American migration to genotype 3 circulation. Journal of medical virology 86(12): 2076-2083
Zanetti, E.M.; Bignardi, C.; Audenino, A.L. 2012: Human pelvis loading rig for static and dynamic stress analysis. Acta of Bioengineering and Biomechanics 14(2): 61-66
de Arruda, H.Oliveira.; de Lima, H.; Ortiz, V. 2007: Human penile ossification: case report. Sao Paulo Medical Journal 125(2): 124-125
Latif, B.; Omar, E.; Heo, C.Chin.; Othman, N.; Tappe, D. 2011: Human pentastomiasis caused by Armillifer moniliformis in Malaysian Borneo. American Journal of Tropical Medicine and Hygiene 85(5): 878-881
Yao, M.Hua.; Wu, F.; Tang, L.Fang. 2008: Human pentastomiasis in China: case report and literature review. Journal of Parasitology 94(6): 1295-1298
Lightowlers, R.N.; Chrzanowska-Lightowlers, Z.M.A. 2013: Human pentatricopeptide proteins: only a few and what do they do?. Rna Biology 10(9): 1433-1438
Tamura, Y.; Ono, T.; Kuwana, M.; Inoue, K.; Takei, M.; Yamamoto, T.; Kawakami, T.; Fujita, J.; Kataoka, M.; Kimura, K.; Sano, M.; Daida, H.; Satoh, T.; Fukuda, K. 2012: Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension. Plos one 7(9): E45834
Braunschweig, A.; Józsi, Mály. 2011: Human pentraxin 3 binds to the complement regulator c4b-binding protein. Plos one 6(8): E23991
Xu, J.; Sclabassi, R.J.; Liu, Q.; Chaparro, L.F.; Marchessault, R.; Sun, M. 2007: Human perception based video preprocessing for telesurgery. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2007: 3086-3089
Liu, M.-C.; Aquilino, S.A.; Lund, P.S.; Vargas, M.A.; Diaz-Arnold, A.M.; Gratton, D.G.; Qian, F. 2010: Human perception of dental porcelain translucency correlated to spectrophotometric measurements. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 19(3): 187-193
Wan, M.; Bolger, N.; Champagne, F.A. 2012: Human perception of fear in dogs varies according to experience with dogs. Plos one 7(12): E51775
Neznal, M.; Neznal, M. 2008: Human perception of radon risk and radon mitigation: some remarks. Radiation Protection Dosimetry 130(1): 85-87
Kappers, A.M.L. 2011: Human perception of shape from touch. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 366(1581): 3106-3114
Tallet, C.él.; Spinka, M.; Maruscáková, I.; Simecek, P. 2010: Human perception of vocalizations of domestic piglets and modulation by experience with domestic pigs (Sus scrofa). Journal of Comparative Psychology 124(1): 81-91
Fleming, R.W. 2012: Human perception: Visual heuristics in the perception of glossiness. Current Biology: Cb 22(20): R865-R866
Enns, J.T. 2013: Human perception: a science of synergy. Canadian Journal of Experimental Psychology 67(4): 238-247
Cardoso-Leite, P.; Waszak, F.; Lepsien, J.ör. 2014: Human perceptual decision making: disentangling task onset and stimulus onset. Human Brain Mapping 35(7): 3170-3187
Tartaglia, E.M.; Bamert, L.; Mast, F.W.; Herzog, M.H. 2009: Human perceptual learning by mental imagery. Current Biology: Cb 19(24): 2081-2085
Praper, T.; Sonnen, A.; Viero, G.; Kladnik, A.; Froelich, C.J.; Anderluh, G.; Dalla Serra, M.; Gilbert, R.J.C. 2011: Human perforin employs different avenues to damage membranes. Journal of Biological Chemistry 286(4): 2946-2955
Trapani, J.A.; Thia, K.Y.T.; Andrews, M.; Davis, I.D.; Gedye, C.; Parente, P.; Svobodova, S.; Chia, J.; Browne, K.; Campbell, I.G.; Phillips, W.A.; Voskoboinik, I.; Cebon, J.S. 2013: Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology 2(4): E24185
Praper, T.; Besenicar, M.P.; Istinic, H.; Podlesek, Z.; Metkar, S.S.; Froelich, C.J.; Anderluh, G. 2010: Human perforin permeabilizing activity, but not binding to lipid membranes, is affected by pH. Molecular Immunology 47(15): 2492-2504
Borland, R.G.; Nicholson, A.N. 1974: Human performance after a barbiturate (heptabarbitone). British Journal of Clinical Pharmacology 1(3): 209-215
Adams, O.S.; Chiles, W.D. 1961: Human performance as a function of the work-rest ratio during prolonged confinement. Asd Technical Report. United States. Air Force. Systems Command. Aeronautical Systems Division 61(720): 44
Reichenbach, J.; Onnasch, L.; Manzey, D. 2011: Human performance consequences of automated decision aids in states of sleep loss. Human Factors 53(6): 717-728
Onnasch, L.; Wickens, C.D.; Li, H.; Manzey, D. 2014: Human performance consequences of stages and levels of automation: an integrated meta-analysis. Human Factors 56(3): 476-488
Clark, B.; Graybiel, A. 1960: Human performance during adaptation to stress in the Pensacola Slow Rotation Room. (Res MR005. 13-6001 Subtask 1, Rep). Research Report. Naval School of Aviation Medicine 52: 1-25
Rabbi, A.F.; Ivanca, K.; Putnam, A.V.; Musa, A.; Thaden, C.B.; Fazel-Rezai, R. 2009: Human performance evaluation based on EEG signal analysis: a prospective review. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 1879-1882
Cullen, R.H.; Rogers, W.A.; Fisk, A.D. 2013: Human performance in a multiple-task environment: effects of automation reliability on visual attention allocation. Applied Ergonomics 44(6): 962-968
King, B.W.; Reisner, L.A.; Ellis, R.D.; Klein, M.D.; Auner, G.W.; Pandya, A.K. 2010: Human performance in the task of port placement for biosensor use. International Journal of Medical Robotics + Computer Assisted Surgery: Mrcas 6(2): 150-159
Chang, Y.-H.; Yeh, C.-H. 2010: Human performance interfaces in air traffic control. Applied Ergonomics 41(1): 123-129
Jia, D.; Bhatti, A.; Nahavandi, S.; Horan, B. 2013: Human performance measures for interactive haptic-audio-visual interfaces. IEEE Transactions on Haptics 6(1): 46-57
Kopec, C.D.; Brody, C.D. 2010: Human performance on the temporal bisection task. Brain and Cognition 74(3): 262-272
Deuster, P.A.; O'Connor, F.G.; Henry, K.A.; Martindale, V.E.; Talbot, L.; Jonas, W.; Friedl, K. 2007: Human performance optimization: an evolving charge to the Department of Defense. Military medicine 172(11): 1133-1137
Carlson, L.D. 1961: Human performance under different thermal loads. Project Report. Usaf School of Aviation Medicine 61(43): 1-13
Walker, G.H.; Stanton, N.A.; Salmon, P.M.; Jenkins, D.P. 2014: Human performance under two different command and control paradigms. Applied Ergonomics 45(3): 706-713
Shibli, J.A.; Grassi, S.; de Figueiredo, L.C.; Feres, M.; Iezzi, G.; Piattelli, A. 2007: Human peri-implant bone response to turned and oxidized titanium implants inserted and retrieved after 2 months. Implant Dentistry 16(3): 252-259
Bae, W.-J.; Chang, S.-W.; Lee, S.-I.; Kum, K.-Y.; Bae, K.-S.; Kim, E.-C. 2010: Human periodontal ligament cell response to a newly developed calcium phosphate-based root canal sealer. Journal of Endodontics 36(10): 1658-1663
Adachi, K.; Amemiya, T.; Nakamura, T.; Honjyo, K.; Kumamoto, S.; Yamamoto, T.; Bentley, A.J.; Fullwood, N.J.; Kinoshita, S.; Kanamura, N. 2014: Human periodontal ligament cell sheets cultured on amniotic membrane substrate. Oral Diseases 20(6): 582-590
Yan, X.-Z.; Both, S.K.; Yang, P.-S.; Jansen, J.A.; van den Beucken, J.J.J.P.; Yang, F. 2014: Human periodontal ligament derived progenitor cells: effect of STRO-1 cell sorting and Wnt3a treatment on cell behavior. Biomed Research International 2014: 145423
Chowdhary, K.Y.; George, J.P.; Gowda, P.; Rao, J.A. 2013: Human periodontal ligament fibroblast response to rhPDGF-BB application on periodontally diseased root surfaces-in vitro. Growth Factors 31(4): 130-138
El-Awady, A.R.; Lapp, C.A.; Gamal, A.Y.; Sharawy, M.M.; Wenger, K.H.; Cutler, C.W.; Messer, R.L.W. 2013: Human periodontal ligament fibroblast responses to compression in chronic periodontitis. Journal of Clinical Periodontology 40(7): 661-671
Kook, S.-H.; Jang, Y.-S.; Lee, J.-C. 2011: Human periodontal ligament fibroblasts stimulate osteoclastogenesis in response to compression force through TNF-α-mediated activation of CD4+ T cells. Journal of Cellular Biochemistry 112(10): 2891-2901
Li, B.; Jung, H.-J.; Kim, S.-M.; Kim, M.-J.; Jahng, J.W.; Lee, J.-H. 2013: Human periodontal ligament stem cells repair mental nerve injury. Neural Regeneration Research 8(30): 2827-2837
Coura, G.S.; Garcez, R.C.; de Aguiar, C.B.N.M.; Alvarez-Silva, M.; Magini, R.S.; Trentin, A.G. 2008: Human periodontal ligament: a niche of neural crest stem cells. Journal of Periodontal Research 43(5): 531-536
Sonnaert, M.; Papantoniou, I.; Bloemen, V.; Kerckhofs, G.; Luyten, F.P.; Schrooten, J. 2017: Human periosteal-derived cell expansion in a perfusion bioreactor system: proliferation, differentiation and extracellular matrix formation. Journal of Tissue Engineering and Regenerative Medicine 11(2): 519-530
Ball, M.D.; Bonzani, I.C.; Bovis, M.J.; Williams, A.; Stevens, M.M. 2011: Human periosteum is a source of cells for orthopaedic tissue engineering: a pilot study. Clinical Orthopaedics and Related Research 469(11): 3085-3093
Kawase, T.; Okuda, K.; Kogami, H.; Nakayama, H.; Nagata, M.; Sato, T.; Wolff, L.F.; Yoshie, H. 2010: Human periosteum-derived cells combined with superporous hydroxyapatite blocks used as an osteogenic bone substitute for periodontal regenerative therapy: an animal implantation study using nude mice. Journal of Periodontology 81(3): 420-427
Jansen, E.J.P.; Emans, P.J.; Guldemond, N.A.; van Rhijn, L.W.; Welting, T.J.M.; Bulstra, S.K.; Kuijer, R. 2008: Human periosteum-derived cells from elderly patients as a source for cartilage tissue engineering?. Journal of Tissue Engineering and Regenerative Medicine 2(6): 331-339
Ferretti, C.; Borsari, V.; Falconi, M.; Gigante, A.; Lazzarini, R.; Fini, M.; Di Primio, R.; Mattioli-Belmonte, M. 2012: Human periosteum-derived stem cells for tissue engineering applications: the role of VEGF. Stem Cell Reviews and Reports 8(3): 882-890
Perez-Andres, M.; Paiva, B.; Nieto, W.G.; Caraux, A.; Schmitz, A.; Almeida, J.; Vogt, R.F.; Marti, G.E.; Rawstron, A.C.; Van Zelm, M.C.; Van Dongen, J.J.M.; Johnsen, H.E.; Klein, B.; Orfao, A. 2010: Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. CYTOMETRY. Part B Clinical Cytometry 78(Suppl 1): S47-S60
Nakamura, T.; Tsutsumi, V.; Torimura, T.; Naitou, M.; Iwamoto, H.; Masuda, H.; Hashimoto, O.; Koga, H.; Abe, M.; Ii, M.; Kawamoto, A.; Asahara, T.; Ueno, T.; Sata, M. 2012: Human peripheral blood CD34-positive cells enhance therapeutic regeneration of chronically injured liver in nude rats. Journal of Cellular Physiology 227(4): 1538-1552
Covassin, L.; Laning, J.; Abdi, R.; Langevin, D.L.; Phillips, N.E.; Shultz, L.D.; Brehm, M.A. 2011: Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease. Clinical and Experimental Immunology 166(2): 269-280
Guerreiro, M.; Na, I.-K.; Letsch, A.; Haase, D.; Bauer, S.; Meisel, C.; Roemhild, A.; Reinke, P.; Volk, H.-D.; Scheibenbogen, C. 2010: Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets. European Journal of Immunology 40(6): 1566-1576
Briney, B.S.; Willis, J.R.; Crowe, J.E. 2012: Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes. Plos one 7(5): E36750
Di Stefano, R.; Barsotti, M.C.; Armani, C.; Santoni, T.; Lorenzet, R.; Balbarini, A.; Celi, A. 2009: Human peripheral blood endothelial progenitor cells synthesize and express functionally active tissue factor. Thrombosis Research 123(6): 925-930
King, M.A.; Covassin, L.; Brehm, M.A.; Racki, W.; Pearson, T.; Leif, J.; Laning, J.; Fodor, W.; Foreman, O.; Burzenski, L.; Chase, T.H.; Gott, B.; Rossini, A.A.; Bortell, R.; Shultz, L.D.; Greiner, D.L. 2009: Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clinical and Experimental Immunology 157(1): 104-118
Di Maio, G.; Formichi, P.; Radi, E.; Bianchi, S.; Onnis, A.; Tarquini, E.; Leoncini, L.; Federico, A. 2012: Human peripheral blood lymphocytes and fibroblasts as Notch3 expression models. Journal of Cellular Physiology 227(4): 1771-1775
Mavropoulos, A.; Smyk, D.; Rigopoulou, E.I.; Bogdanos, D.P. 2012: Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases. Methods in Molecular Biology 806: 275-285
Rao, S.P.; Sancho, J.; Campos-Rivera, J.; Boutin, P.M.; Severy, P.B.; Weeden, T.; Shankara, S.; Roberts, B.L.; Kaplan, J.M. 2012: Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis. Plos one 7(6): E39416
Kim, S.-W.; Kim, H.; Cho, H.-J.; Lee, J.-U.; Levit, R.; Yoon, Y.-s. 2010: Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. Journal of the American College of Cardiology 56(7): 593-607
Kühl, A.A.; Pawlowski, N.N.; Grollich, K.; Blessenohl, M.; Westermann, J.ür.; Zeitz, M.; Loddenkemper, C.; Hoffmann, J.ör.C. 2009: Human peripheral gammadelta T cells possess regulatory potential. Immunology 128(4): 580-588
Poliani, P.L.; Kisand, K.; Marrella, V.; Ravanini, M.; Notarangelo, L.D.; Villa, A.; Peterson, P.är.; Facchetti, F. 2010: Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells. American Journal of Pathology 176(3): 1104-1112
Yang, L.-M.; Liu, X.-L.; Zhu, Q.-T.; Zhang, Y.; Xi, T.-F.; Hu, J.; He, C.-F.; Jiang, L. 2011: Human peripheral nerve-derived scaffold for tissue-engineered nerve grafts: histology and biocompatibility analysis. Journal of Biomedical Materials Research. Part B Applied Biomaterials 96(1): 25-33
Takeda, Y.; Nara, H.; Araki, A.; Asao, H. 2014: Human peripheral neutrophils express functional IL-21 receptors. Inflammation 37(5): 1521-1532
Ribeiro, R.; Monteiro, C.át.; Cunha, V.ín.; Oliveira, M.J.é; Freitas, M.; Fraga, A.; Príncipe, P.; Lobato, C.; Lobo, F.; Morais, A.ón.; Silva, V.ít.; Sanches-Magalhães, J.é; Oliveira, J.; Pina, F.; Mota-Pinto, A.; Lopes, C.; Medeiros, R. 2012: Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro. Journal of Experimental and Clinical Cancer Research: Cr 31: 32
Sacca, P.A.; Creydt, V.P.; Choi, H.; Mazza, O.N.és.; Fletcher, S.J.; Vallone, V.B.F.án.; Scorticati, C.; Chasseing, N.A.; Calvo, J.C. 2012: Human periprostatic adipose tissue: its influence on prostate cancer cells. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 30(1): 113-122
Ribeiro, R.; Monteiro, C.át.; Silvestre, R.; Castela, A.; Coutinho, H.; Fraga, A.; Príncipe, P.; Lobato, C.; Costa, C.; Cordeiro-da-Silva, A.; Lopes, J.é M.; Lopes, C.; Medeiros, R. 2012: Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma. Experimental Biology and Medicine 237(10): 1155-1162
Chang, T.L.; Klepper, A.; Ding, J.; Garber, J.; Rapista, A.; Mosoian, A.; Hubner, W.; Gutierrez, J.; Walewski, J.; Abergel, J.; Schiano, T.; Branch, A. 2010: Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates. Journal of Acquired Immune Deficiency Syndromes 53(3): 292-302
Xu, W.; Schlagwein, N.; Roos, A.; van den Berg, T.K.; Daha, M.R.; van Kooten, C. 2007: Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. European Journal of Immunology 37(6): 1594-1599
Jin, J.; Voskerician, G.; Hunter, S.A.; McGee, M.F.; Cavazzola, L.T.; Schomisch, S.; Harth, K.; Rosen, M.J. 2009: Human peritoneal membrane controls adhesion formation and host tissue response following intra-abdominal placement in a porcine model. Journal of Surgical Research 156(2): 297-304
Voskerician, G.; Jin, J.; Hunter, S.A.; Williams, C.P.; White, M.; Rosen, M.J. 2009: Human peritoneal membrane reduces the formation of intra-abdominal adhesions in ventral hernia repair: experimental study in a chronic hernia rat model. Journal of Surgical Research 157(1): 108-114
Lv, Z.-D.; Na, D.; Ma, X.-Y.; Zhao, C.; Zhao, W.-J.; Xu, H.-M. 2011: Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ß1 in vitro. International Journal of Molecular Medicine 27(2): 187-193
Tee, M.M.; Tesch, G.H.; Nikolic-Paterson, D.J.; Brown, F.G. 2007: Human peritoneal mesothelial cells isolated from spent dialysate fluid maintain contaminating macrophages via production of macrophage colony stimulating factor. Nephrology 12(2): 160-165
Askarinam, A.; James, A.W.; Zara, J.N.; Goyal, R.; Corselli, M.; Pan, A.; Liang, P.; Chang, L.; Rackohn, T.; Stoker, D.; Zhang, X.; Ting, K.; Péault, B.; Soo, C. 2013: Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule i protein. Tissue Engineering. Part a 19(11-12): 1386-1397
Pereira, E.A.C.; Wang, S.; Owen, S.L.F.; Aziz, T.Z.; Green, A.L. 2013: Human periventricular grey somatosensory evoked potentials suggest rostrocaudally inverted somatotopy. Stereotactic and Functional Neurosurgery 91(5): 290-297
Ha, B.; Kim, E.-K.; Kim, J.-H.; Lee, H.N.; Lee, K.O.; Lee, S.Y.; Jang, H.H. 2012: Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity. Biochemical and Biophysical Research Communications 421(1): 33-37
Sgreccia, E. 2013: Human person and personalism. Cuadernos de Bioetica: Revista Oficial de la Asociacion Espanola de Bioetica y Etica Medica 24(80): 115-123
Levin, S.A. 1997: Human perspectives on the environment. Trends in Ecology and Evolution 12(3): 91-92
Accetta, D.; Syverson, G.; Bonacci, B.; Reddy, S.; Bengtson, C.; Surfus, J.; Harbeck, R.; Huttenlocher, A.; Grossman, W.; Routes, J.; Verbsky, J. 2011: Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. Journal of Allergy and Clinical Immunology 127(2): 535-538.E1-2
Bobadilla, K.; Sada, E.; Jaime, M.E.; González, Y.; Ramachandra, L.; Rojas, R.E.; Pedraza-Sánchez, S.; Michalak, C.; González-Noriega, A.; Torres, M. 2013: Human phagosome processing of Mycobacterium tuberculosis antigens is modulated by interferon-γ and interleukin-10. Immunology 138(1): 34-46
Taylor, D.; Senac, T. 2014: Human pharmaceutical products in the environment - the "problem" in perspective. Chemosphere 115: 95-99
Khetan, S.K.; Collins, T.J. 2007: Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry. Chemical Reviews 107(6): 2319-2364
Brausch, J.M.; Connors, K.A.; Brooks, B.W.; Rand, G.M. 2012: Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing. Reviews of Environmental Contamination and Toxicology 218: 1-99
Elorriaga, Y.; Marino, D.án.J.; Carriquiriborde, P.; Ronco, A.E. 2013: Human pharmaceuticals in wastewaters from urbanized areas of Argentina. Bulletin of Environmental Contamination and Toxicology 90(4): 397-400
Caminada, D.; Zaja, R.; Smital, T.; Fent, K. 2008: Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1. Aquatic Toxicology 90(3): 214-222
Hu, Y.; Wu, M.; Nishimura, T.; Zheng, M.; Peltz, G. 2013: Human pharmacogenetic analysis in chimeric mice with 'humanized livers'. Pharmacogenetics and Genomics 23(2): 78-83
Polimanti, R.; Iorio, A.; Piacentini, S.; Manfellotto, D.; Fuciarelli, M. 2014: Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine. Pharmacogenomics 15(2): 157-167
Mathis, G.A.; Toggenburger, A.; Pokorny, R.; Autzen, S.; Ibanez, R.; Romeis, P.; Bachmann, H. 2014: Human pharmacokinetic profile of 1,25-dihydroxyvitamin D3-glycoside of herbal origin. Journal of Steroid Biochemistry and Molecular Biology 144 Pt A: 40-43
Fields, B.A.; Reeve, J.; Bartholomaeus, A.; Mueller, U. 2014: Human pharmacokinetic study of tutin in honey; a plant-derived neurotoxin. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 72: 234-241
Patel, H.; Andresen, A.; Vente, A.; Heilmann, H.-D.; Stubbings, W.; Seiberling, M.; Lopez-Lazaro, L.; Pokorny, R.; Labischinski, H. 2011: Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers. Antimicrobial Agents and ChemoTherapy 55(9): 4386-4393
Klickovic, U.; Doberer, D.; Gouya, G.; Aschauer, S.; Weisshaar, S.; Storka, A.; Bilban, M.; Wolzt, M. 2014: Human pharmacokinetics of high dose oral curcumin and its effect on heme oxygenase-1 expression in healthy male subjects. Biomed Research International 2014: 458592
Schaller, G.; Dittrich, P.; Felizeter, M.; Gouya, G.; Leuchten, N.; Kapiotis, S.; Vcelar, B.; Vorauer-Uhl, K.; Wolzt, M. 2012: Human pharmacokinetics of intravenous recombinant human Cu/Zn superoxide dismutase. International Journal of Clinical Pharmacology and Therapeutics 50(6): 413-417
Melilli, B.; Piazza, C.; Vitale, D.C.; Marano, M.R.; Pecori, A.; Mattana, P.; Volsi, V.L.; Iuculano, C.; Cardì, F.; Drago, F. 2011: Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry. European Journal of Drug Metabolism and Pharmacokinetics 36(2): 71-78
Legette, L.; Karnpracha, C.; Reed, R.L.; Choi, J.; Bobe, G.; Christensen, J.M.; Rodriguez-Proteau, R.; Purnell, J.Q.; Stevens, J.F. 2014: Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Molecular Nutrition and Food Research 58(2): 248-255
Burmeister Getz, E.; Fisher, D.M.; Fuller, R. 2009: Human pharmacokinetics/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma. Journal of Clinical Pharmacology 49(9): 1025-1036
Peiró, A.M.; Farré, M.; Roset, P.N.; Carbó, M.; Pujadas, M.; Torrens, M.; Camí, J.; de la Torre, R. 2013: Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart. Psychopharmacology 225(4): 883-893
Ritter, J.M. 2010: Human pharmacology of hydrogen sulfide, putative gaseous mediator. British Journal of Clinical Pharmacology 69(6): 573-575
Jasinski, D.R.; Krishnan, S. 2009: Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers. Journal of Psychopharmacology 23(4): 410-418
Gao, Z.; Kang, Y.; Yu, J.; Ren, L. 2014: Human pharyngeal microbiome may play a protective role in respiratory tract infections. Genomics Proteomics and Bioinformatics 12(3): 144-150
St Hilaire, M.A.; Gooley, J.J.; Khalsa, S.B.S.; Kronauer, R.E.; Czeisler, C.A.; Lockley, S.W. 2012: Human phase response curve to a 1 h pulse of bright white light. Journal of Physiology 590(13): 3035-3045
Rüger, M.; St Hilaire, M.A.; Brainard, G.C.; Khalsa, S.-B.S.; Kronauer, R.E.; Czeisler, C.A.; Lockley, S.W. 2013: Human phase response curve to a single 6.5 h pulse of short-wavelength light. Journal of Physiology 591(1): 353-363
Revell, V.L.; Molina, T.A.; Eastman, C.I. 2012: Human phase response curve to intermittent blue light using a commercially available device. Journal of Physiology 590(19): 4859-4868
Burgess, H.J.; Revell, V.L.; Molina, T.A.; Eastman, C.I. 2010: Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. Journal of Clinical Endocrinology and Metabolism 95(7): 3325-3331
Ciovacco, W.A.; Raskind, W.H.; Kacena, M.A. 2008: Human phenotypes associated with GATA-1 mutations. Gene 427(1-2): 1-6
Runager, K.; Basaiawmoit, R.V.; Deva, T.; Andreasen, M.; Valnickova, Z.; Sørensen, C.S.; Karring, H.; Thøgersen, I.B.; Christiansen, G.; Underhaug, J.; Kristensen, T.; Nielsen, N.C.; Klintworth, G.K.; Otzen, D.E.; Enghild, J.J. 2011: Human phenotypically distinct TGFBi corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp. Journal of Biological Chemistry 286(7): 4951-4958
Boonyapiwat, B.; Panaretou, B.; Forbes, B.; Mitchell, S.C.; Steventon, G.B. 2009: Human phenylalanine monooxygenase and thioether metabolism. Journal of Pharmacy and Pharmacology 61(1): 63-67
Mast, T.G.; Samuelsen, C.L. 2009: Human pheromone detection by the vomeronasal organ: unnecessary for mate selection?. Chemical Senses 34(6): 529-531
Meyer, B.T.; Jürgens, T.; Wesker, T.; Brand, T.; Kollmeier, B. 2010: Human phoneme recognition depending on speech-intrinsic variability. Journal of the Acoustical Society of America 128(5): 3126-3141
Qiu, J.; Yang, G.; Lin, A.; Shen, Z.; Wang, D.; Ding, L. 2014: Human phosphatidylethanolamine-binding protein 4 promoted the radioresistance of human rectal cancer by activating Akt in an ROS-dependent way. Plos one 9(3): E90062
Liu, H.; Qiu, J.; Li, N.; Chen, T.; Cao, X. 2010: Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src. Journal of Biological Chemistry 285(29): 21934-21942
Fan, J.; Teng, X.; Liu, L.; Mattaini, K.R.; Looper, R.E.; Vander Heiden, M.G.; Rabinowitz, J.D. 2015: Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. Acs Chemical Biology 10(2): 510-516
Kusano, S.; Eizuru, Y. 2012: Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax. Virology 432(2): 343-352
Sutherland, J.C.; Sutherland, B.M. 1975: Human photoreactivating enzyme action spectrum and safelight conditions. Biophysical Journal 15(5): 435-440
Abràmoff, M.D.; Mullins, R.F.; Lee, K.; Hoffmann, J.M.; Sonka, M.; Critser, D.B.; Stasheff, S.F.; Stone, E.M. 2013: Human photoreceptor outer segments shorten during light adaptation. Investigative Ophthalmology and Visual Science 54(5): 3721-3728
Renner, R. 2000: Human phthalate study changes exposure picture. Environmental Science and Technology 34(21): 451a-452a
Scanni, G. 2012: Human phthiriasis. can dermoscopy really help dermatologists? Entodermoscopy: a new dermatological discipline on the edge of entomology. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 147(1): 111-117
Richardson, G.S. 2007: Human physiological models of insomnia. Sleep Medicine 8(Suppl 4): S9-14
Grocott, M.P.W. 2008: Human physiology in extreme environments: lessons from life at the limits?. Postgraduate Medical Journal 84(987): 2-3
Wübben, Y. 2010: Human physiology: images and practices of the reflex. Early Science and Medicine 15(1-2): 105-121
Natochin, I.V. 2010: Human physiology: kidney. Fiziologiia Cheloveka 36(5): 9-18
Dixson, B.J.; Dixson, A.F.; Bishop, P.J.; Parish, A. 2010: Human physique and sexual attractiveness in men and women: a new Zealand-U.S. comparative study. Archives of Sexual Behavior 39(3): 798-806
Lukic, S.; Chen, K. 2011: Human pi RNAs are under selection in Africans and repress transposable elements. Molecular Biology and Evolution 28(11): 3061-3067
Van Leeuwen, M.; Williams, M.M.W.; Koraka, P.; Simon, J.H.; Smits, S.L.; Osterhaus, A.D.M.E. 2010: Human picobirnaviruses identified by molecular screening of diarrhea samples. Journal of Clinical Microbiology 48(5): 1787-1794
Arianayagam, S.; Ryan, T.J. 2014: Human pigmentation: a side effect adapted from a primitive organism's survival, acting through cell attachment with an affinity for the keratinocyte and for elastin: Part i. Indian Dermatology Online Journal 5(2): 201-209
Arianayagam, S.; Ryan, T.J. 2014: Human pigmentation: a side effect adapted from a primitive organism's survival. Part 2: the melanocyte as mentor of the keratinocye. Indian Dermatology Online Journal 5(3): 328-333
Joosten, E.R.M.; Neri, P. 2012: Human pitch detectors are tuned on a fine scale, but are perceptually accessed on a coarse scale. Biological Cybernetics 106(8-9): 465-482
Hook, V.; Funkelstein, L.; Toneff, T.; Mosier, C.; Hwang, S.-R. 2009: Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, alpha-MSH, and beta-endorphin. Endocrine 35(3): 429-437
Solov'ev, G.S.; Bogdanov, A.V.; Panteleev, S.M.; Ianin, V.L. 2007: Human pituitary embryonic morphogenesis. Morfologiia 132(4): 52-56
Bárcena, A.; Muench, M.O.; Kapidzic, M.; Gormley, M.; Goldfien, G.A.; Fisher, S.J. 2011: Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion 51(Suppl 4): 94s
Pigatto, P.D.; Minoia, C.; Ronchi, A.; Guzzi, G. 2013: Human placenta and markers of heavy metals exposure. Environmental Health Perspectives 121(1): A10
Oliveira Magaldi, M.; Nicolato, A.; Godinho, J.V.; Santos, M.; Prosdocimi, A.; Malheiros, J.A.; Lei, T.; Belykh, E.; Almefty, R.O.; Almefty, K.K.; Preul, M.C.; Spetzler, R.F.; Nakaji, P. 2014: Human placenta aneurysm model for training neurosurgeons in vascular microsurgery. Neurosurgery 10(Suppl 4): 592-600; Discussion: 600-601
Kwok, J.C.K.; Huang, W.; Leung, W.-C.; Chan, S.-K.; Chan, K.-Y.; Leung, K.-M.; Chu, A.C.H.; Lam, A.K.N. 2014: Human placenta as an ex vivo vascular model for neurointerventional research. Journal of Neurointerventional Surgery 6(5): 394-399
Hedlund, M.; Stenqvist, A.-C.; Nagaeva, O.; Kjellberg, L.; Wulff, M.; Baranov, V.; Mincheva-Nilsson, L. 2009: Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. Journal of Immunology 183(1): 340-351
Robin, C.; Bollerot, K.; Mendes, S.; Haak, E.; Crisan, M.; Cerisoli, F.; Lauw, I.; Kaimakis, P.; Jorna, R.; Vermeulen, M.; Kayser, M.; van der Linden, R.; Imanirad, P.; Verstegen, M.; Nawaz-Yousaf, H.; Papazian, N.; Steegers, E.; Cupedo, T.; Dzierzak, E. 2009: Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 5(4): 385-395
Kang, S-Seong.; Woo, S.Su.; Im, J.; Yang, J.Seung.; Yun, C-Heui.; Ju, H.Ran.; Son, C.Gue.; Moon, E-Yi.; Han, S.Hyun. 2007: Human placenta promotes IL-8 expression through activation of JNK/SAPK and transcription factors NF-kappaB and AP-1 in PMA-differentiated THP-1 cells. International Immunopharmacology 7(11): 1488-1495
Milovanov, A.P.; Erofeeva, L.M.; Aleksandrovich, N.V.; Zolotukhina, I.A. 2012: Human placenta structure in Ii and IIi trimesters of physiological pregnancy. Morfologiia 142(5): 64-67
Shehadah, A.; Chen, J.; Pal, A.; He, S.; Zeitlin, A.; Cui, X.; Zacharek, A.; Cui, Y.; Roberts, C.; Lu, M.; Hariri, R.; Chopp, M. 2014: Human placenta-derived adherent cell treatment of experimental stroke promotes functional recovery after stroke in young adult and older rats. Plos one 9(1): E86621
Li, X.; Ling, W.; Pennisi, A.; Wang, Y.; Khan, S.; Heidaran, M.; Pal, A.; Zhang, X.; He, S.; Zeitlin, A.; Abbot, S.; Faleck, H.; Hariri, R.; Shaughnessy, J.D.; van Rhee, F.; Nair, B.; Barlogie, B.; Epstein, J.; Yaccoby, S. 2011: Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Stem Cells 29(2): 263-273
Kim, S.J.; Song, C.H.; Sung, H.J.; Yoo, Y.D.; Geum, D.H.; Park, S.H.; Yoo, J.H.; Oh, J.H.; Shin, H.J.; Kim, S.H.; Kim, J.S.; Kim, B.S. 2007: Human placenta-derived feeders support prolonged undifferentiated propagation of a human embryonic stem cell line, SNUhES3: comparison with human bone marrow-derived feeders. Stem Cells and Development 16(3): 421-428
Martini, M.M.; Jeremias, T.d.S.; Kohler, M.C.íl.; Marostica, L.L.ço.; Trentin, A.éa.G.ça.; Alvarez-Silva, M. 2013: Human placenta-derived mesenchymal stem cells acquire neural phenotype under the appropriate niche conditions. Dna and Cell Biology 32(2): 58-65
Kadam, S.; Muthyala, S.; Nair, P.; Bhonde, R. 2010: Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes. Review of Diabetic Studies: Rds 7(2): 168-182
Jung, J.; Choi, J.H.; Lee, Y.; Park, J.-W.; Oh, I.-H.; Hwang, S.-G.; Kim, K.-S.; Kim, G.J. 2013: Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism. Stem Cells 31(8): 1584-1596
Li, F.; Chen, Y.-Z.; Miao, Z.-N.; Zheng, S.-Y.; Jin, J. 2012: Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects. Cellular Reprogramming 14(4): 334-341
Amendola, D.; Nardella, M.; Guglielmi, L.; Cerquetti, L.; Carico, E.; Alesi, V.; Porru, M.; Leonetti, C.; Bearzi, C.; Rizzi, R.; D'Agnano, I.; Stigliano, A.; Novelli, G.; Bucci, B. 2014: Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion. Stem Cell Research and Therapy 5(2): 55
Suciu, L.; Popescu, L.M.; Gherghiceanu, M. 2007: Human placenta: de visu demonstration of interstitial Cajal-like cells. Journal of Cellular and Molecular Medicine 11(3): 590-597
Von Versen-Höynck, F.; Rajakumar, A.; Bainbridge, S.A.; Gallaher, M.J.; Roberts, J.M.; Powers, R.W. 2009: Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor. Placenta 30(5): 434-442
Balmayor, E.R.; Flicker, M.; Käser, T.; Saalmüller, A.; Erben, R.G. 2013: Human placental alkaline phosphatase as a tracking marker for bone marrow mesenchymal stem cells. Bioresearch Open Access 2(5): 346-355
Yang, Y.; Wang, K.; Li, W.; Adelstein, S.J.; Kassis, A.I. 2011: Human placental alkaline phosphatase-mediated hydrolysis correlates tightly with the electrostatic contribution from tail group. Chemical Biology and Drug Design 78(6): 923-931
Florio, P.; Petraglia, F. 2001: Human placental corticotropin-releasing factor (CRF) in the adaptive response to pregnancy. Stress 4(4): 247-261
Lu, G.-h.; Yong, W.-s.; Xu, Z.-m.; Ke, Y.-q.; Jiang, X.-d.; Zhang, S.-z. 2012: Human placental decidua basalis-derived mesenchymal stem cells differentiate into dopamine neuron-like cells with no response to long-term culture in vitro. Neuroreport 23(8): 513-518
Takemoto, Y.; Kawata, H.; Soeda, T.; Imagawa, K.; Somekawa, S.; Takeda, Y.; Uemura, S.; Matsumoto, M.; Fujimura, Y.; Jo, J-ichiro.; Kimura, Y.; Tabata, Y.; Saito, Y. 2009: Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis. Arteriosclerosis Thrombosis and Vascular Biology 29(6): 857-862
Sharma, K.; Mukherjee, C.; Roy, S.; De, D.; Bhattacharyya, D. 2014: Human placental extract mediated inhibition of proteinase K: implications of heparin and glycoproteins in wound physiology. Journal of Cellular Physiology 229(9): 1212-1223
Kim, B.-Y.; Park, H.R.; Shin, J.-H.; Kim, S.W.; Kim, S.W. 2014: Human placental extract reduces allergic inflammation in a murine allergic rhinitis model. Laryngoscope 124(10): E399-E404
Shimokobe, H.; Sumida, Y.; Tanaka, S.; Mori, K.; Kitamura, Y.; Fukumoto, K.; Kakutani, A.; Ohno, T.; Kanemasa, K.; Imai, S.; Hibino, S.; Yoshikawa, T. 2015: Human placental extract treatment for non-alcoholic steatohepatitis non-responsive to lifestyle intervention: a pilot study. Hepatology Research: the Official Journal of the Japan Society of Hepatology 45(9): 1034-1040
Obolenskaya, M.Y.; Teplyuk, N.M.; Divi, R.L.; Poirier, M.C.; Filimonova, N.B.; Zadrozna, M.; Pasanen, M.J. 2010: Human placental glutathione S-transferase activity and polycyclic aromatic hydrocarbon DNA adducts as biomarkers for environmental oxidative stress in placentas from pregnant women living in radioactivity- and chemically-polluted regions. Toxicology Letters 196(2): 80-86
Zamudio, S.; Wu, Y.; Ietta, F.; Rolfo, A.; Cross, A.; Wheeler, T.; Post, M.; Illsley, N.P.; Caniggia, I. 2007: Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo. American Journal of Pathology 170(6): 2171-2179
Lombardo, M.F.; De Angelis, F.; Bova, L.; Bartolini, B.; Bertuzzi, F.; Nano, R.; Capuani, B.; Lauro, R.; Federici, M.; Lauro, D.; Donadel, G. 2011: Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets. Islets 3(5): 250-258
Zepiridis, L.; Zafrakas, M.; Theodoridis, T.D.; Assimakopoulos, E.; Tzevelekis, P.; Athanatos, D.; Bontis, J.N.; Tarlatzis, B.C. 2009: Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: a new clinical observation. Archives of Gynecology and Obstetrics 280(6): 1041-1044
Lee, J.K.; Chung, H.J.; Fischer, L.; Fischer, J.; Gonzalez, F.J.; Jeong, H. 2014: Human placental lactogen induces CYP2E1 expression via Pi 3-kinase pathway in female human hepatocytes. Drug Metabolism and Disposition: the Biological Fate of Chemicals 42(4): 492-499
Robertson, A.; Sprecher, H. 1967: Human placental lipid metabolism. III. Synthesis and hydrolysis of phospholipids. Lipids 2(5): 403-405
Tissot van Patot, M.C.; Murray, A.J.; Beckey, V.; Cindrova-Davies, T.; Johns, J.; Zwerdlinger, L.; Jauniaux, E.; Burton, G.J.; Serkova, N.J. 2010: Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 298(1): R166-R172
Maier, C.L.; Pober, J.S. 2011: Human placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses. Arteriosclerosis Thrombosis and Vascular Biology 31(1): 183-189
Malek, A.; Bersinger, N.A. 2011: Human placental stem cells: biomedical potential and clinical relevance. Journal of Stem Cells 6(2): 75-92
Sedlmeier, E.-M.; Brunner, S.; Much, D.; Pagel, P.; Ulbrich, S.E.; Meyer, H.H.; Amann-Gassner, U.; Hauner, H.; Bader, B.L. 2014: Human placental transcriptome shows sexually dimorphic gene expression and responsiveness to maternal dietary n-3 long-chain polyunsaturated fatty acid intervention during pregnancy. Bmc Genomics 15: 941
Knöfler, M.; Pollheimer, J.ür. 2013: Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling. Frontiers in Genetics 4: 190
Delorme-Axford, E.; Donker, R.B.; Mouillet, J.-F.; Chu, T.; Bayer, A.; Ouyang, Y.; Wang, T.; Stolz, D.B.; Sarkar, S.N.; Morelli, A.E.; Sadovsky, Y.; Coyne, C.B. 2013: Human placental trophoblasts confer viral resistance to recipient cells. Proceedings of the National Academy of Sciences of the United States of America 110(29): 12048-12053
Lanoix, D.; Beghdadi, H.; Lafond, J.; Vaillancourt, C. 2008: Human placental trophoblasts synthesize melatonin and express its receptors. Journal of Pineal Research 45(1): 50-60
Yuen, R.K.C.; Avila, L.; Peñaherrera, M.S.; von Dadelszen, P.; Lefebvre, L.; Kobor, M.S.; Robinson, W.P. 2009: Human placental-specific epipolymorphism and its association with adverse pregnancy outcomes. Plos one 4(10): E7389
Ben Ari, T.; Gershunov, A.; Gage, K.L.; Snäll, T.; Ettestad, P.; Kausrud, K.L.; Stenseth, N.C. 2008: Human plague in the USA: the importance of regional and local climate. Biology Letters 4(6): 737-740
Yin, J.X.; Dong, X.Q.; Liang, Y.; Wang, P.; Siriarayaporn, P.; Thaikruea, L. 2007: Human plague outbreak in two villages, Yunnan Province, China, 2005. Southeast Asian Journal of Tropical Medicine and Public Health 38(6): 1115-1119
Pupek, M.łg.; Lemańska-Perek, A.; Jasonek, J.; Kątnik-Prastowska, I. 2010: Human plasma and cerebrospinal fibronectins differ in the accessibility of the epitopes on the N-terminal domains. Acta Biochimica Polonica 57(3): 333-337
Mandagini, G.; Subramanian, S.P.; Vasantha, K.; Appukuttan, P.S. 2013: Human plasma anti-α-galactoside antibody forms immune complex with autologous lipoprotein(a). Immunological Investigations 42(4): 324-340
Na, K.; Lee, E.-Y.; Lee, H.-J.; Kim, K.-Y.; Lee, H.; Jeong, S.-K.; Jeong, A.-S.; Cho, S.Y.; Kim, S.A.; Song, S.Y.; Kim, K.S.; Cho, S.W.; Kim, H.; Paik, Y.-K. 2009: Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics 9(16): 3989-3999
Xu, W.; Narayanan, P.; Kang, N.; Clayton, S.; Ohne, Y.; Shi, P.; Herve, M.-C.; Balderas, R.; Picard, C.; Casanova, J.-L.; Gorvel, J.-P.; Oh, S.; Pascual, V.; Banchereau, J. 2014: Human plasma cells express granzyme B. European Journal of Immunology 44(1): 275-284
van Greevenbroek, M.M.J.; Jacobs, M.; van der Kallen, C.J.H.; Blaak, E.E.; Jansen, E.H.J.M.; Schalkwijk, C.G.; Feskens, E.J.M.; Stehouwer, C.D.A. 2012: Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study). International Journal of Cardiology 154(2): 158-162
Yamashita, M.; Suemizu, H.; Murayama, N.; Nishiyama, S.; Shimizu, M.; Yamazaki, H. 2014: Human plasma concentrations of herbicidal carbamate molinate extrapolated from the pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and physiologically based pharmacokinetic modeling. Regulatory Toxicology and Pharmacology: Rtp 70(1): 214-221
Dreissigacker, U.; Suchy, M-Theresia.; Maassen, N.; Tsikas, D. 2010: Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF(2alpha) may be markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications. Clinical Biochemistry 43(1-2): 159-167
O'Nuallain, B.; Acero, L.; Williams, A.D.; Koeppen, H.P.M.; Weber, A.; Schwarz, H.P.; Wall, J.S.; Weiss, D.T.; Solomon, A. 2008: Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies. Biochemistry 47(47): 12254-12256
El Balkhi, S.; Poupon, J.ël.; Trocello, J.-M.; Massicot, F.; Woimant, F.; Laprévote, O. 2010: Human plasma copper proteins speciation by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry. Solutions for columns calibration by sulfur detection. Analytical Chemistry 82(16): 6904-6910
Cardile, A.P.; Sanchez, C.J.; Samberg, M.E.; Romano, D.R.; Hardy, S.K.; Wenke, J.C.; Murray, C.K.; Akers, K.S. 2014: Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance in Vitro. Bmc Research Notes 7: 457
Kekwick, R.A. 1947: Human plasma fractionation. Pharmaceutical Journal 105(4379): 247
Pivac, N.; Knezević, A.; Gornik, O.; Pucić, M.; Igl, W.; Peeters, H.; Crepel, A.; Steyaert, J.; Novokmet, M.; Redzić, I.; Nikolac, M.; Hercigonja, V.N.ć; Curković, K.D.; Curković, M.; Nedić, G.; Muck-Seler, D.; Borovecki, F.; Rudan, I.; Lauc, G. 2011: Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders. Molecular and Cellular Proteomics: Mcp 10(1): M110.004200
Martins da Fonseca, C.íq.S.; Pimenta Filho, A.A.; dos Santos, B.S.; da Silva, C.és.A.; Domingues, A.L.úc.C.; Owen, J.S.; Lima, V.L.úc.d.M. 2014: Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein e polymorphism. Plos one 9(7): E101964
Bellis, C.; Kulkarni, H.; Mamtani, M.; Kent, J.W.; Wong, G.; Weir, J.M.; Barlow, C.K.; Diego, V.; Almeida, M.; Dyer, T.D.; Göring, H.H.H.; Almasy, L.; Mahaney, M.C.; Comuzzie, A.G.; Williams-Blangero, S.; Meikle, P.J.; Blangero, J.; Curran, J.E. 2014: Human plasma lipidome is pleiotropically associated with cardiovascular risk factors and death. CIRCULATION. Cardiovascular Genetics 7(6): 854-863
Ansa-Addo, E.A.; Lange, S.; Stratton, D.; Antwi-Baffour, S.; Cestari, I.; Ramirez, M.I.; McCrossan, M.V.; Inal, J.M. 2010: Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells. Journal of Immunology 185(9): 5236-5246
Antwi-Baffour, S.; Kholia, S.; Aryee, Y.K.-D.; Ansa-Addo, E.A.; Stratton, D.; Lange, S.; Inal, J.M. 2010: Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells--possible role in SLE. Biochemical and Biophysical Research Communications 398(2): 278-283
Mehdi, M.M.; Rizvi, S.I. 2012: Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Archives of Medical Research 43(6): 438-443
Vinante, M.; Digregorio, G.; Lunelli, L.; Forti, S.; Musso, S.; Vanzetti, L.; Lui, A.; Pasquardini, L.; Giorcelli, M.; Tagliaferro, A.; Anderle, M.; Pederzolli, C. 2009: Human plasma protein adsorption on carbon-based materials. Journal of Nanoscience and Nanotechnology 9(6): 3785-3791
Tsai, I.Y.; Tomczyk, N.; Eckmann, J.I.; Composto, R.J.; Eckmann, D.M. 2011: Human plasma protein adsorption onto dextranized surfaces: a two-dimensional electrophoresis and mass spectrometry study. Colloids and Surfaces. B Biointerfaces 84(1): 241-252
Delanghe, J.; Speeckaert, M.; De Buyzere, M.L.; Langlois, M.; Torck, M. 2012: Human plasma protein polymorphisms and the persistence of cultural diversity. Proceedings of the National Academy of Sciences of the United States of America 109(43): E2914
Alvarez, J-Claude.; Charbit, B.; Grassin-Delyle, S.; Demolis, J-Louis.; Funck-Brentano, C.; Abe, E. 2011: Human plasma quantification of droperidol and ondansetron used in preventing postoperative nausea and vomiting with a LC/ESI/MS/MS method. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 879(2): 186-190
Ribot, Mégane.; Polito, A.; Grassin-Delyle, S.; Annane, D.; Alvarez, J-Claude. 2013: Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration. Clinica Chimica Acta; International Journal of Clinical Chemistry 420: 109-113
Pinto, J.; Domingues, M.R.ár.M.; Galhano, E.ál.; Pita, C.; Almeida, M.d.C.éu.; Carreira, I.M.; Gil, A.M. 2014: Human plasma stability during handling and storage: impact on NMR metabolomics. Analyst 139(5): 1168-1177
Queiroz, K.C.S.; Tio, R.A.; Zeebregts, C.J.; Bijlsma, M.F.; Zijlstra, F.; Badlou, B.; de Vries, M.; Ferreira, C.V.; Spek, C.A.; Peppelenbosch, M.P.; Rezaee, F. 2010: Human plasma very low density lipoprotein carries Indian hedgehog. Journal of Proteome Research 9(11): 6052-6059
Berntorp, E. 2007: Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P) in von Willebrand disease and haemophilia A: a viewpoint by Eric Berntorp. Drugs 67(10): 1520
Carter, N.J.; Scott, L.J. 2007: Human plasma von Willebrand factor/factor VIIi complex (Haemate P/Humate-P): in von Willebrand disease and haemophilia a. Drugs 67(10): 1513-1519
Merrill, M.H. 1946: Human plasma, surplus dried; its distribution in California. California and Western Medicine 64: 351
Lee, K.; Hoots, W.K. 2010: Human plasma-derived concentrates: preventing thrombosis and controlling haemorrhage. Haemophilia: the Official Journal of the World Federation of Hemophilia 16(6): 949-951
Longet, S.ép.; Miled, S.; Lötscher, M.; Miescher, S.M.; Zuercher, A.W.; Corthésy, B. 2013: Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies. Journal of Biological Chemistry 288(6): 4085-4094
Huang, B.; Tang, S.; Desai, A.; Cheng, X.-m.; Kotlyar, A.; Van Der Spek, A.; Thomas, T.P.; Baker, J.R. 2009: Human plasma-mediated hypoxic activation of indolequinone-based naloxone pro-drugs. Bioorganic and Medicinal Chemistry Letters 19(17): 5016-5020
Liao, A.P.; Salajegheh, M.; Morehouse, C.; Nazareno, R.; Jubin, R.G.; Jallal, B.; Yao, Y.; Greenberg, S.A. 2010: Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production. Clinical Immunology 136(1): 130-138
Piccioli, D.; Sammicheli, C.; Tavarini, S.; Nuti, S.; Frigimelica, E.; Manetti, A.G.O.; Nuccitelli, A.; Aprea, S.; Valentini, S.; Borgogni, E.; Wack, A.; Valiante, N.M. 2009: Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation. Blood 113(18): 4232-4239
Sandgren, K.J.; Smed-Sörensen, A.; Forsell, M.N.; Soldemo, M.; Adams, W.C.; Liang, F.; Perbeck, L.; Koup, R.A.; Wyatt, R.T.; Karlsson Hedestam, G.B.; Loré, K. 2013: Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation. Journal of Immunology 191(1): 60-69
Tel, J.; Schreibelt, G.; Sittig, S.P.; Mathan, T.S.M.; Buschow, S.I.; Cruz, L.J.; Lambeck, A.J.A.; Figdor, C.G.; de Vries, I.J.M. 2013: Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood 121(3): 459-467
Morita, R.; Fujita, T.; Uchiyama, T.; Hori, T. 2009: Human plasmacytoid dendritic cells express an atrial natriuretic peptide receptor, guanylyl cyclase-A. Microbiology and Immunology 53(7): 403-411
Hong, J.; Li, Y.; Gong, Z.-j. 2009: Human plasmacytoid dendritic cells from patients with chronic hepatitis B induce the generation of CD4+CD25+Treg in vitro. Zhonghua Gan Zang Bing Za Zhi 17(8): 574-579
Boor, P.P.C.; Metselaar, H.J.; Jonge, S.d.; Mancham, S.; van der Laan, L.J.W.; Kwekkeboom, J. 2011: Human plasmacytoid dendritic cells induce CD8⁺ LAG-3⁺ Foxp3⁺ CTLA-4⁺ regulatory T cells that suppress allo-reactive memory T cells. European Journal of Immunology 41(6): 1663-1674
De Filippo, A.; Binder, R.J.; Camisaschi, C.; Beretta, V.; Arienti, F.; Villa, A.; Della Mina, P.; Parmiani, G.; Rivoltini, L.; Castelli, C. 2008: Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses. Journal of Immunology 181(9): 6525-6535
Tel, J.; Lambeck, A.J.A.; Cruz, L.J.; Tacken, P.J.; de Vries, I.J.M.; Figdor, C.G. 2010: Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen. Journal of Immunology 184(8): 4276-4283
Chao, Y.; Kaliaperumal, N.; Chretien, A.-S.; Tang, S.; Lee, B.; Poidinger, M.; Fairhurst, A.-M.; Connolly, J.E. 2014: Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. Journal of Leukocyte Biology 96(6): 1037-1046
Wieland, S.F.; Takahashi, K.; Boyd, B.; Whitten-Bauer, C.; Ngo, N.; de la Torre, J.-C.; Chisari, F.V. 2014: Human plasmacytoid dendritic cells sense lymphocytic choriomeningitis virus-infected cells in vitro. Journal of Virology 88(1): 752-757
Yu, C.-F.; Peng, W.-M.; Oldenburg, J.; Hoch, J.; Bieber, T.; Limmer, A.; Hartmann, G.; Barchet, W.; Eis-Hübinger, A.M.; Novak, N. 2010: Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation. Journal of Immunology 184(3): 1159-1167
Mathan, T.S.M.Manuel.; Figdor, C.G.; Buschow, S.I. 2013: Human plasmacytoid dendritic cells: from molecules to intercellular communication network. Frontiers in Immunology 4: 372
Cho, C.-F.; Chen, P.-K.; Chang, P.-C.; Wu, H.-L.; Shi, G.-Y. 2013: Human plasminogen kringle 1-5 inhibits angiogenesis and induces thrombomodulin degradation in a protein kinase A-dependent manner. Journal of Molecular and Cellular Cardiology 63: 79-88
Chang, P.C.; Wu, H.L.; Lin, H.C.; Wang, K.C.; Shi, G.Y. 2010: Human plasminogen kringle 1-5 reduces atherosclerosis and neointima formation in mice by suppressing the inflammatory signaling pathway. Journal of Thrombosis and Haemostasis: Jth 8(1): 194-201
Christen, M.T.; Frank, P.; Schaller, J.; Llinás, M. 2010: Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape. Biochemistry 49(33): 7131-7150
Aleem, A.M.; Wells, L.; Jankun, J.; Walther, M.; Kühn, H.; Reinartz, J.; Skrzypczak-Jankun, E. 2009: Human platelet 12-lipoxygenase: naturally occurring Q261/R261 variants and N544L mutant show altered activity but unaffected substrate binding and membrane association behavior. International Journal of Molecular Medicine 24(6): 759-764
Huang, Z.-Y.; Chien, P.; Indik, Z.K.; Schreiber, A.D. 2011: Human platelet FcγRIIA and phagocytes in immune-complex clearance. Molecular Immunology 48(4): 691-696
Al-Jafari, A.A.; Shakil, S.; Reale, M.; Kamal, M.A. 2011: Human platelet acetylcholinesterase inhibition by cyclophosphamide: a combined experimental and computational approach. Cns and Neurological Disorders Drug Targets 10(8): 928-935
Mousa, S.S.; Davis, F.B.; Davis, P.J.; Mousa, S.A. 2010: Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA). Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 16(3): 288-293
Al-Subaie, A.M.; Fawaz, N.A.; Mahdi, N.; Al-Absi, I.K.; Al-Ola, K.; Ameen, G.; Almawi, W.Y. 2009: Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis. European Journal of Haematology 83(6): 579-585
Abboud, N.; Ghazouani, L.; Ben-Hadj-Khalifa, S.; Anabi, F.; Added, F.; Khalfallah, A.; Nsiri, B.; Almawi, W.Y.; Mahjoub, T. 2010: Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease. Journal of Thrombosis and Thrombolysis 29(4): 409-415
Jackson, D.J.; Eastlake, J.L.; Kumpel, B.M. 2014: Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model. Clinical and Experimental Immunology 176(1): 23-36
Allen, D.L.; Abrahamsson, S.; Murphy, M.F.; Roberts, D.J. 2012: Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa). Journal of Immunological Methods 375(1-2): 166-175
Xu, X.; Liu, Y.; Ying, Y.; Tao, S.; Hong, X.; Zhu, F.; Lv, H.; Yan, L. 2011: Human platelet antigen allele frequencies and new mutations on platelet glycoprotein genes in the Chinese Han population. Transfusion Medicine 21(5): 330-337
Brouk, H.; Halle, L.; Bertrand, G.; Neche, F.Z.; Ouelaa, H.; Kaplan, C. 2010: Human platelet antigen allele frequencies in different Algerian populations. Tissue Antigens 75(6): 673-678
Pai, S.-C.; Burnouf, T.; Chen, J.-W.; Lin, L.-I. 2013: Human platelet antigen alleles in 998 Taiwanese blood donors determined by sequence-specific primer polymerase chain reaction. Biomed Research International 2013: 973789
Hwang, S.M.; Kim, M.J.; Chang, H.E.; Hong, Y.J.; Kim, T.S.; Song, E.Y.; Park, K.U.; Song, J.; Han, K.-S. 2013: Human platelet antigen genotyping and expression of CD109 (human platelet antigen 15) mRNA in various human cell types. Biomed Research International 2013: 946403
Bhatti, F.A.; Uddin, M.; Ahmed, A.; Bugert, P. 2010: Human platelet antigen polymorphisms (HPA-1, -2, -3, -4, -5 and -15) in major ethnic groups of Pakistan. Transfusion Medicine 20(2): 78-87
Lemnrau, A.G.; Cardoso, S.; Creary, L.E.; Brown, C.; Miretti, M.; Girdlestone, J.; Navarrete, C.V. 2009: Human platelet antigen typing of neonatal alloimmune thrombocytopenia patients using whole genome amplified DNA and a 5'-nuclease assay. Transfusion 49(5): 953-958
Gentile, I.; Meola, M.; Buonomo, A.R.; Minei, G.; Coppola, N.; Foggia, M.; Ferruzzi, F.; Fratellanza, G.; Scarpato, N.; Borgia, G. 2013: Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection. In Vivo 27(6): 773-777
Curtis, B.R.; McFarland, J.G. 2014: Human platelet antigens - 2013. Vox Sanguinis 106(2): 93-102
Gorgi, Y.; Sfar, I.; Ben Aabdallah, T.; Aouadi, H.; Abderrahim, E.; Bardi, R.; Jendoubi-Ayed, S.; Ayed, K. 2008: Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients. Hemodialysis International. International Symposium on Home Hemodialysis 12(3): 331-335
Edelblute, C.M.; Donate, A.L.; Hargrave, B.Y.; Heller, L.C. 2015: Human platelet gel supernatant inactivates opportunistic wound pathogens on skin. Platelets 26(1): 13-16
Shanskii, Y.D.; Sergeeva, N.S.; Sviridova, I.K.; Kirakozov, M.S.; Kirsanova, V.A.; Akhmedova, S.A.; Antokhin, A.I.; Chissov, V.I. 2013: Human platelet lysate as a promising growth-stimulating additive for culturing of stem cells and other cell types. Bulletin of Experimental Biology and Medicine 156(1): 146-151
Walenda, G.; Hemeda, H.; Schneider, R.K.; Merkel, R.; Hoffmann, B.; Wagner, W. 2012: Human platelet lysate gel provides a novel three dimensional-matrix for enhanced culture expansion of mesenchymal stromal cells. Tissue Engineering. Part C Methods 18(12): 924-934
Hofbauer, P.; Riedl, S.; Witzeneder, K.; Hildner, F.; Wolbank, S.; Groeger, M.; Gabriel, C.; Redl, H.; Holnthoner, W. 2014: Human platelet lysate is a feasible candidate to replace fetal calf serum as medium supplement for blood vascular and lymphatic endothelial cells. CytoTherapy 16(9): 1238-1244
Govindasamy, V.; Ronald, V.Sainik.; Abdullah, A.Naim.Binti.; Ganesan Nathan, K.R.; Aziz, Z.Adura.Che.Abdul.; Abdullah, M.; Zain, R.Binti.; Kasim, N.Hayaty.Abu.; Musa, S.; Bhonde, R.R. 2012: Human platelet lysate permits scale-up of dental pulp stromal cells for clinical applications. CytoTherapy 13(10): 1221-1233
Griffiths, S.; Baraniak, P.R.; Copland, I.B.; Nerem, R.M.; McDevitt, T.C. 2013: Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro. CytoTherapy 15(12): 1469-1483
Xia, W.; Li, H.; Wang, Z.; Xu, R.; Fu, Y.; Zhang, X.; Ye, X.; Huang, Y.; Xiang, A.P.; Yu, W. 2011: Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biology International 35(6): 639-643
Xu, R.; Xia, W.-j.; Rong, X.; Ye, X.; Shao, Y.; Wang, M.; Luo, G.-p.; Fu, Y.-s. 2011: Human platelet lysates promotes the proliferation of mesenchymal stem cells in vitro. Nan Fang Yi Ke da Xue Xue Bao 31(8): 1396-1400
Simon, L.M.; Edelstein, L.C.; Nagalla, S.; Woodley, A.B.; Chen, E.S.; Kong, X.; Ma, L.; Fortina, P.; Kunapuli, S.; Holinstat, M.; McKenzie, S.E.; Dong, J.-F.; Shaw, C.A.; Bray, P.F. 2014: Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 123(16): E37-E45
Van Geet, C.; Izzi, B.; Labarque, V.; Freson, K. 2009: Human platelet pathology related to defects in the G-protein signaling cascade. Journal of Thrombosis and Haemostasis: Jth 7(Suppl 1): 282-286
Badr Eslam, R.; Lang, I.M.; Kaider, A.; Panzer, S. 2013: Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition. Translational Research: the Journal of Laboratory and Clinical Medicine 161(5): 414-420
Parizi, A.M.; Oryan, A.; Shafiei-Sarvestani, Z.; Bigham, A.S. 2012: Human platelet rich plasma plus Persian Gulf coral effects on experimental bone healing in rabbit model: radiological, histological, macroscopical and biomechanical evaluation. Journal of Materials Science. Materials in Medicine 23(2): 473-483
Krüger, J.P.; Ketzmar, A.-K.; Endres, M.; Pruss, A.; Siclari, A.; Kaps, C. 2014: Human platelet-rich plasma induces chondrogenic differentiation of subchondral progenitor cells in polyglycolic acid-hyaluronan scaffolds. Journal of Biomedical Materials Research. Part B Applied Biomaterials 102(4): 681-692
Takeuchi, M.; Kamei, N.; Shinomiya, R.; Sunagawa, T.; Suzuki, O.; Kamoda, H.; Ohtori, S.; Ochi, M. 2012: Human platelet-rich plasma promotes axon growth in brain-spinal cord coculture. Neuroreport 23(12): 712-716
Demidova-Rice, T.N.; Wolf, L.; Deckenback, J.; Hamblin, M.R.; Herman, I.M. 2012: Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. Plos one 7(2): E32146
De La Vega Elena, C.D.; Nogués, N.; Fernández Montoya, A.; Chialina, S.; Blanzaco, P.D.; Theiller, E.; Raillon, M.A.; Arancegui, N.; Solis, E.; Oyonarte, S.; Crespo Ferrer, V.; Campos Muñoz, A.; Muñiz-Díaz, E. 2008: Human platelet-specific antigens frequencies in the Argentinean population. Transfusion Medicine 18(2): 83-90
Basu, S.S.; Deutsch, E.C.; Schmaier, A.A.; Lynch, D.R.; Blair, I.A. 2013: Human platelets as a platform to monitor metabolic biomarkers using stable isotopes and LC-MS. Bioanalysis 5(24): 3009-3021
Jones, M.; Peden, A.H.; Yull, H.; Wight, D.; Bishop, M.T.; Prowse, C.V.; Turner, M.L.; Ironside, J.W.; MacGregor, I.R.; Head, M.W. 2009: Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease. Transfusion 49(2): 376-384
Berthet, J.; Damien, P.; Hamzeh-Cognasse, H.; Arthaud, C.-A.; Eyraud, M.-A.; Zéni, F.; Pozzetto, B.; McNicol, A.; Garraud, O.; Cognasse, F. 2012: Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clinical Immunology 145(3): 189-200
Newman, P.J.; Aster, R.; Boylan, B. 2007: Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders. Journal of Thrombosis and Haemostasis: Jth 5(Suppl 1): 305-309
Meyer, T.; Amaya, M.; Desai, H.; Robles-Carrillo, L.; Hatfield, M.; Francis, J.L.; Amirkhosravi, A. 2010: Human platelets contain and release TWEAK. Platelets 21(7): 571-574
Sarabia, S.F.; Raya, J.L.; Hoogeveen, R.C.; Bray, P.F. 2008: Human platelets differentially concentrate estradiol, estrone and testosterone. Journal of Thrombosis and Haemostasis: Jth 6(4): 703-705
Østerud, B.; Olsen, J.O. 2013: Human platelets do not express tissue factor. Thrombosis Research 132(1): 112-115
Gupalo, E.; Buriachkovskaia, L.; Othman, M. 2011: Human platelets express CAR with localization at the sites of intercellular interaction. Virology Journal 8: 456
Anabel, A.-S.; Eduardo, P.ér.-C.; Pedro Antonio, H.án.-C.; Carlos, S.ór.-M.; Juana, N.áe.-M.; Honorio, T.-A.; Nicolás, V.-S.úl.; Sergio Roberto, A.-R. 2014: Human platelets express Toll-like receptor 3 and respond to poly I:C. Human Immunology 75(12): 1244-1251
Romaniuk, M.A.; Tribulatti, M.V.; Cattaneo, V.; Lapponi, M.J.; Molinas, F.C.; Campetella, O.; Schattner, M. 2010: Human platelets express and are activated by galectin-8. Biochemical Journal 432(3): 535-547
Schedel, A.; Thornton, S.; Schloss, P.; Klüter, H.; Bugert, P. 2011: Human platelets express functional alpha7-nicotinic acetylcholine receptors. Arteriosclerosis Thrombosis and Vascular Biology 31(4): 928-934
Wang, B.; Peng, Y.; Dong, J.; Lin, J.; Wu, C.; Su, Y.; Fang, H.; Wang, L.; Huang, K.; Li, D. 2013: Human platelets express functional thymic stromal lymphopoietin receptors: a potential role in platelet activation in acute coronary syndrome. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 32(6): 1741-1750
Niessen, J.; Jedlitschky, G.; Grube, M.; Bien, S.; Schwertz, H.ör.; Ohtsuki, S.; Kawakami, H.; Kamiie, J.; Oswald, S.; Starke, K.; Strobel, U.; Siegmund, W.; Rosskopf, D.; Greinacher, A.; Terasaki, T.; Kroemer, H.K. 2009: Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metabolism and Disposition: the Biological Fate of Chemicals 37(5): 1129-1137
Aldrovandi, M.; Hammond, V.J.; Podmore, H.; Hornshaw, M.; Clark, S.R.; Marnett, L.J.; Slatter, D.A.; Murphy, R.C.; Collins, P.W.; O'Donnell, V.B. 2013: Human platelets generate phospholipid-esterified prostaglandins via cyclooxygenase-1 that are inhibited by low dose aspirin supplementation. Journal of Lipid Research 54(11): 3085-3097
Takahashi, K.; Murata, S.; Fukunaga, K.; Ohkohchi, N. 2013: Human platelets inhibit liver fibrosis in severe combined immunodeficiency mice. World Journal of Gastroenterology 19(32): 5250-5260
Novokmet, S.; Jakovljevic, V.L.; Jankovic, S.; Davidovic, G.; Andjelkovic, N.; Milanovic, Z.; Djuric, D.M. 2009: Human platelets perfusion through isolated guinea-pig heart: the effects on coronary flow and oxidative stress markers. General Physiology and Biophysics 28(Special Issue): 98-104
Salles, I.I.; Thijs, T.; Brunaud, C.; De Meyer, S.F.; Thys, J.; Vanhoorelbeke, K.; Deckmyn, H. 2009: Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow model of thrombosis. Blood 114(24): 5044-5051
Petersen, H.J.; Keane, C.; Jenkinson, H.F.; Vickerman, M.M.; Jesionowski, A.; Waterhouse, J.C.; Cox, D.; Kerrigan, S.W. 2010: Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. Infection and Immunity 78(1): 413-422
Neumann, K.; Farías, G.; Slachevsky, A.; Perez, P.; Maccioni, R.B. 2011: Human platelets tau: a potential peripheral marker for Alzheimer's disease. Journal of Alzheimer's Disease: Jad 25(1): 103-109
Qiu, M.-h.; Qiu, M.-d. 2009: Human plerocercoidosis and sparganosis: I. a historical review on aetiology. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 27(1): 54-60
Qiu, M.-H.; Qiu, M.-D. 2009: Human plerocercoidosis and sparganosis: II. a historical review on pathology, clinics, epidemiology and control. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 27(3): 251-260
Schierloh, P.; Landoni, V.ón.; Balboa, L.; Musella, R.M.; Castagnino, J.; Moraña, E.; de Casado, G.C.; Palmero, D.; Sasiain, M.ía.C. 2014: Human pleural B-cells regulate IFN-γ production by local T-cells and NK cells in a Mycobacterium tuberculosis-induced delayed hypersensitivity reaction. Clinical Science 127(6): 391-403
Rampalli, S.; Bhatia, M. 2012: Human pluripotency: a difficult state to make smart choices. Cell Cycle 11(13): 2411-2412
Simões, P.D.; Ramos, T. 2007: Human pluripotent embryonal carcinoma NTERA2 cl.D1 cells maintain their typical morphology in an angiomyogenic medium. Journal of Negative Results in Biomedicine 6: 5
Wataya, T.; Muguruma, K.; Sasai, Y. 2008: Human pluripotent stem cell and neural differentiation. Brain and Nerve 60(10): 1165-1172
Chen, K.G.; Mallon, B.S.; McKay, R.D.G.; Robey, P.G. 2014: Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell 14(1): 13-26
Aigner, S.; Heckel, T.; Zhang, J.D.; Andreae, L.C.; Jagasia, R. 2014: Human pluripotent stem cell models of autism spectrum disorder: emerging frontiers, opportunities, and challenges towards neuronal networks in a dish. Psychopharmacology 231(6): 1089-1104
Davidson, K.C.; Guymer, R.H.; Pera, M.F.; Pébay, A. 2014: Human pluripotent stem cell strategies for age-related macular degeneration. Optometry and Vision Science: Official Publication of the American Academy of Optometry 91(8): 887-893
Nicoleau, C.; Viegas, P.; Peschanski, M.; Perrier, A.L. 2011: Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 8(4): 562-576
Poon, E.; Kong, C.-W.; Li, R.A. 2011: Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Molecular Pharmaceutics 8(5): 1495-1504
Acimovic, I.; Vilotic, A.; Pesl, M.; Lacampagne, A.; Dvorak, P.; Rotrekl, V.; Meli, A.C. 2014: Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed Research International 2014: 512831
Chow, M.; Boheler, K.R.; Li, R.A. 2013: Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives. Stem Cell Research and Therapy 4(4): 97
Sheng, X.; Reppel, M.; Nguemo, F.; Mohammad, F.I.; Kuzmenkin, A.; Hescheler, J.ür.; Pfannkuche, K. 2012: Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability. Plos one 7(9): E45963
Parvini, M.; Satarian, L.; Parivar, K.; Javan, M.; Tondar, M.; Ahmad, S.; Baharvand, H. 2014: Human pluripotent stem cell-derived retinal pigmented epithelium in retinal treatment: from bench to bedside. Molecular Neurobiology 50(2): 597-612
Hibaoui, Y.; Feki, A. 2013: Human pluripotent stem cells as alternative models to study trophoblast development. Frontiers in Physiology 4: 374
Chicha, L.; Feki, A.; Boni, A.; Irion, O.; Hovatta, O.; Jaconi, M. 2011: Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics. Plos one 6(2): E14733
Maury, Y.; Gauthier, M.; Peschanski, M.; Martinat, C.éc. 2012: Human pluripotent stem cells for disease modelling and drug screening. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 34(1): 61-71
Gauthier, M.; Maury, Y.; Peschanski, M.; Martinat, C.éc. 2011: Human pluripotent stem cells for genetic disease modeling and drug screening. Regenerative Medicine 6(5): 607-622
Lin, B.; Gupta, D.; Heinen, C.D. 2014: Human pluripotent stem cells have a novel mismatch repair-dependent damage response. Journal of Biological Chemistry 289(35): 24314-24324
Laustriat, D.; Gide, J.; Peschanski, M. 2010: Human pluripotent stem cells in drug discovery and predictive toxicology. Biochemical Society Transactions 38(4): 1051-1057
Viswanathan, P.; Gaskell, T.; Moens, N.; Culley, O.J.; Hansen, D.; Gervasio, M.K.R.; Yeap, Y.J.; Danovi, D. 2014: Human pluripotent stem cells on artificial microenvironments: a high content perspective. Frontiers in Pharmacology 5: 150
Ni, Z.; Knorr, D.A.; Clouser, C.L.; Hexum, M.K.; Southern, P.; Mansky, L.M.; Park, I.-H.; Kaufman, D.S. 2011: Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of Virology 85(1): 43-50
Zhu, Z.; Huangfu, D. 2013: Human pluripotent stem cells: an emerging model in developmental biology. Development 140(4): 705-717
Hibaoui, Y.; Feki, A. 2012: Human pluripotent stem cells: applications and challenges in neurological diseases. Frontiers in Physiology 3: 267
Kao, C.-F.; Chuang, C.-Y.; Chen, C.-H.; Kuo, H.-C. 2008: Human pluripotent stem cells: current status and future perspectives. Chinese Journal of Physiology 51(4): 214-225
Li, W.; Ding, S. 2011: Human pluripotent stem cells: decoding the naïve state. Science Translational Medicine 3(76): 76ps10
Ramirez, J.-M.; Bai, Q.; Dijon-Grinand, M.; Assou, S.; Gerbal-Chaloin, S.; Hamamah, S.; De Vos, J. 2010: Human pluripotent stem cells: from biology to cell therapy. World Journal of Stem Cells 2(2): 24-33
Maury, Y.; Gauthier, M.; Peschanski, M.; Martinat, C.éc. 2011: Human pluripotent stem cells: opening key for pathological modeling. Medecine Sciences: M/S 27(4): 443-446
Sherman, S.P.; Alva, J.A.; Thakore-Shah, K.; Pyle, A.D. 2011: Human pluripotent stem cells: the development of high-content screening strategies. Methods in Molecular Biology 767: 283-295
Borza, C.M.; Borza, D-Bogdan.; Pedchenko, V.; Saleem, M.A.; Mathieson, P.W.; Sado, Y.; Hudson, H.M.; Pozzi, A.; Saus, J.; Abrahamson, D.R.; Zent, R.; Hudson, B.G. 2008: Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. Journal of the American Society of Nephrology: Jasn 19(4): 677-684
Dobrinskikh, E.; Okamura, K.; Kopp, J.B.; Doctor, R.B.; Blaine, J. 2014: Human podocytes perform polarized, caveolae-dependent albumin endocytosis. American Journal of Physiology. Renal Physiology 306(9): F941-F951
Chamandi, S.C.; Kallab, K.; Mattar, H.; Nader, E. 2009: Human poisoning after ingestion of puffer fish caught from Mediterranean Sea. Middle East Journal of Anaesthesiology 20(2): 285-288
David, D.; Prabhakar, A.; Peter, J.Victor.; Pichamuthu, K. 2008: Human poisoning with hexastar: a hexaconazole-containing agrochemical fungicide. Clinical Toxicology 46(7): 692-693
Chen, H.-H.; Lin, J.-L.; Yen, T.-H.; Lin, W.-R. 2013: Human poisoning with prochloraz imidazole fungicide. Clinical Toxicology 51(10): 1237-1238
Su, T.-Y.; Lin, J.-L.; Lin-Tan, D.-T.; Tseng, H.-H.; Yen, T.-H. 2011: Human poisoning with spinosad and flonicamid insecticides. Human and Experimental Toxicology 30(11): 1878-1881
Agrawal, N.; Banerjee, R. 2008: Human polycomb 2 protein is a SUMO E3 ligase and alleviates substrate-induced inhibition of cystathionine beta-synthase sumoylation. Plos one 3(12): E4032
Esposito, C.I.; Oliver, R.A.; Campbell, P.A.; Yu, Y.; Walter, W.L.; Walter, W.K.; Walsh, W.R. 2014: Human polyethylene granuloma tissues inhibit bone healing in a novel xenograft animal model. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 32(6): 735-743
Robinson, A.K.; Leal, B.Z.; Nanyes, D.R.; Kaur, Y.; Ilangovan, U.; Schirf, V.; Hinck, A.P.; Demeler, B.; Kim, C.A. 2012: Human polyhomeotic homolog 3 (PHC3) sterile alpha motif (SAM) linker allows open-ended polymerization of PHC3 SAM. Biochemistry 51(27): 5379-5386
Höltje, M.; Richartz, A.; Zdrazil, B.; Schwanke, A.; Dugovic, B.; Murruzzu, C.; Reissig, H.-U.; Korting, H.C.; Kleuser, B.; Höltje, H.-D.; Schäfer-Korting, M. 2010: Human polymerase alpha inhibitors for skin tumors. Part 2. Modeling, synthesis and influence on normal and transformed keratinocytes of new thymidine and purine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry 25(2): 250-265
Mukherjee, P.; Lahiri, I.; Pata, J.D. 2013: Human polymerase kappa uses a template-slippage deletion mechanism, but can realign the slipped strands to favour base substitution mutations over deletions. Nucleic Acids Research 41(9): 5024-5035
Moore, E.E.; Moore, F.A.; Fabian, T.C.; Bernard, A.C.; Fulda, G.J.; Hoyt, D.B.; Duane, T.M.; Weireter, L.J.; Gomez, G.A.; Cipolle, M.D.; Rodman, G.H.; Malangoni, M.A.; Hides, G.A.; Omert, L.A.; Gould, S.A. 2009: Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. Journal of the American College of Surgeons 208(1): 1-13
Davies, S.M.; Dickinson, A.; Miller, J.S. 2008: Human polymorphism and variable outcomes of cancer chemotherapy and transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(1 Suppl 1: 120-128
Keyhani, A.; Riazi-Rad, F.; Pakzad, S.R.; Ajdary, S. 2014: Human polymorphonuclear leukocytes produce cytokines in response to Leishmania major promastigotes. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 122(9): 891-897
Chanchamroen, S.; Kewcharoenwong, C.; Susaengrat, W.; Ato, M.; Lertmemongkolchai, G. 2009: Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infection and Immunity 77(1): 456-463
Riegel, A.; Maurer, T.; Prior, B.; Stegmaier, S.; Heppert, V.; Wagner, C.; Hänsch, G.M. 2012: Human polymorphonuclear neutrophils express RANK and are activated by its ligand, RANKL. European Journal of Immunology 42(4): 975-981
Sokhi, U.K.; Das, S.K.; Dasgupta, S.; Emdad, L.; Shiang, R.; DeSalle, R.; Sarkar, D.; Fisher, P.B. 2013: Human polynucleotide phosphorylase (hPNPaseold-35): should I eat you or not--that is the question?. Advances in Cancer Research 119: 161-190
Das, S.K.; Sokhi, U.K.; Bhutia, S.K.; Azab, B.; Su, Z.-Z.; Sarkar, D.; Fisher, P.B. 2010: Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells. Proceedings of the National Academy of Sciences of the United States of America 107(26): 11948-11953
Saribas, A.S.; Mun, S.; Johnson, J.; El-Hajmoussa, M.; White, M.K.; Safak, M. 2014: Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: evidence for their involvement in regulation of the viral DNA replication. Virology 449: 1-16
Boothpur, R.; Brennan, D.C. 2010: Human polyoma viruses and disease with emphasis on clinical BK and JC. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 47(4): 306-312
Ho, J.; Jedrych, J.J.; Feng, H.; Natalie, A.A.; Grandinetti, L.; Mirvish, E.; Crespo, M.M.; Yadav, D.; Fasanella, K.E.; Proksell, S.; Kuan, S.-F.; Pastrana, D.V.; Buck, C.B.; Shuda, Y.; Moore, P.S.; Chang, Y. 2015: Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. Journal of Infectious Diseases 211(10): 1560-1565
Van der Meijden, E.; Wunderink, H.F.; van der Blij-de Brouwer, C.S.; Zaaijer, H.L.; Rotmans, J.I.; Bavinck, J.N.B.; Feltkamp, M.C.W. 2014: Human polyomavirus 9 infection in kidney transplant patients. Emerging Infectious Diseases 20(6): 991-999
Chapagain, M.L.; Nerurkar, V.R. 2010: Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. Journal of Infectious Diseases 202(2): 184-191
Bellizzi, A.; Nardis, C.; Anzivino, E.; Rodìo, D. M.; Fioriti, D.; Mischitelli, M.; Chiarini, F.; Pietropaolo, V. 2012: Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. Journal of Neurovirology 18(1): 1-11
Huijskens, E.G.W.; van Erkel, A.J.M.; Peeters, M.F.; Rossen, J.W.A. 2010: Human polyomavirus KI and WU in adults with community acquired pneumonia in The Netherlands, 2008-2009. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 49(4): 306-307
Sauvage, V.; Foulongne, V.; Cheval, J.; Ar Gouilh, M.; Pariente, K.; Dereure, O.; Manuguerra, J.C.; Richardson, J.; Lecuit, M.; Burguière, A.; Caro, V.ér.; Eloit, M. 2011: Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerging Infectious Diseases 17(8): 1364-1370
Duncavage, E.J.; Pfeifer, J.D. 2011: Human polyomaviruses 6 and 7 are not detectable in Merkel cell polyomavirus-negative Merkel cell carcinoma. Journal of Cutaneous Pathology 38(10): 790-796
Wieland, U.; Silling, S.; Hellmich, M.; Potthoff, A.; Pfister, H.; Kreuter, A. 2014: Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men. Journal of General Virology 95(Part 4): 928-932
Machado, D.M.; Fink, M.C.; Pannuti, C.áu.S.ér.; Succi, R.C.él.d.M.; Machado, A.A.; Carmo, F.B.d.; Gouvêa, A.íd.d.F.át.B.; Urbano, P.R.; Beltrão, S.V.; Santos, I.C.L.d.; Machado, C.M. 2011: Human polyomaviruses JC and BK in the urine of Brazilian children and adolescents vertically infected by HIV. Memorias do Instituto Oswaldo Cruz 106(8): 931-935
Moens, U.; Johannessen, M. 2008: Human polyomaviruses and cancer: expanding repertoire. Journal der Deutschen Dermatologischen Gesellschaft 6(9): 704-708
Siebrasse, E.A.; Bauer, I.; Holtz, L.R.; Le, B-minh.; Lassa-Claxton, S.; Canter, C.; Hmiel, P.; Shenoy, S.; Sweet, S.; Turmelle, Y.; Shepherd, R.; Wang, D. 2012: Human polyomaviruses in children undergoing transplantation, United States, 2008-2010. Emerging infectious diseases 18(10): 1676-1679
Moens, U.; Ludvigsen, M.; Van Ghelue, M. 2011: Human polyomaviruses in skin diseases. Pathology Research International 2011: 123491
Anonymous 2009: Human polyvalent immunoglobulin: new indication. Multifocal motor neuropathy: slightly more muscle strength. Improvement in muscle strength, but frequent hypersensitivity reactions. Prescrire International 18(100): 62
Caretti, V.; Sewing, A.C.P.; Lagerweij, T.; Schellen, P.; Bugiani, M.; Jansen, M.H.A.; van Vuurden, D.G.; Navis, A.C.; Horsman, I.; Vandertop, W.P.; Noske, D.P.; Wesseling, P.; Kaspers, G.J.L.; Nazarian, J.; Vogel, H.; Hulleman, E.; Monje, M.; Wurdinger, T. 2014: Human pontine glioma cells can induce murine tumors. Acta Neuropathologica 127(6): 897-909
Xu, S. 2012: Human population admixture in Asia. Genomics and Informatics 10(3): 133-144
Keinan, A.; Reich, D. 2010: Human population differentiation is strongly correlated with local recombination rate. Plos Genetics 6(3): E1000886
Garte, S. 2010: Human population genetic diversity as a function of SNP type from HapMap data. American Journal of Human Biology: the Official Journal of the Human Biology Council 22(3): 297-300
Spuhler, J.N. 1966: Human population genetics. Science 153(3736): 660-661
Yilmaz, S.; Toy, S.ül.; Demircioglu Yildiz, N.; Yilmaz, H. 2009: Human population growth and temperature increase along with the increase in urbanisation, motor vehicle numbers and green area amount in the sample of Erzurum city, Turkey. Environmental Monitoring and Assessment 148(1-4): 205-213
Bongaarts, J. 2009: Human population growth and the demographic transition. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 364(1532): 2985-2990
Bradshaw, C.J.A.; Brook, B.W. 2014: Human population reduction is not a quick fix for environmental problems. Proceedings of the National Academy of Sciences of the United States of America 111(46): 16610-16615
Novembre, J.; Han, E. 2012: Human population structure and the adaptive response to pathogen-induced selection pressures. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 367(1590): 878-886
Campbell, H.; Rudan, I.; Bittles, A.H.; Wright, A.F. 2009: Human population structure, genome autozygosity and human health. Genome Medicine 1(9): 91
Ceppi, M.; Biasotti, B.; Fenech, M.; Bonassi, S. 2010: Human population studies with the exfoliated buccal micronucleus assay: statistical and epidemiological issues. Mutation Research 705(1): 11-19
Crawford, M.H. 1977: Human population study. Science 196(4286): 153-155
Eichner, M.; Ferrari, V. 2012: Human pose co-estimation and applications. IEEE Transactions on Pattern Analysis and Machine Intelligence 34(11): 2282-2288
Lin, J.Feng-Shun.; Kulić, D. 2013: Human pose recovery for rehabilitation using ambulatory sensors. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013: 4799-4802
Lin, J.F.S.; Kulić, D. 2012: Human pose recovery using wireless inertial measurement units. Physiological Measurement 33(12): 2099-2115
Lee, M.W.; Nevatia, R. 2009: Human pose tracking in monocular sequence using multilevel structured models. IEEE Transactions on Pattern Analysis and Machine Intelligence 31(1): 27-38
Chen, L.; Du, C.; Wang, L.; Yang, C.; Zhang, J.-r.; Li, N.; Li, Y.; Xie, X.-D.; Gao, G.-d. 2014: Human positive coactivator 4 (PC4) is involved in the progression and prognosis of astrocytoma. Journal of the Neurological Sciences 346(1-2): 293-298
Das, C.; Gadad, S.S.; Kundu, T.K. 2010: Human positive coactivator 4 controls heterochromatinization and silencing of neural gene expression by interacting with REST/NRSF and CoREST. Journal of Molecular Biology 397(1): 1-12
Bernier, P-Michel.; Grafton, S.T. 2010: Human posterior parietal cortex flexibly determines reference frames for reaching based on sensory context. Neuron 68(4): 776-788
Lindner, A.; Iyer, A.; Kagan, I.; Andersen, R.A. 2010: Human posterior parietal cortex plans where to reach and what to avoid. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(35): 11715-11725
Shah, S.N.; Eckert, K.A. 2009: Human postmeiotic segregation 2 exhibits biased repair at tetranucleotide microsatellite sequences. Cancer Research 69(3): 1143-1149
Sin, H.-S.; Ichijima, Y.; Koh, E.; Namiki, M.; Namekawa, S.H. 2012: Human postmeiotic sex chromatin and its impact on sex chromosome evolution. Genome Research 22(5): 827-836
Laszczyńska, M.; Brodowska, A.; Starczewski, A.; Masiuk, M.; Brodowski, J. 2008: Human postmenopausal ovary--hormonally inactive fibrous connective tissue or more?. Histology and Histopathology 23(2): 219-226
Lemons, J.; Brott, B.; Eberhardt, A. 2010: Human postmortem device retrieval and analysis--orthopaedic, cardiovascular, and dental systems. Journal of Long-Term Effects of Medical Implants 20(1): 81-85
Ramaswami, M.; Gautam, M.; Kamb, A.; Rudy, B.; Tanouye, M.A.; Mathew, M.K. 1990: Human potassium channel genes: Molecular cloning and functional expression. Molecular and Cellular Neurosciences 1(3): 214-223
Anbazhagan, K.; Rabbind Singh, A.; Isabelle, P.; Stella, I.; Céline, A.-D.M.; Bissac, E.; Bertrand, B.; Rémy, N.; Naomi, T.; Vincent, F.; Rochette, J.; Lassoued, K.ïs. 2013: Human pre-B cell receptor signal transduction: evidence for distinct roles of PI3kinase and MAP-kinase signalling pathways. Immunity Inflammation and Disease 1(1): 26-36
Niakan, K.K.; Han, J.; Pedersen, R.A.; Simon, C.; Pera, R.A.R. 2012: Human pre-implantation embryo development. Development 139(5): 829-841
Zimmermann, M.; Armeanu, S.; Smirnow, I.; Kupka, S.; Wagner, S.; Wehrmann, M.; Rots, M.G.; Groothuis, G.M.M.; Weiss, T.S.; Königsrainer, A.; Gregor, M.; Bitzer, M.; Lauer, U.M. 2009: Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses. International Journal of Oncology 34(5): 1247-1256
Darimont, C.T.; Carlson, S.M.; Kinnison, M.T.; Paquet, P.C.; Reimchen, T.E.; Wilmers, C.C. 2009: Human predators outpace other agents of trait change in the wild. Proceedings of the National Academy of Sciences of the United States of America 106(3): 952-954
van Schaik, P.; Kusev, P.; Juliusson, A. 2011: Human preferences and risky choices. Frontiers in Psychology 2: 333
Trapp, S.; Shenhav, A.; Bitzer, S.; Bar, M. 2015: Human preferences are biased towards associative information. Cognition and Emotion 29(6): 1054-1068
Scott, I.M.; Clark, A.P.; Josephson, S.C.; Boyette, A.H.; Cuthill, I.C.; Fried, R.L.; Gibson, M.A.; Hewlett, B.S.; Jamieson, M.; Jankowiak, W.; Honey, P.Lynne.; Huang, Z.; Liebert, M.A.; Purzycki, B.G.; Shaver, J.H.; Snodgrass, J.Josh.; Sosis, R.; Sugiyama, L.S.; Swami, V.; Yu, D.W.; Zhao, Y.; Penton-Voak, I.S. 2014: Human preferences for sexually dimorphic faces may be evolutionarily novel. Proceedings of the National Academy of Sciences of the United States of America 111(40): 14388-14393
Evans, D.W.; Orr, P.T.; Lazar, S.M.; Breton, D.; Gerard, J.; Ledbetter, D.H.; Janosco, K.; Dotts, J.; Batchelder, H. 2012: Human preferences for symmetry: subjective experience, cognitive conflict and cortical brain activity. Plos one 7(6): E38966
Sörgjerd, K.Margareta.; Zako, T.; Sakono, M.; Stirling, P.C.; Leroux, M.R.; Saito, T.; Nilsson, P.; Sekimoto, M.; Saido, T.C.; Maeda, M. 2013: Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates. Biochemistry 52(20): 3532-3542
Teffer, K.; Semendeferi, K. 2012: Human prefrontal cortex: evolution, development, and pathology. Progress in Brain Research 195: 191-218
Shah, M.; Nunes, M.R.; Stearns, V. 2018: CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer?. Oncology 32(5): 216-222
Hönger, G.; Cardinal, H.; Dieudé, M.él.; Buser, A.; Hösli, I.; Dragun, D.; Hébert, M.-J.ée.; Schaub, S. 2014: Human pregnancy and generation of anti-angiotensin receptor and anti-perlecan antibodies. Transplant International: Official Journal of the European Society for Organ Transplantation 27(5): 467-474
Pérez-López, F.R.; Blackwell, S.C.; Funai, E.F.; Jiang, S.-W.; Keirse, M.J.N.C.; Voto, L.S. 2010: Human pregnancy and parturition clinical management. Obstetrics and Gynecology International 2010: 915875
Krackow, S. 1998: Human pregnancy filtering: yesterday's news?. Trends in Ecology and Evolution 13(4): 156
Ha, C.T.; Wu, J.A.; Irmak, S.; Lisboa, F.A.; Dizon, A.M.; Warren, J.W.; Ergun, S.; Dveksler, G.S. 2010: Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis. Biology of Reproduction 83(1): 27-35
Zhao, J.; Lei, Z.; Liu, Y.; Li, B.; Zhang, L.; Fang, H.; Song, C.; Wang, X.; Zhang, G.-M.; Feng, Z.-H.; Huang, B. 2009: Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. Journal of Immunology 182(10): 6618-6624
Valdés S, G. 2011: Human pregnancy, a biological paradigm of tolerance and adaptation. Revista Medica de Chile 139(3): 400-405
Duniec-Dmuchowski, Z.; Fang, H.-L.; Strom, S.C.; Ellis, E.; Runge-Morris, M.; Kocarek, T.A. 2009: Human pregnane X receptor activation and CYP3A4/CYP2B6 induction by 2,3-oxidosqualene:lanosterol cyclase inhibition. Drug Metabolism and Disposition: the Biological Fate of Chemicals 37(4): 900-908
Lau, A.Jiang.; Yang, G.; Rajaraman, G.; Baucom, C.C.; Chang, T.K.H. 2010: Human pregnane X receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides. Journal of Pharmacology and Experimental Therapeutics 335(3): 771-780
Conde, I.; Lobo, M.ía.V.T.; Zamora, J.; Pérez, J.; González, F.J.; Alba, E.; Fraile, B.; Paniagua, R.; Arenas, M.ía.I. 2008: Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. Bmc Cancer 8: 174
Xu, Y.; Zhang, Y.; Zhou, F.; Zheng, Y.; Zhu, X. 2011: Human pregnane X receptor-mediated transcriptional regulation of CYP3A4 by extracts of 7 traditional Chinese medicines. Zhongguo Zhong Yao Za Zhi 36(11): 1524-1527
Rathod, V.; Jain, S.; Nandekar, P.; Sangamwar, A.T. 2014: Human pregnane X receptor: a novel target for anticancer drug development. Drug Discovery Today 19(1): 63-70
Barnicot, N.A. 1949: Human prehistory. Science Progress 37(147): 543-551
Trigger, B.G. 1983: Human prehistory legitimated. Science 220(4599): 834-835
Rowley-Conwy, P. 2009: Human prehistory: Hunting for the earliest farmers. Current Biology: Cb 19(20): R948-R949
Summers, M.C.; Bird, S.; Mirzai, F.M.; Thornhill, A.; Biggers, J.D. 2013: Human preimplantation embryo development in vitro: a morphological assessment of sibling zygotes cultured in a single medium or in sequential media. Human Fertility 16(4): 278-285
Kornysheva, K.; Diedrichsen, J.ör. 2014: Human premotor areas parse sequences into their spatial and temporal features. Elife 3: E03043
Hussain, S.; Ram, M.S.; Kumar, A.; Shivaji, S.; Umapathy, G. 2013: Human presence increases parasitic load in endangered lion-tailed macaques (Macaca silenus) in its fragmented rainforest habitats in Southern India. Plos one 8(5): E63685
Liu, F.; Qi, H. 2010: Human preterm amnion cells cultured in three-dimensional collagen i matrix. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(2): 384-388
Meijer, K.; de Vries, M.; Al-Lahham, S.; Bruinenberg, M.; Weening, D.ée.; Dijkstra, M.; Kloosterhuis, N.; van der Leij, R.J.; van der Want, H.; Kroesen, B.-J.; Vonk, R.; Rezaee, F. 2011: Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. Plos one 6(3): E17154
Karlsen, T.A.; Shahdadfar, A.; Brinchmann, J.E. 2011: Human primary articular chondrocytes, chondroblasts-like cells, and dedifferentiated chondrocytes: differences in gene, microRNA, and protein expression and phenotype. Tissue Engineering. Part C Methods 17(2): 219-227
Da Costa, S.; van der Zwaag, W.; Marques, J.P.; Frackowiak, R.S.J.; Clarke, S.; Saenz, M. 2011: Human primary auditory cortex follows the shape of Heschl's gyrus. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 31(40): 14067-14075
Ekstrand-Hammarström, B.; Akfur, C.M.; Andersson, P.Ola.; Lejon, C.; Osterlund, L.; Bucht, A. 2012: Human primary bronchial epithelial cells respond differently to titanium dioxide nanoparticles than the lung epithelial cell lines A549 and BEAS-2B. Nanotoxicology 6(6): 623-634
Bérubé, K.; Prytherch, Z.ë; Job, C.; Hughes, T. 2010: Human primary bronchial lung cell constructs: the new respiratory models. Toxicology 278(3): 311-318
Diercke, K.; König, A.; Kohl, A.; Lux, C.J.; Erber, R. 2012: Human primary cementoblasts respond to combined IL-1β stimulation and compression with an impaired BSP and CEMP-1 expression. European Journal of Cell Biology 91(5): 402-412
Nakamura, A.; Ueno, T.; Yagi, Y.; Okuda, K.; Ogata, T.; Nakamura, T.; Torimura, T.; Iwamoto, H.; Ramadoss, S.; Sata, M.; Tsutsumi, V.; Yasuda, K.; Tomiyasu, Y.; Obayashi, K.; Tashiro, K.; Kuhara, S. 2010: Human primary cultured hepatic stellate cells can be cryopreserved. Medical Molecular Morphology 43(2): 107-115
Zahn, S.; Kirschsiefen, P.; Jonuleit, H.; Steinbrink, K.; Von Stebut, E. 2010: Human primary dendritic cell subsets differ in their IL-12 release in response to Leishmania major infection. Experimental Dermatology 19(10): 924-926
Wong, T.; Yeung, J.; Hildebrand, K.J.; Junker, A.K.; Turvey, S.E. 2013: Human primary immunodeficiencies causing defects in innate immunity. Current Opinion in Allergy and Clinical Immunology 13(6): 607-613
Zeitvogel, J.; Dalpke, A.; Eiz-Vesper, B.; Kracht, M.; Dittrich-Breiholz, O.; Werfel, T.; Wittmann, M. 2012: Human primary keratinocytes show restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 protein compared with autologous macrophages. Journal of Biological Chemistry 287(13): 9923-9930
Ray, B.; Chopra, N.; Long, J.M.; Lahiri, D.K. 2014: Human primary mixed brain cultures: preparation, differentiation, characterization and application to neuroscience research. Molecular Brain 7: 63
Hari, R.; Bourguignon, M.; Piitulainen, H.; Smeds, E.; De Tiège, X.; Jousmäki, V. 2014: Human primary motor cortex is both activated and stabilized during observation of other person's phasic motor actions. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 369(1644): 20130171
Boukhechba, F.; Balaguer, T.; Michiels, J.-F.ço.; Ackermann, K.; Quincey, D.; Bouler, J.-M.; Pyerin, W.; Carle, G.F.; Rochet, N. 2009: Human primary osteocyte differentiation in a 3D culture system. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 24(11): 1927-1935
Hallum, L.E.; Landy, M.S.; Heeger, D.J. 2011: Human primary visual cortex (V1) is selective for second-order spatial frequency. Journal of Neurophysiology 105(5): 2121-2131
Cho, K.H.; Rodríguez-Vázquez, J.F.; Han, E.H.; Verdugo-López, S.; Murakami, G.; Cho, B.H. 2010: Human primitive meninges in and around the mesencephalic flexure and particularly their topographical relation to cranial nerves. Annals of Anatomy 192(5): 322-328
Kee, K.; Flores, M.; Cedars, M.I.; Reijo Pera, R.A. 2010: Human primordial germ cell formation is diminished by exposure to environmental toxicants acting through the AHR signaling pathway. Toxicological Sciences: An Official Journal of the Society of Toxicology 117(1): 218-224
Teng, Y.; Chen, B.; Tao, M. 2009: Human primordial germ cell-derived progenitors give rise to neurons and glia in vivo. Biochemical and Biophysical Research Communications 390(3): 463-468
Møllgård, K.; Jespersen, A.; Lutterodt, M.C.; Yding Andersen, C.; Høyer, P.E.; Byskov, A.G. 2010: Human primordial germ cells migrate along nerve fibers and Schwann cells from the dorsal hind gut mesentery to the gonadal ridge. Molecular Human Reproduction 16(9): 621-631
Ye, J.; Han, J.; Shi, Q.; Zhang, B.-Y.; Wang, G.-R.; Tian, C.; Gao, C.; Chen, J.-M.; Li, C.-J.; Liu, Z.; Li, X.-Z.; Zhang, L.-Z.; Dong, X.-P. 2008: Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series. Journal of Medical Case Reports 2: 331
Bradford, B.M.; Piccardo, P.; Ironside, J.W.; Mabbott, N.A. 2014: Human prion diseases and the risk of their transmission during anatomical dissection. Clinical Anatomy 27(6): 821-832
Jansen, C.; Parchi, P.; Capellari, S.; Ibrahim-Verbaas, C.A.; Schuur, M.; Strammiello, R.; Corrado, P.; Bishop, M.T.; van Gool, W.A.; Verbeek, M.M.; Baas, F.; van Saane, W.; Spliet, W.G.M.; Jansen, G.H.; van Duijn, C.M.; Rozemuller, A.J.M. 2012: Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. PloS one 7(4): e36333
Holman, R.C.; Belay, E.D.; Christensen, K.Y.; Maddox, R.A.; Minino, A.M.; Folkema, A.M.; Haberling, D.L.; Hammett, T.A.; Kochanek, K.D.; Sejvar, J.J.; Schonberger, L.B. 2010: Human prion diseases in the United States. Plos one 5(1): E8521
Sikorska, B.; Liberski, P.P. 2012: Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease. Sub-Cellular Biochemistry 65: 457-496
Head, M.W. 2013: Human prion diseases: molecular, cellular and population biology. Neuropathology: Official Journal of the Japanese Society of Neuropathology 33(3): 221-236
Zerr, I. 2013: Human prion diseases: progress in clinical trials. Brain: a Journal of Neurology 136(Part 4): 996-997
Kovács, Gábor.Géza.; Bakos, A.; Mitrova, E.; Minárovits, János.; László, L.; Majtényi, K. 2007: Human prion diseases: the Hungarian experience. Ideggyogyaszati Szemle 60(11-12): 447-452
Hizume, M.; Kobayashi, A.; Teruya, K.; Ohashi, H.; Ironside, J.W.; Mohri, S.; Kitamoto, T. 2009: Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. Journal of Biological Chemistry 284(6): 3603-3609
Xu, K.; Wang, X.; Shi, Q.; Chen, C.; Tian, C.; Li, X.-L.; Zhou, R.-M.; Chu, Y.-L.; Dong, X.-P. 2011: Human prion protein mutants with deleted and inserted octarepeats undergo different pathways to trigger cell apoptosis. Journal of Molecular Neuroscience: Mn 43(3): 225-234
Giles, K.; Glidden, D.V.; Patel, S.; Korth, C.; Groth, D.; Lemus, A.; DeArmond, S.J.; Prusiner, S.B. 2010: Human prion strain selection in transgenic mice. Annals of Neurology 68(2): 151-161
Exley, C.; House, E.; Patel, T.; Wu, L.; Fraser, P.E. 2010: Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro. Journal of Inorganic Biochemistry 104(10): 1125-1129
Awong, G.én.èv.; Singh, J.; Mohtashami, M.; Malm, M.; La Motte-Mohs, R.N.; Benveniste, P.M.; Serra, P.; Herer, E.; van den Brink, M.R.; Zúñiga-Pflücker, J.C. 2013: Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. Blood 122(26): 4210-4219
Moreira, L.A.; Saig, E.; Turley, A.P.; Ribeiro, J.é M.C.; O'Neill, S.L.; McGraw, E.A. 2009: Human probing behavior of Aedes aegypti when infected with a life-shortening strain of Wolbachia. Plos Neglected Tropical Diseases 3(12): E568
Hatch, T.F. 1949: Human problems in industrial machine design. Journal of Industrial Hygiene and Toxicology 31(4): 201-203
Bronk, D.W. 1946: Human problems in military aviation. Annual Report of the Board of Regents of the Smithsonian Institution. Smithsonian Institution. Board of Regents 1946: 401-411
Heymann, M.C.; Winkler, S.; Luksch, H.; Flecks, S.; Franke, M.; Ruß, S.; Ozen, S.; Yilmaz, E.; Klein, C.; Kallinich, T.; Lindemann, D.; Brenner, S.; Ganser, G.; Roesler, J.; Rösen-Wolff, A.; Hofmann, S.R. 2014: Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signaling. Journal of Immunology 192(9): 4379-4385
Nahum, L.; Gabriel, D.; Schnider, A. 2011: Human processing of behaviorally relevant and irrelevant absence of expected rewards: a high-resolution ERP study. Plos one 6(1): E16173
Kawalec, M.ł; Sitkowska, A.; Sobota, M.ł; Sieroń, A.L.; Komar, P.; Kurcok, P. 2014: Human procollagen type i surface-modified PHB-based non-woven textile scaffolds for cell growth: preparation and short-term biological tests. Biomedical Materials 9(6): 065005
Classen, H.G. 1961: Human procreation in civilized society. Eugenics Review 52(4): 251
Ramalho-Santos, Jão. 2011: Human procreation in unchartered territory: new twists in ethical discussions. Human Reproduction 26(6): 1284-1287
Lee, K.-W.; Johnson, N.R.; Gao, J.; Wang, Y. 2013: Human progenitor cell recruitment via SDF-1α coacervate-laden PGS vascular grafts. Biomaterials 34(38): 9877-9885
Bayes-Genis, A.; Soler-Botija, C.; Farré, J.; Sepúlveda, P.; Raya, A.; Roura, S.; Prat-Vidal, C.; Gálvez-Montón, C.; Montero, J.é A.; Büscher, D.; Izpisúa Belmonte, J.C. 2010: Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. Journal of Molecular and Cellular Cardiology 49(5): 771-780
Hess, D.A.; Bonde, J.; Craft, T.P.; Craft, T.C.; Wirthlin, L.; Hohm, S.; Lahey, R.; Todt, L.M.; Dipersio, J.F.; Devine, S.M.; Nolta, J.A. 2007: Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 13(4): 398-411
Zhou, P.; Hohm, S.; Olusanya, Y.; Hess, D.A.; Nolta, J. 2009: Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model. Hepatology 49(6): 1992-2000
Thebaud, N.él.B.; Bareille, R.; Remy, M.; Bourget, C.; Daculsi, R.; Bordenave, L. 2010: Human progenitor-derived endothelial cells vs. venous endothelial cells for vascular tissue engineering: an in vitro study. Journal of Tissue Engineering and Regenerative Medicine 4(6): 473-484
Cifarelli, V.; Luppi, P.; Tse, H.M.; He, J.; Piganelli, J.; Trucco, M. 2008: Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis 201(2): 248-257
Zhou, J.; Guo, S.-Y.; Zhang, Y.; Li, C.-Q. 2014: Human prokinetic drugs promote gastrointestinal motility in zebrafish. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 26(4): 589-595
Adamson, A.D.; Friedrichsen, S.; Semprini, S.; Harper, C.V.; Mullins, J.J.; White, M.R.H.; Davis, J.R.E. 2008: Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling. Endocrinology 149(2): 687-694
Lupi, A.; Tenni, R.; Rossi, A.; Cetta, G.; Forlino, A. 2008: Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. Amino Acids 35(4): 739-752
Karbanová, J.; Laco, J.; Marzesco, A.-M.; Janich, P.; Voborníková, M.; Mokrý, J.; Fargeas, C.A.; Huttner, W.B.; Corbeil, D. 2014: Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form. Plos one 9(6): E98927
Hernández, A.; Villegas, A.; Anguita, E. 2010: Human promoter mutations unveil Oct-1 and GATA-1 opposite action on Gfi1b regulation. Annals of Hematology 89(8): 759-765
Pérez, O.; Batista-Duharte, A.; González, E.; Zayas, C.; Balboa, J.; Cuello, M.; Cabrera, O.; Lastre, M.; Schijns, V.E.J.C. 2012: Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations. Brazilian Journal of Medical and Biological Research 45(8): 681-692
Fletcher, R. 1883: Human proportion. Science 2(37): 539-540
Davis, J.R.; Horslen, B.C.; Nishikawa, K.; Fukushima, K.; Chua, R.; Inglis, J.T.; Carpenter, M.G. 2011: Human proprioceptive adaptations during states of height-induced fear and anxiety. Journal of Neurophysiology 106(6): 3082-3090
Ian McCloskey, D. 1994: Human proprioceptive sensation. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 1(3): 173-177
Morales, R.; Watier, Y.; Böcskei, Z. 2012: Human prorenin structure sheds light on a novel mechanism of its autoinhibition and on its non-proteolytic activation by the (pro)renin receptor. Journal of Molecular Biology 421(1): 100-111
Ross, M.; Lanyon, L.J.; Viswanathan, J.; Manoach, D.S.; Barton, J.J.S. 2011: Human prosaccades and antisaccades under risk: effects of penalties and rewards on visual selection and the value of actions. Neuroscience 196: 168-177
Ramkissoon, A.; Wells, P.G. 2011: Human prostaglandin H synthase (hPHS)-1 and hPHS-2 in amphetamine analog bioactivation, DNA oxidation, and cytotoxicity. Toxicological Sciences: An Official Journal of the Society of Toxicology 120(1): 154-162
Ramkissoon, A.; Wells, P.G. 2011: Human prostaglandin H synthase (hPHS)-1- and hPHS-2-dependent bioactivation, oxidative macromolecular damage, and cytotoxicity of dopamine, its precursor, and its metabolites. Free Radical Biology and Medicine 50(2): 295-304
Ronquist, K.G.ör.; Ronquist, G.; Carlsson, L.; Larsson, A. 2009: Human prostasomes contain chromosomal DNA. Prostate 69(7): 737-743
Tarazona, R.; Delgado, E.; Guarnizo, M.C.; Roncero, R.G.; Morgado, S.; Sánchez-Correa, B.; Gordillo, J.J.; Dejulián, J.; Casado, J.G. 2011: Human prostasomes express CD48 and interfere with NK cell function. Immunobiology 216(1-2): 41-46